[go: up one dir, main page]

WO2025105223A1 - Film-forming agent for application and kit including said forming agent - Google Patents

Film-forming agent for application and kit including said forming agent Download PDF

Info

Publication number
WO2025105223A1
WO2025105223A1 PCT/JP2024/039102 JP2024039102W WO2025105223A1 WO 2025105223 A1 WO2025105223 A1 WO 2025105223A1 JP 2024039102 W JP2024039102 W JP 2024039102W WO 2025105223 A1 WO2025105223 A1 WO 2025105223A1
Authority
WO
WIPO (PCT)
Prior art keywords
agent
less
unsaturated organopolysiloxane
group
mass
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
PCT/JP2024/039102
Other languages
French (fr)
Japanese (ja)
Inventor
慧 氏本
めぐみ 廣石
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiseido Co Ltd
Original Assignee
Shiseido Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiseido Co Ltd filed Critical Shiseido Co Ltd
Publication of WO2025105223A1 publication Critical patent/WO2025105223A1/en
Pending legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/895Polysiloxanes containing silicon bound to unsaturated aliphatic groups, e.g. vinyl dimethicone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09DCOATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
    • C09D183/00Coating compositions based on macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon, with or without sulfur, nitrogen, oxygen, or carbon only; Coating compositions based on derivatives of such polymers
    • C09D183/04Polysiloxanes

Definitions

  • the present disclosure relates to a coating-type film-forming agent and a kit containing the agent.
  • Patent document 1 discloses a composition for in situ formation of a layer on the skin surface of a subject, the composition comprising one or more crosslinkable polymers, and an artificial skin comprising a layer formed from the composition.
  • the subject of this disclosure is therefore to provide a coating-type film-forming agent that contains an oil-soluble UV absorber and is capable of forming a film that exhibits excellent UV protection performance.
  • a coating-type film-forming agent comprising a first agent containing a crosslinkable reactive component that constitutes a coating, and a second agent containing a catalyst that crosslinks the crosslinkable reactive component, the first agent and/or the second agent contains an unsaturated organopolysiloxane having a phenyl group and a vinyl group, and the first agent and/or the second agent containing the unsaturated organopolysiloxane having a phenyl group and a vinyl group contains an oil-soluble ultraviolet absorber, In the unsaturated organopolysiloxane having a phenyl group and a vinyl group, the molar ratio of the phenyl group to the molar ratio of the vinyl group is 0.40 or less.
  • the first agent comprises at least one selected from the group consisting of a first unsaturated organopolysiloxane and a first hydride-functionalized polysiloxane;
  • the second agent contains the second hydride-functionalized polysiloxane;
  • the second agent contains the second unsaturated organopolysiloxane;
  • the oil-soluble UV absorber comprises an UV absorber having an IOB of 0.10 or more.
  • the first agent comprises the unsaturated organopolysiloxane having a phenyl group and a vinyl group, and the oil-soluble ultraviolet absorber.
  • ⁇ Aspect 5> The forming agent according to any one of aspects 1 to 4, wherein the unsaturated organopolysiloxane having a phenyl group and a vinyl group has a molar ratio of the phenyl group to the molar number of the vinyl group of 0.0040 or more.
  • Aspect 6 Aspect 6. The forming agent according to any one of aspects 1 to 5, wherein the weight average molecular weight of the unsaturated organopolysiloxane having a phenyl group and a vinyl group is 100,000 or less.
  • Aspect 7 A forming agent according to any one of Aspects 1 to 6, wherein the first agent containing the unsaturated organopolysiloxane having a phenyl group and a vinyl group and/or the second agent contains a silicone oil.
  • Aspect 8> A forming agent according to any one of Aspects 1 to 7, wherein the first agent and/or the second agent containing the unsaturated organopolysiloxane having a phenyl group and a vinyl group contains inorganic particles.
  • ⁇ Aspect 9> The forming agent according to any one of aspects 1 to 8, wherein the unsaturated organopolysiloxane having a phenyl group and a vinyl group is at least one selected from the group consisting of vinyl-terminated diphenylsiloxane-dimethylsiloxane copolymer, vinyl-terminated polyphenylmethylsiloxane, and vinylphenylmethyl-terminated vinylphenylsiloxane-phenylmethylsiloxane copolymer.
  • Aspect 10 A forming agent according to any one of aspects 2 to 9, wherein the first hydride-functionalized polysiloxane and the second hydride-functionalized polysiloxane are non-terminally and/or terminally hydrogenated organopolysiloxanes. ⁇ Aspect 11> 11.
  • first hydride-functionalized polysiloxane and the second hydride-functionalized polysiloxane are at least one selected from the group consisting of hydride-terminated polydimethylsiloxane, hydride-terminated polyphenyl-(dimethylhydrosiloxy)siloxane, hydride-terminated methylhydrosiloxane-phenylmethylsiloxane copolymer, trimethylsiloxy-terminated methylhydrosiloxane-dimethylsiloxane copolymer, polymethylhydrosiloxane, trimethylsiloxy-terminated polyethylhydrosiloxane, triethylsiloxane, methylhydrosiloxane-phenyloctylmethylsiloxane copolymer, and methylhydrosiloxane-phenyloctylmethylsiloxane terpolymer.
  • a coating-type film-forming agent that contains an oil-soluble UV absorber and is capable of forming a film that exhibits excellent UV protection performance.
  • the applied film-forming agent of the present disclosure includes a first agent containing a crosslinkable reactive component that constitutes a film, and a second agent containing a catalyst that crosslinks the crosslinkable reactive component, the first agent and/or the second agent containing an unsaturated organopolysiloxane having a phenyl group and a vinyl group, and the first agent and/or the second agent containing the unsaturated organopolysiloxane having a phenyl group and a vinyl group contains an oil-soluble ultraviolet absorber, and the unsaturated organopolysiloxane having a phenyl group and a vinyl group has a ratio of the number of moles of phenyl groups to the number of moles of vinyl groups of 0.40 or less.
  • the principle of action of the applied film-forming agent disclosed herein is believed to be as follows, which allows the agent to contain an oil-soluble UV absorber and form a film that exhibits excellent UV protection performance.
  • the paint-type film-forming agent described in Patent Document 1 typically contains unsaturated organopolysiloxanes, which are also considered to be oils. Therefore, it was expected that if an oil-soluble UV absorber was used when an ultraviolet absorber was used, the resulting film would exhibit good ultraviolet protection performance. However, it was found that even if an oil-soluble UV absorber was used, the resulting film may not exhibit good ultraviolet protection performance.
  • the inventors have unexpectedly discovered that when an unsaturated organopolysiloxane containing a phenyl group and a vinyl group, in which the phenyl group is contained in a specific ratio, is used as the unsaturated organopolysiloxane, and when an oil-soluble ultraviolet absorber is used, the resulting film exhibits excellent ultraviolet protection performance.
  • the oil-soluble UV absorber does not bleed out from the film and is therefore believed to be present in the film.
  • the oil-soluble UV absorber has poor compatibility and is not uniformly dispersed in the film, but exists locally as one body, and it is believed that this is why UV protection performance is not fully demonstrated.
  • the oil-soluble UV absorber becomes more easily mixed due to the influence of the specific proportion of phenyl groups, and as a result, the oil-soluble UV absorber becomes uniformly dispersed in the film, which is believed to improve UV protection performance.
  • Conventional sunscreen cosmetics have had the problem that, for example, when applied to the skin, the cosmetics peel off due to sweat or rubbing.
  • the applied-type film-forming agent of the present disclosure can be applied to the skin, for example, to cause crosslinking to form a film, and the resulting crosslinked film has superior resistance to peeling due to rubbing, etc., compared to films obtained by applying conventional sunscreen cosmetics to the skin. Therefore, it is believed that the applied-type film-forming agent of the present disclosure, which can exhibit good UV protection performance, can also contribute to solving the problem of peeling that conventional sunscreen cosmetics have.
  • the film formed by the applied film-forming agent of the present disclosure has a crosslinked structure, and therefore has superior film strength compared to films that do not have a crosslinked structure.
  • this film has the advantage that it can be easily peeled off from the skin, for example.
  • a “body correction coating” refers to a coating that is intended to provide a coating that, when applied to a subject's skin, has the appearance of natural skin.
  • “natural skin appearance” means that when applied to the skin, the body correction coating will provide performance similar to or identical to at least one of the appearance, feel, and texture of actual skin, e.g., the treated skin may provide physical properties (e.g., elasticity and firmness) of actual (e.g., current) skin.
  • body correction means to mask, conceal or cover a body or skin imperfection of a subject to visually and/or tactilely improve the body or skin imperfection, but does not include methods of surgery, treatment or diagnosis of a human.
  • body imperfection can mean, for example, such part of the subject's body that the subject perceives as a blemish or blemish, or that a person skilled in the art, e.g., a dermatologist, esthetician or plastic surgeon, would consider to be a blemish or blemish.
  • Body imperfection includes skin imperfections and loose soft tissues of the body (e.g., loose or sagging skin, looseness of breasts, buttocks, abdomen, chin, neck, etc.), and the like. Also, “skin imperfection” includes those items of the subject's skin that the subject perceives as a blemish or blemish.
  • nevus flammeus or nevus flameus e.g., hemangioma simplex or midline nevus flammeus
  • melasma wrinkles, age spots
  • acne moles
  • scars tattoos
  • birthmarks skin deformities
  • birthmarks sun damage
  • aging uneven skin tone, loose skin, rough skin, hyperpigmentation, enlarged pores, telangiectasias, redness, shine, cellulite, stretch marks, or reduced skin elasticity.
  • viscosity refers to a measure of the resistance of a fluid to being deformed by either shear or tensile stress.
  • the viscosity of the first and second parts of a paint-on film former affects the thickness, spreadability, and uniformity and/or uniformity of the layer formed on a substrate.
  • Viscosity can be reported as either dynamic viscosity (also known as absolute viscosity, typical units are Pa ⁇ s, poise, P, cP) or kinematic viscosity (typical units are cm 2 /s, stokes, St, cst), which is the dynamic viscosity divided by the density of the measured fluid.
  • the viscosity ranges of the components disclosed herein are generally provided by the suppliers of each component in units of kinematic viscosity (e.g., cst) measured using a rheometer or a Cannon-Fenske tube viscometer, although the viscosity of a fluid can also be measured using, for example, a rheometer (e.g., a linear shear rheometer or a dynamic shear rheometer) or a viscometer (a viscometric meter, also called a capillary viscometer or a rotational viscometer).
  • a rheometer e.g., a linear shear rheometer or a dynamic shear rheometer
  • a viscometer a viscometric meter, also called a capillary viscometer or a rotational viscometer.
  • crosslinking also includes the concept commonly referred to as “curing.”
  • target area refers to the area (e.g., skin) to which it is desired to impart UV protection performance.
  • the apply-type film-forming agent (which may be simply referred to as a "former") of the present disclosure comprises a first agent containing a crosslinkable reactive component that constitutes a film, and a second agent containing a catalyst that crosslinks this crosslinkable reactive component, wherein the first agent and/or the second agent contains an unsaturated organopolysiloxane having a phenyl group and a vinyl group, and the first agent and/or the second agent containing the unsaturated organopolysiloxane having a phenyl group and a vinyl group contains an oil-soluble ultraviolet absorber, and further wherein the unsaturated organopolysiloxane having a phenyl group and a vinyl group has a ratio of the number of moles of phenyl groups to the number of moles of vinyl groups of 0.40 or less.
  • the film obtained by the applied-type film-forming agent of the present disclosure may be a body-correcting film having a body-correcting function, or may be a film without a body-correcting function.
  • the film obtained by the applied-type film-forming agent of the present disclosure can improve the strength (e.g., toughness) of the film, and as a result, can also improve the body-correcting function. Therefore, the applied-type film-forming agent of the present disclosure can be suitably used as an applied-type body-correcting film-forming agent.
  • the paint-type film-forming agent of the present disclosure includes a first agent that includes a crosslinking reactive component that forms a film.
  • the first agent may contain the above-mentioned unsaturated organopolysiloxane having a phenyl group and a vinyl group, which contains a specific ratio of phenyl groups (sometimes simply referred to as "unsaturated organopolysiloxane having a phenyl group and a vinyl group"). Since the first agent contains a crosslinking reactive component that constitutes the film and can form the final film, if the first agent contains an oil-soluble UV absorber together with the unsaturated organopolysiloxane having a phenyl group and a vinyl group, the UV protection performance of the resulting film can be further improved.
  • the molar number of phenyl groups relative to the molar number of vinyl groups is preferably 0.37 or less, 0.35 or less, 0.33 or less, 0.30 or less, 0.27 or less, 0.25 or less, or 0.23 or less, from the viewpoints of the strength of the resulting coating, compatibility with the oil-soluble ultraviolet absorber, and ultraviolet protection performance, and is also preferably 0.0040 or more, 0.0045 or more, 0.0050 or more, 0.0070 or more, 0.010 or more, more than 0.010, 0.011 or more, 0.012 or more, 0.013 or more, or 0.014 or more.
  • the molar numbers of vinyl groups and phenyl groups in the unsaturated organopolysiloxane can be measured by a relative quantitative method using 1 H-NMR (nuclear magnetic resonance).
  • the unsaturated organopolysiloxane having phenyl groups and vinyl groups preferably has a weight average molecular weight of 100,000 or less, 80,000 or less, 60,000 or less, 50,000 or less, or 40,000 or less, more preferably 30,000 or less, 29,000 or less, 28,000 or less, or 27,000 or less, and more preferably 5,000 or more, 6,000 or more, 7,000 or more, or 8,000 or more, and more preferably 9,000 or more, 9,300 or more, or 9,500 or more.
  • the "weight average molecular weight” in this disclosure refers to the weight average molecular weight in terms of polystyrene in gel permeation chromatography measurement.
  • the unsaturated organopolysiloxane having phenyl groups and vinyl groups can have a viscosity of 100 to 200,000 cst at 25°C.
  • the lower limit of the viscosity can be 200 cst or more, 300 cst or more, 400 cst or more, or 500 cst or more.
  • the upper limit of the viscosity can be 150,000 cst or less, 100,000 cst or less, 80,000 cst or less, or 60,000 cst or less.
  • the unsaturated organopolysiloxane having a phenyl group and a vinyl group is not particularly limited, and may be, for example, at least one selected from the group consisting of vinyl-terminated diphenylsiloxane-dimethylsiloxane copolymer, vinyl-terminated polyphenylmethylsiloxane, and vinylphenylmethyl-terminated vinylphenylsiloxane-phenylmethylsiloxane copolymer.
  • the unsaturated organopolysiloxane having a phenyl group and a vinyl group contains a vinyl-terminated diphenylsiloxane-dimethylsiloxane copolymer.
  • the first agent of the present disclosure contains at least one selected from the group consisting of a first unsaturated organopolysiloxane and a first hydride-functionalized polysiloxane as such a crosslinking reactive component.
  • the second agent in the forming agent of the present disclosure contains a second hydride-functionalized polysiloxane
  • the first agent contains only the first hydride-functionalized polysiloxane among the first unsaturated organopolysiloxane and the first hydride-functionalized polysiloxane
  • it is preferable that the second agent contains a second unsaturated organopolysiloxane.
  • the first agent contains both the first unsaturated organopolysiloxane and the first hydride-functionalized polysiloxane. At least one of the first unsaturated organopolysiloxane and the second unsaturated organopolysiloxane contains the above-mentioned unsaturated organopolysiloxane having a phenyl group and a vinyl group.
  • the dosage form of the first agent is not particularly limited, and may be, for example, a single-phase system composed of an oil phase, a non-emulsified oil-in-water or water-in-oil two-phase system, or a two-phase system composed of an oil-in-water emulsion composition or a water-in-oil emulsion composition.
  • a single-phase system composed of an oil phase is typically an anhydrous form.
  • “anhydrous” not only means that the composition does not contain water, but also means that the water content is low, i.e., 10% by mass or less, 5% by mass or less, 2% by mass or less, 1% by mass or less, 0.1% by mass or less, or 0.01% by mass or less.
  • a non-emulsified two-phase system may include a water-in-oil composition in which water droplets are forcibly dispersed in a dispersion medium containing oil by shaking a liquid in a state in which the water and oil are separated, or an oil-in-water composition in which oil droplets are forcibly dispersed in a dispersion medium containing water.
  • Each of these formulations can be prepared appropriately by conventional methods using a crosslinking reactive component and, optionally, known materials such as oils, emulsifiers, and water, as described below.
  • the first agent is applied to the target site (e.g., skin) by painting, etc., and therefore, from the viewpoint of application performance, it preferably has a glass transition temperature below body temperature.
  • the glass transition temperature can be 37°C or lower, 25°C or lower, 10°C or lower, or 0°C or lower.
  • There is no particular restriction on the lower limit of the glass transition temperature but it can be, for example, -30°C or higher, -20°C or higher, or -10°C or higher.
  • glass transition temperature refers to the temperature at which a transition from a solid state to a liquid state occurs, and can be measured, for example, using a differential scanning calorimeter (DSC) in accordance with ASTM D3418-03.
  • DSC differential scanning calorimeter
  • the first unsaturated organopolysiloxane may be an organopolysiloxane having an unsaturated portion, for example, one or more organopolysiloxanes having at least two carbon-carbon double bonds or at least one carbon-carbon triple bond in the molecule.
  • Such unsaturated organopolysiloxanes are preferably one or more organopolysiloxanes having at least two alkenyl functional groups (e.g., vinyl functional groups) on average and having a viscosity of 1,00 to 2,000,000 cst at 25°C.
  • the "unsaturated portion” in the present disclosure means a portion having a "carbon-carbon double bond” and a “carbon-carbon triple bond", which may be simply referred to as a "double bond” and a “triple bond".
  • the first unsaturated organopolysiloxane may be used alone or in combination of two or more kinds.
  • Such organopolysiloxanes may contain unsaturation (double or triple bond moieties) in the terminal units of the polymer, in the non-terminal monomer units of the polymer, or in a combination thereof.
  • the double bond-containing monomer units in the first unsaturated organopolysiloxane may be separated on average by 40 monomer units or more, 200 monomer units or more, 400 monomer units or more, 1,000 monomer units or more, or 2,000 monomer units or more.
  • the content of unsaturated moieties in the first unsaturated organopolysiloxane, particularly the other unsaturated organopolysiloxane can be 0.001 mmol/g or more, 0.005 mmol/g or more, 0.010 mmol/g or more, 0.050 mmol/g or more, or 0.10 mmol/g or more, and can be 5.0 mmol/g or less, 3.0 mmol/g or less, 1.0 mmol/g or less, 0.50 mmol/g or less, 0.40 mmol/g or less, 0.30 mmol/g or less, 0.25 mmol/g or less, 0.20 mmol/g or less, or 0.15 mmol/g or less.
  • the approximate molar amount of unsaturated moieties in such organopolysiloxanes can be calculated based on the average molecular weight of the organopolysiloxane.
  • the first unsaturated organopolysiloxane can have a viscosity of 500 to 2,000,000 cst at 25° C.
  • the lower limit of the viscosity can be 700 cst or more, 1,000 cst or more, 3,000 cst or more, 5,000 cst or more, 10,000 cst or more, 20,000 cst or more, 40,000 cst or more, 60,000 cst or more, 80,000 cst or more, 100,000 cst or more, 125,000 cst or more, or 150,000 cst or more.
  • the upper limit of the viscosity can be 1,000,000 cst or less, 500,000 cst or less, 450,000 cst or less, 400,000 cst or less, 350,000 cst or less, 300,000 cst or less, 250,000 cst or less, 200,000 cst or less, 180,000 cst or less, 170,000 cst or less, or 165,000 cst or less.
  • the first unsaturated organopolysiloxane can have an average molecular weight of 30,000 Da to 500,000 Da.
  • the lower limit of such average molecular weight is preferably 35,000 Da or more, 40,000 Da or more, 50,000 Da or more, 60,000 Da or more, 72,000 Da or more, 84,000 Da or more, 96,000 Da or more, or 100,000 Da or more, and more preferably 140,000 Da or more or 150,000 Da or more.
  • the upper limit of the average molecular weight is preferably 200,000 Da or less, 190,000 Da or less, 180,000 Da or less, or 170,000 Da or less, more preferably 160,000 Da or less, and even more preferably 155,000 Da or less.
  • the average molecular weight in this disclosure can be determined by gel permeation chromatography (GPC).
  • the first unsaturated organopolysiloxane for example, at least one unsaturated organopolysiloxane selected from the group consisting of the above-mentioned unsaturated organopolysiloxanes having phenyl groups and vinyl groups, and other unsaturated organopolysiloxanes, can be used.
  • unsaturated organopolysiloxanes that can be used as the first unsaturated organopolysiloxane include, for example, at least one unsaturated organopolysiloxane selected from the group consisting of organopolysiloxanes having vinyl groups, vinyl-terminated organopolysiloxanes, and organopolysiloxanes having vinylated branched chains.
  • unsaturated organopolysiloxanes include vinyl-terminated polydimethylsiloxane, vinyl-terminated trifluoropropylmethylsiloxane-dimethylsiloxane copolymer, vinyl-terminated diethylsiloxane-dimethylsiloxane copolymer, vinylmethylsiloxane-dimethylsiloxane copolymer, trimethylsiloxy-terminated vinylmethylsiloxane-dimethylsiloxane copolymer, silanol-terminated vinylmethylsiloxane-dimethylsiloxane copolymer, vinylmethylsiloxane homopolymer, vinyl T-structure polymer, vinyl Q-structure polymer, monovinyl-terminated polydimethylsiloxane, vinylmethylsiloxane terpolymer, and vinylmethoxysilane homopolymer.
  • the first unsaturated organopolysiloxane can be used alone or in combination of two or more kinds. Among them, vinyl-terminated polydimethylsiloxane is preferred, and vinyl dimethicone (divinyl dimethicone) is more preferred.
  • end refers to either one end or both ends. When distinguishing between these, they can be written as, for example, “vinyl one-terminated” and “vinyl both-terminated”.
  • the amount of unsaturated organopolysiloxane in the first agent can be 5.0% by mass or more, 10% by mass or more, 20% by mass or more, 25% by mass or more, 30% by mass or more, 35% by mass or more, or 40% by mass or more, and can be 90% by mass or less, 85% by mass or less, 80% by mass or less, 75% by mass or less, 70% by mass or less, 65% by mass or less, 60% by mass or less, 55% by mass or less, 50% by mass or less, 45% by mass or less, or 40% by mass or less, based on the entire first agent.
  • the amount of the unsaturated organopolysiloxane having a phenyl group and a vinyl group can be 40% by mass or more, 50% by mass or more, 60% by mass or more, 70% by mass or more, 80% by mass or more, or 90% by mass or more relative to the total amount of the unsaturated organopolysiloxane, and can be 100% by mass or less or less than 100% by mass, from the standpoint of compatibility with the oil-soluble ultraviolet absorber and ultraviolet protection performance, etc.
  • the first hydride-functionalized polysiloxane is not particularly limited, and may be a polysiloxane having a hydride-functionalized moiety, such as a compound represented by the following formula 1.
  • the first hydride-functionalized polysiloxane may be used alone or in combination of two or more kinds:
  • R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b , R 9b and R 10b are each independently selected from hydrogen, C 1-20 alkyl, C 2-20 alkenyl, C 5-10 aryl, hydroxyl, or C 1-20 alkoxy, and m and n are each independently an integer from 10 to 6,000, provided that at least one of R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b , R 9b and R 10b is hydrogen.
  • At least one of R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b , R 9b and R 10b is hydrogen, and the remainder are C 1-20 alkyl.
  • R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b , R 9b and R 10b are hydrogen (e.g., two Si—H units per functionalized hydridopolysiloxane molecule).
  • R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b , R 9b and R 10b are hydrogen (e.g., three Si—H units per functionalized hydridopolysiloxane molecule).
  • R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b , R 9b and R 10b are hydrogen (e.g., two Si—H units per functionalized hydridopolysiloxane molecule), and the remainder are C 1-20 alkyl.
  • R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b , R 9b and R 10b are hydrogen (e.g., three Si—H units per functionalized hydridopolysiloxane molecule), and the remainder are C 1-20 alkyl.
  • At least two of R 4b , R 5b , R 9b and R 10b are hydrogen (eg, two Si—H units per functionalized hydridopolysiloxane molecule), and the remainder are C 1-20 alkyl.
  • R 4b , R 5b , R 9b and R 10b are hydrogen (eg, three Si—H units per functionalized hydridopolysiloxane molecule), and the remainder are C 1-20 alkyl.
  • the sum of m and n is an integer between 10 and 1,300, between 10 and 1,100, between 10 and 600, between 15 and 500, between 15 and 400, between 20 and 300, between 20 and 200, between 25 and 100, between 25 and 75, between 30 and 50, or between 40 and 45.
  • the first hydride-functionalized polysiloxane can be a non-terminally and/or terminally hydrogenated organopolysiloxane, which is composed of one or more organopolysiloxanes having at least two Si-H units in the molecule, and preferably one or more organopolysiloxanes having an average of at least two Si-H units and a viscosity of 2 to 100,000 cst at 25°C.
  • the organopolysiloxane having Si—H units may contain such Si—H units in a terminal unit of the polymer, in a non-terminal monomer unit of the polymer, or in a combination thereof. Of these, it is preferred that the Si—H units are contained in a non-terminal monomer unit of the polymer.
  • the first hydride-functionalized polysiloxane may be alkyl-terminated. For example, in formula 1, one or both of R 2b and R 7b may be a C 1-20 alkyl.
  • one, two, three, four, five or six of R 1b , R 2b , R 3b , R 6b , R 7b and R 8b may be C 1-20 alkyl.
  • R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b and R 10b are each C 1-20 alkyl, for example C 1 alkyl (for example methyl), and R 9b may be hydrogen.
  • R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b and R 9b are each C 1-20 alkyl, for example C 1 alkyl (for example methyl), and R 10b may be hydrogen.
  • the Si-H containing monomer units in the organopolysiloxane may be spaced apart, on average, by 1 monomer unit or more, 2 monomer units or more, 5 monomer units or more, 10 monomer units or more, 20 monomer units or more, 40 monomer units or more, 200 monomer units or more, 400 monomer units or more, 1,000 monomer units or more, or 2,000 monomer units or more.
  • the Si-H content of the organopolysiloxane having Si-H units can be 0.10 mmol/g or more, 0.50 mmol/g or more, 1.0 mmol/g or more, 2.0 mmol/g or more, 3.0 mmol/g or more, or 4.0 mmol/g or more, and can be 20 mmol/g or less, 10 mmol/g or less, 9.0 mmol/g or less, 8.0 mmol/g or less, 7.0 mmol/g or less, 6.0 mmol/g or less, or 5.0 mmol/g or less.
  • the approximate molar amount of Si-H units in the organopolysiloxane can be calculated based on the average molecular weight of the organopolysiloxane.
  • the first hydride-functionalized polysiloxane can have a viscosity of 2 to 500,000 cst at 25° C.
  • the lower limit of the viscosity is preferably 3 cst or more, 4 cst or more, 5 cst or more, 10 cst or more, 12 cst or more, 15 cst or more, 20 cst or more, 25 cst or more, or 30 cst or more, and more preferably 40 cst or more.
  • the upper limit of the viscosity is preferably 200,000 cst or less, 100,000 cst or less, 50,000 cst or less, 20,000 cst or less, 10,000 cst or less, 5,000 cst or less, 2,000 cst or less, or 1,000 cst or less, and more preferably 500 cst or less.
  • the viscosity of the hydride-functionalized polysiloxane is particularly preferably in the range of 45 to 100 cst or 45 to 50 cst at 25°C.
  • the hydride-functionalized polysiloxane can have an average molecular weight of 400 to 500,000 Da.
  • the lower limit of the average molecular weight is preferably 500 Da or more, 800 Da or more, 900 Da or more, 1,000 Da or more, 1,200 Da or more, 1,400 Da or more, 1,600 Da or more, 1,800 Da or more, 2,000 Da or more, or 2,200 Da or more, and more preferably 2,300 Da or more.
  • the upper limit of the average molecular weight is preferably 250,000 Da or less, 140,000 Da or less, 100,000 Da or less, 72,000 Da or less, 62,700 Da or less, 60,000 Da or less, 50,000 Da or less, 49,500 Da or less, 36,000 Da or less, 28,000 Da or less, 25,000 Da or less, 20,000 Da or less, 15,000 Da or less, 10,000 Da or less, 5,000 Da or less, or 4,000 Da or less, and more preferably 2,500 Da or less.
  • the first hydride-functionalized polysiloxane may be, but is not limited to, at least one selected from the group consisting of hydride-terminated polydimethylsiloxane, hydride-terminated polyphenyl-(dimethylhydrosiloxy)siloxane, hydride-terminated methylhydrosiloxane-phenylmethylsiloxane copolymer, trimethylsiloxy-terminated methylhydrosiloxane-dimethylsiloxane copolymer, polymethylhydrosiloxane, trimethylsiloxy-terminated polyethylhydrosiloxane, triethylsiloxane, methylhydrosiloxane-phenyloctylmethylsiloxane copolymer, and methylhydrosiloxane-phenyloctylmethylsiloxane terpolymer.
  • hydride-terminated polydimethylsiloxane is
  • the amount of the first hydride-functionalized polysiloxane in the first agent can be, for example, 1.0% by mass or more, 2.0% by mass or more, 3.0% by mass or more, 4.0% by mass or more, or 4.5% by mass or more relative to the entire first agent, and can be 50% by mass or less, 40% by mass or less, 30% by mass or less, 20% by mass or less, 15% by mass or less, 10% by mass or less, 8.0% by mass or less, or 5.0% by mass or less.
  • the second agent constituting the paint-on type film-forming agent of the present disclosure contains a catalyst that crosslinks the crosslinking reactive component in the first agent described above.
  • the second agent of the present disclosure may also contain the unsaturated organopolysiloxane having a phenyl group and a vinyl group described above.
  • the catalyst is not particularly limited, and may be, for example, any substance capable of causing, promoting, or initiating a physical and/or chemical crosslinking reaction of the unsaturated organopolysiloxane and hydride-functionalized polysiloxane, which are crosslinking reactive components constituting the coating.
  • the catalyst may or may not undergo permanent physical and/or chemical changes during or at the end of the process.
  • the catalyst may be, but is not limited to, a metal catalyst capable of initiating and/or promoting crosslinking at or below body temperature, such as Group VIII metal catalysts, for example, platinum catalysts, rhodium catalysts, palladium catalysts, cobalt catalysts, nickel catalysts, ruthenium catalysts, osmium catalysts, and iridium catalysts, and Group IVA metal catalysts, for example, germanium catalysts and tin catalysts. Of these, platinum catalysts, rhodium catalysts, and tin catalysts are preferred.
  • the catalysts may be used alone or in combination of two or more.
  • Platinum catalysts include, for example, platinum carbonylcyclovinylmethylsiloxane complexes, platinum divinyltetramethyldisiloxane complexes, platinum cyclovinylmethylsiloxane complexes, platinum octanaldehyde/octanol complexes, and other Pt(0) catalysts, such as Karstedt's catalyst, platinum-alcohol complexes, platinum-alkoxide complexes, platinum-ether complexes, platinum-aldehyde complexes, platinum-ketone complexes, platinum-halogen complexes, platinum-sulfur complexes, platinum-nitrogen complexes, platinum-phosphorus complexes, platinum-phosphorus complexes, platinum-carbon double bond complexes, platinum-carbon triple bond complexes, platinum-imido complexes, platinum-amide complexes, platinum-ester complexes, platinum-phosphate ester complexes, platinum-thiol ester complexes, platinum lone
  • At least one selected from the group consisting of platinum carbonylcyclovinylmethylsiloxane complex, platinum divinyltetramethyldisiloxane complex, platinum cyclovinylmethylsiloxane complex, and platinum octanaldehyde/octanol complex is preferred.
  • Rhodium catalysts include, for example, tris(dibutylsulfide)rhodium trichloride and rhodium trichloride hydrate.
  • tin catalysts include tin(II) octanoate, tin(II) neodecanoate, dibutyltin diisooctylmaleate, di-n-butyl bis(2,4-pentanedionate)tin, di-n-butylbutoxychlorotin, dibutyltin dilaurate, dimethyltin dineodecanoate, dimethylhydroxy(oleate)tin, and tin(II) oleate.
  • the amount of catalyst in the second agent is not particularly limited and may be adjusted as appropriate according to the required film performance, etc.
  • the amount of catalyst may be 0.001 mass% or more, 0.005 mass% or more, or 0.010 mass% or more, and 5.0 mass% or less, 3.0 mass% or less, 1.0 mass% or less, 0.10 mass% or less, or 0.050 mass% or less, relative to the total amount of the second agent.
  • the formulation of the second agent of the present disclosure is not particularly limited, and may be, for example, a single-phase system composed of an oil phase in an anhydrous form, a non-emulsified oil-in-water or water-in-oil two-phase system, or a two-phase system composed of an oil-in-water emulsion composition or a water-in-oil emulsion composition.
  • Each of these formulations can be prepared appropriately by conventional methods using a catalyst and, optionally, known materials such as oil, emulsifier, and water, as described below.
  • Silicone oil can be used as the oil, and the first unsaturated organopolysiloxane and the first hydride-functionalized polysiloxane that can be used in the first agent described above may be used as this silicone oil.
  • the unsaturated organopolysiloxane and the hydride-functionalized polysiloxane in the second agent can be called the second unsaturated organopolysiloxane and the second hydride-functionalized polysiloxane to distinguish them from the first unsaturated organopolysiloxane and the first hydride-functionalized polysiloxane in the first agent.
  • the second unsaturated organopolysiloxane can have a viscosity of 50 to 165,000 cst at 25°C.
  • the upper limit of the viscosity is preferably 150,000 cst or less, 100,000 cst or less, 80,000 cst or less, 50,000 cst or less, 30,000 cst or less, or 10,000 cst or less, and more preferably 5,000 cst or less, 2,000 cst or less, or 1,000 cst or less, and most preferably 500 cst or less.
  • the lower limit of the viscosity is preferably 70 cst or more, 100 cst or more, 130 cst or more, or 150 cst or more.
  • At least the first agent and/or the second agent containing an unsaturated organopolysiloxane having a phenyl group and a vinyl group contains an oil-soluble ultraviolet absorber.
  • the oil-soluble ultraviolet absorber may not be blended with the agent that does not contain such an unsaturated organopolysiloxane, or may be blended with the agent.
  • the oil-soluble ultraviolet absorber may be contained in at least one of the first agent and the second agent. Therefore, in the present disclosure, "the first agent and the second agent containing the unsaturated organopolysiloxane having a phenyl group and a vinyl group contain an oil-soluble ultraviolet absorber" means that the oil-soluble ultraviolet absorber is contained in at least one of the first agent and the second agent.
  • the oil-soluble ultraviolet absorber can be used alone or in combination of two or more.
  • the term "oil-soluble" refers to the ability to dissolve in the oil in the first agent and/or the second agent in which the ultraviolet absorbent is blended.
  • UV absorbers with an IOB of 0.10 or more are preferred from the viewpoints of compatibility with unsaturated organopolysiloxanes having phenyl and vinyl groups, and UV protection performance.
  • the IOB value of such UV absorbers can be, for example, 0.10 or more, 0.11 or more, 0.12 or more, or 0.13 or more, and can be 0.50 or less, 0.45 or less, or 0.40 or less.
  • the IOB value is an abbreviation for Inorganic/Organic Balance, which is a value that represents the ratio of the inorganic value to the organic value, and is an index that indicates the degree of polarity of an organic compound.
  • IOB value inorganic value / organic value.
  • an "organic value” of 20 for one carbon atom in a molecule and an “inorganic value” of 100 for one hydroxyl group are set according to the type of atom or functional group, and the IOB value of an organic compound can be calculated by accumulating the "inorganic value” and “organic value” of all atoms and functional groups in the organic compound (see, for example, Koda Yoshio, "Organic Conceptual Diagram - Basics and Applications", pp. 11-17, Sankyo Publishing, 1984).
  • UV absorbers with an IOB of 0.10 or more include organic UV absorbers such as ethylhexyl methoxycinnamate, octocrylene, polysilicone-15, t-butyl methoxydibenzoylmethane, ethylhexyl triazone, bisethylhexyloxyphenol methoxyphenyl triazine, diethylamino hydroxybenzoyl hexyl benzoate, oxybenzone-3, methylene bisbenzotriazolyl tetramethylbutylphenol, homosalate, ethylhexyl salicylate (sometimes called "octyl salicylate”), cresyl methoxycinnamate, drometrizole trisiloxane, and phenylene bis-diphenyl triazine.
  • organic UV absorbers such as ethylhexyl methoxycinnamate, octocry
  • At least one selected from the group consisting of octocrylene, t-butyl methoxydibenzoylmethane, homosalate, and ethylhexyl salicylate is preferred from the standpoint of compatibility with unsaturated organopolysiloxanes having phenyl and vinyl groups, and UV protection performance.
  • the amount of oil-soluble UV absorber blended can be, for example, 1.0% by mass or more, 3.0% by mass or more, 5.0% by mass or more, 7.0% by mass or more, 10% by mass or more, 13% by mass or more, 15% by mass or more, 17% by mass or more, or 20% by mass or more relative to the entire first or second agent, and can be 40% by mass or less, 37% by mass or less, 35% by mass or less, 33% by mass or less, 30% by mass or less, or 25% by mass or less.
  • various components can be appropriately blended with the first agent and/or the second agent within a range that does not adversely affect the effects of the present disclosure.
  • These optional components can also be blended with the first agent and/or the second agent containing the unsaturated organopolysiloxane having a phenyl group and a vinyl group.
  • the optional components can be used alone or in combination of two or more.
  • the optional components are not particularly limited, but examples include feel modifiers, adhesion modifiers, spreadability promoters, diluents, adhesion modifiers, oils, emulsifiers (surfactants), inorganic particles, organic particles, water, humectants, preservatives, coloring materials (e.g., pigments, dyes, colorants), pearling agents, matting agents, beads, cloth, rubber materials (e.g., rubber sheets made of silicone rubber, etc.), components that thicken the water or oil phase (thickeners), protective colloids, skin permeation promoters, optical modifiers, scattering agents, adsorbents, magnetic materials, gas transport modifiers, liquid transport modifiers, pH modifiers, sensitization modifiers, and aesthetic modifiers.
  • feel modifiers e.g., feel modifiers, adhesion modifiers, spreadability promoters, diluents, adhesion modifiers, oils, emulsifiers (surfactants), inorganic particles, organic particles, water,
  • the skin care products include cosmetic agents such as moisturizers, skin protectants, skin soothing agents, skin whitening agents, skin brighteners, skin softeners, skin smoothing agents, skin bleaching agents, skin exfoliants, skin tightening agents, beauty agents, vitamins, antioxidants, cell signaling agents, cell regulating agents, cell interacting agents, skin tanning agents, anti-aging agents, anti-wrinkle agents, spot reducers, alpha-hydroxy acids, beta-hydroxy acids, and ceramides; and other cosmetic agents such as pain relievers, analgesics, anti-pruritic agents, anti-acne agents (e.g., beta-hydroxy acids, salicylic acid, benzoyl peroxide), anti-inflammatory agents, anti Included may be therapeutic agents such as histamines, corticosteroids, NSAIDs (nonsteroidal anti-inflammatory drugs), antiseptics, antibiotics, antibacterials, antifungals, antivirals, antiallergy agents, anti-irritants, insect repellents, phototherapy
  • oils and fats examples include liquid oils and fats, solid oils and fats, waxes, hydrocarbon oils, ester oils, silicone oils, and polar oils other than the above-mentioned oil-soluble UV absorbers.
  • the oil may be a non-volatile oil or a volatile oil.
  • the oil may be used alone or in combination of two or more.
  • volatile refers to an oil that exhibits a volatile content of more than 5% when left at atmospheric pressure and 105°C for 3 hours.
  • Such a volatile content can be specified as 10% or more, 20% or more, 40% or more, 50% or more, 60% or more, 80% or more, or 100%.
  • the boiling point at 1 atmosphere (101.325 kPa) can be used as an indicator of volatility.
  • non-volatile refers to a material that exhibits a volatile content of 5% or less when left at 105°C for 3 hours.
  • silicone oils other than the above-mentioned unsaturated organopolysiloxanes and hydride-functionalized polysiloxanes can be used as the silicone oil.
  • silicone oils that can be used include linear silicones such as dimethylpolysiloxane (dimethicone), methylphenylpolysiloxane, and methylhydrogenpolysiloxane; and cyclic silicones such as diphenylsiloxyphenyltrimethicone, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, and dodecamethylcyclohexasiloxane.
  • Silicone oils are easily compatible with unsaturated organopolysiloxanes having phenyl and vinyl groups, and can therefore be suitably blended with the first agent and/or the second agent that contains unsaturated organopolysiloxanes having phenyl and vinyl groups.
  • the amount of oil (e.g., silicone oil) to be blended is not particularly limited, and can be blended appropriately depending on, for example, the type of formulation used, the required film strength, etc.
  • the amount of oil (e.g., silicone oil) to be blended can be, for example, 5.0% by mass or more, 7.0% by mass or more, 10% by mass or more, 15% by mass or more, 20% by mass or more, 23% by mass or more, 25% by mass or more, 27% by mass or more, or 30% by mass or more relative to the entire first or second agent, and can be 60% by mass or less, 57% by mass or less, 55% by mass or less, 50% by mass or less, 45% by mass or less, 40% by mass or less, 35% by mass or less, 30% by mass or less, 25% by mass or less, or 20% by mass or less.
  • At least one of the first agent and the second agent in the coating-type film-forming agent of the present disclosure may contain inorganic particles.
  • inorganic particles when inorganic particles are blended with the first agent and/or the second agent containing the unsaturated organopolysiloxane having a phenyl group and a vinyl group and the oil-soluble ultraviolet absorber, the ultraviolet protection performance can be further improved.
  • the inorganic particles can be used alone or in combination of two or more kinds.
  • the inorganic particles are preferably inorganic oxide particles.
  • the inorganic particles only hydrophobically treated particles (hydrophobic inorganic particles) or only untreated particles (e.g., hydrophilic inorganic particles) may be used, or hydrophobically treated particles (hydrophobic inorganic particles) and untreated particles (e.g., hydrophilic inorganic particles) may be used in combination.
  • inorganic oxides constituting the inorganic oxide particles include zinc oxide, titanium oxide, aluminum oxide, and silicon oxide (e.g., fumed silica and anhydrous silica).
  • silicon oxide e.g., fumed silica and anhydrous silica.
  • at least one selected from the group consisting of silicon oxide, titanium oxide, and zinc oxide is preferred, and silicon oxide is more preferred.
  • the hydrophobic inorganic particles can typically be inorganic particles that have been hydrophobized with a surface treatment agent.
  • a surface treatment agent There are no particular limitations on the hydrophobization treatment, and examples of the treatment include at least one selected from the group consisting of silylation treatment, dimethylsilylation treatment, and trimethylsilylation treatment.
  • the amount of inorganic particles can be, for example, 0.1% by mass or more, 0.5% by mass or more, 1.0% by mass or more, 2.0% by mass or more, 3.0% by mass or more, 4.0% by mass or more, 4.5% by mass or more, or 5.0% by mass or more relative to the entire first or second agent, and can be 20% by mass or less, 15% by mass or less, 10% by mass or less, 7.0% by mass or less, or 5.0% by mass or less, from the viewpoint of further improving the UV protection performance.
  • emulsifier for example, anionic, cationic, amphoteric, or nonionic emulsifiers can be used.
  • the emulsifiers can be used alone or in combination of two or more.
  • the emulsifier in the present disclosure refers to an agent having an emulsifying function (surface activity), and can also include agents generally called surfactants.
  • emulsifier examples include at least one selected from the group consisting of hydrocarbon surfactants, silicone surfactants, and amphiphilic powders.
  • hydrocarbon surfactants include polyoxyethylene alkyl ethers, polyoxyethylene steryl ethers, polyoxyethylene fatty acid esters, polyoxyethylene polyhydric alcohol fatty acid esters, polyoxyethylene hydrogenated castor oil, polyoxyethylene sorbitan fatty acid esters, glycol fatty acid esters, glycerin fatty acid esters, sorbitan fatty acid esters, sucrose fatty acid esters, and polyglycerin fatty acid esters.
  • silicone surfactants include polyether-modified silicone and alkyl-co-modified polyether-modified silicone.
  • the amount of emulsifier used can be 0.01% by mass or more, 0.05% by mass or more, 0.1% by mass or more, or 0.2% by mass or more relative to the total amount of the first or second agent.
  • the upper limit of the amount of emulsifier used can be, for example, 5.0% by mass or less, 4.0% by mass or less, 3.0% by mass or less, 2.0% by mass or less, 1.0% by mass or less, or 0.5% by mass or less.
  • the water is not particularly limited, and for example, water used in cosmetics or quasi-drugs can be used, such as ion-exchanged water, distilled water, ultrapure water, and tap water.
  • the method of using the applied-type film-forming agent of the present disclosure is not particularly limited, and may include, for example, any of the following steps.
  • makeup can be applied to the face, and therefore the method can also be called a makeup method.
  • the method of using the applied-type film-forming agent of the present disclosure does not include methods for surgery, treatment, or diagnosis of humans: Applying the first agent to the target site to form a first agent layer, and then applying the second agent onto the first agent layer to form a coating, or The second agent is applied to the target area to form a second agent layer, and then the first agent is applied onto the second agent layer to form a film; or, the first agent and the second agent are mixed to prepare a mixture, and then the mixture is applied to the target area to form a film.
  • the preferred method of use is to apply the first agent to the target area to form a first agent layer, and then apply the second agent onto this first agent layer and crosslink it to form a coating.
  • the materials described above can be used for the first agent and the second agent in the same way.
  • This method may be performed once, or may be performed multiple times (e.g., two or more times, or three or more times) on the formed coating.
  • the method may include, for example, any of the following operations: Applying a first agent to the formed coating to form a first agent layer, and then applying a second agent onto the first agent layer to further form a coating; or An operation of applying a second agent to the formed coating to form a second agent layer, and then applying a first agent onto the second agent layer to further form a coating; or an operation of mixing the first agent and the second agent to prepare a mixture, and then applying the mixture to the formed coating to further form a coating.
  • a cosmetic may be applied to the target site before applying the first agent, the second agent, or a mixture containing the first agent and the second agent to the target site; a first agent may be applied to the target site to form a first agent layer, a cosmetic may be applied onto the first agent layer, and the second agent may then be applied to cover the cosmetic; a second agent may be applied to the target site to form a second agent layer, a cosmetic may be applied onto the second agent layer, and the first agent may then be applied to cover the cosmetic; or a film may be formed, and then a cosmetic may be applied to the film.
  • cosmetics there are no particular limitations on the cosmetics, and examples of the cosmetics that can be used include skin care cosmetics such as serums, lotions, and emulsions, sunscreen cosmetics (sun protection cosmetics), base cosmetics, or make-up cosmetics such as foundations, glosses, lipsticks, eye shadows, and nail polishes, or cosmetics that combine the functions of two or more of these cosmetics.
  • skin care cosmetics such as serums, lotions, and emulsions
  • sunscreen cosmetics unsun protection cosmetics
  • base cosmetics or make-up cosmetics such as foundations, glosses, lipsticks, eye shadows, and nail polishes, or cosmetics that combine the functions of two or more of these cosmetics.
  • make-up cosmetics such as foundations, glosses, lipsticks, eye shadows, and nail polishes, or cosmetics that combine the functions of two or more of these cosmetics.
  • the method of using the applied film-forming agent of the present disclosure can also be used as a cosmetic method.
  • a cosmetic method For example, when skin is exposed to dryness, moisture is unknowingly lost, and the stratum corneum on the skin surface may not be able to maintain its moisture content. When the skin does not have enough moisture, it is no longer able to effectively produce the moisturizing components (Natural Moisturizing Factors (NMFs)) that it produces itself. As a result, the barrier function and moisturizing function of the skin surface are reduced, making the skin more susceptible to damage, which is thought to cause a loss of moisture and lead to rough skin, etc.
  • NMFs Natural Moisturizing Factors
  • a film made from the applied film-forming agent of the present disclosure when a film made from the applied film-forming agent of the present disclosure is applied to the skin, it is possible to protect the skin from harmful ultraviolet rays, and the occlusion effect of the film (the effect of preventing moisture from escaping from the skin) allows the skin to be well moisturized.
  • the skin's own production function of moisturizing ingredients is improved, and turnover problems in the stratum corneum are also improved, making skin problems such as roughness less likely to occur, and improving the beauty effect.
  • a "beauty method” refers to applying the applied film-forming agent of the present disclosure to a target site to form a film and improve the condition of the target site (for example, skin), and is different from a method of surgery, treatment, or diagnosis of humans.
  • the method for applying the first or second agent to the target area, the cosmetic application layer, or the first or second agent layer there are no particular limitations on the method for applying the first or second agent to the target area, the cosmetic application layer, or the first or second agent layer, and for example, methods such as spreading with fingers, spray application, transfer, etc. can be used.
  • the first agent and/or the second agent are separated into water and oil
  • the applied film-forming agent of the present disclosure can be applied to any part of the body, for example, the surface of the skin.
  • the applied film-forming agent of the present disclosure can be appropriately applied to, for example, the head (e.g., scalp, etc.), face (e.g., lips, eyes, nose, cheeks, forehead, etc.), neck, ears, hands, arms, legs, feet, chest, abdomen, back, buttocks, nails, body hair (e.g., hair, eyelashes, eyebrows, beard, etc.), etc.
  • the paint-type film-forming agent of the present disclosure can be provided as a kit having the above-mentioned first and second agents constituting the agent.
  • the kit may have optional components such as a component for facilitating application of the first agent, etc. to a target site, the various cosmetics described above, or the kit may be used in combination with optional components.
  • Optional components include, for example, an instruction manual, a spatula-shaped applicator, a brush, a cotton swab, a cutter, scissors, the various cosmetics mentioned above, a remover for removing the formed film from the target area, a mirror, etc.
  • "instructions for use” can include not only general instructions for use that are attached in the form of a document within the kit, but also instructions for use printed on, for example, the packaging container that contains the kit, or the packaging container such as a tube for injecting the first agent, etc.
  • the kit may include, for example, the first and second agents packaged in separate containers or in separate compartments of a container having two or more compartments to prevent contact between the first and second agents.
  • the packaged agents may be configured to be applied one at a time or to be mixed together before or during use.
  • the kit can be used in combination with a remover for removing the formed film from the target site.
  • “use in combination” includes using the kit and remover as an integrated unit, i.e., including the remover in the kit, or using the kit and remover separately.
  • a kit including a coat-type film-forming agent in combination with a separate remover, since it is possible to provide an optimal coat-type film-forming agent and remover for each individual.
  • the film formed on the target site by the applied film-forming agent of the present disclosure can be suitably removed from the target site by using the specific remover shown below.
  • the specific remover of the present disclosure When the specific remover of the present disclosure is used, the strength of the film is not reduced, so the film can be peeled off from the target site in one go without breaking.
  • a conventional sunscreen cosmetic is applied to the skin and then removed from the skin, it is necessary to wash it off with a detergent or the like.
  • the film formed by the applied film-forming agent of the present disclosure does not require such a procedure, and the film exhibiting ultraviolet protection performance can be peeled off from the target site (e.g., skin) more easily.
  • a suitable remover used to remove a film formed by the applied film-forming agent of the present disclosure contains at least one selected from the group consisting of a hydrocarbon oil having a weight-average molecular weight of 300 or more and 800 or less, and a polar oil having a weight-average molecular weight of 260 or more and 400 or less. From the viewpoint of effectively removing the film, it is preferable to use such a hydrocarbon oil and a polar oil in combination.
  • the weight average molecular weight of the hydrocarbon oil is preferably 320 or more, or 350 or more, and more preferably 380 or more, and is preferably 750 or less, or 700 or less, and more preferably 690 or less.
  • the hydrocarbon oils can be used alone or in combination of two or more kinds.
  • hydrocarbon oil is not particularly limited, and examples include liquid paraffin (mineral oil), olefin oligomers and their hydrogenated products (e.g., hydrogenated polydecene), and squalane.
  • the amount of hydrocarbon oil is not particularly limited, and from the viewpoint of effectively removing the film, it can be, for example, 1.0 mass% or more, 5.0 mass% or more, 10 mass% or more, 20 mass% or more, or 30 mass% or more relative to the total amount of the composition constituting the remover. There is no particular upper limit to the amount, and it can be, for example, 100 mass% or less, less than 100 mass%, 80 mass% or less, 70 mass% or less, 60 mass% or less, or 50 mass% or less.
  • the weight average molecular weight of the polar oil is preferably 265 or more or 270 or more, and preferably 390 or less, 380 or less, or 370 or less.
  • the IOB value of the polar oil is preferably 0.12 or more or 0.13 or more, and preferably 1.48 or less, 1.47 or less, or 1.46 or less.
  • the polar oils may be used alone or in combination of two or more kinds.
  • the amount of polar oil blended can be 1.0 mass% or more, 5.0 mass% or more, 10 mass% or more, 15 mass% or more, or 20 mass% or more relative to the total amount of the composition constituting the remover.
  • the upper limit of the blended amount can be, for example, 100 mass% or less, less than 100 mass%, 80 mass% or less, 70 mass% or less, 60 mass% or less, or 50 mass% or less.
  • the remover of the present disclosure can be appropriately blended with various components within a range that does not adversely affect the film removal effect.
  • various components include surfactants (emulsifiers), moisturizers, thickeners, water-soluble polymers, oil-soluble polymers, film-forming agents, higher fatty acids, sequestering agents, lower alcohols, higher alcohols, polyhydric alcohols, denatured alcohols, various extracts, sugars, amino acids, organic amines, polymer emulsions, chelating agents, UV absorbers, pH adjusters, skin nutrients, vitamins, water-soluble drugs applicable to medicines, quasi-drugs, cosmetics, etc., buffers, color-fading inhibitors, antioxidants, preservatives, dispersants, propellants, fillers, pigments, dyes, colorings, fragrances, water, and other oils other than those mentioned above.
  • Optional components can be used alone or in combination of two or more.
  • the remover of the present disclosure may contain oils other than the above-mentioned hydrocarbon oils and polar oils.
  • silicone oils may reduce the strength of the film, and as a result, may reduce the film removal performance. Therefore, from the viewpoint of effectively removing the film, the amount of silicone oil is preferably 10 mass % or less, 5.0 mass % or less, 1.0 mass % or less, 0.5 mass % or less, or 0.1 mass % or less relative to the total amount of the composition constituting the remover, and it is more preferable that silicone oil is not included in the composition constituting the remover.
  • the remover can be applied to a part or the whole of the film formed on the target site, and then optionally rubbed. Then, the film can be removed by pulling the film that has peeled off from the target site with a finger or the like.
  • the thickness of the film formed using the coating-type film-forming agent of the present disclosure described above is not particularly limited, and can be appropriately adjusted in consideration of, for example, UV protection performance, breathability, invisibility, occlusion to the target site (e.g., skin), aesthetics, etc.
  • the thickness of the film can be, for example, 0.5 ⁇ m or more, 1 ⁇ m or more, 10 ⁇ m or more, 30 ⁇ m or more, or 40 ⁇ m or more.
  • the thickness can be defined as the average value calculated by measuring the thickness of any part of the film five times using a high-precision digital micrometer (MDH-25MB, manufactured by Mitutoyo Corporation).
  • the coating film formed using the coating-type coating agent of the present disclosure can exhibit excellent ultraviolet protection performance (ultraviolet light absorption ability). Such performance can be evaluated by the improvement rate of ultraviolet protection performance calculated using the absorbance integrated value described below.
  • the coating film of the present disclosure can exhibit an improvement rate of more than 130%, 135% or more, 140% or more, 143% or more, 145% or more, 147% or more, or 150% or more.
  • the upper limit of such improvement rate can be, for example, 250% or less, 230% or less, or 200% or less.
  • the present invention will be described in more detail below with reference to examples, but the present invention is not limited to these. Unless otherwise specified, the blend amounts are shown in mass %.
  • the evaluation methods described in the examples are not limited to the forming agents and films formed by the forming agents described in the examples, but can be similarly applied to the above-mentioned forming agents and films formed by the forming agents.
  • the first agent of the test sample was dropped in an amount of 1 mg/ cm2 onto a measurement plate (S plate) (5 x 5 cm V-groove PMMA plate, SPFMASTER-PA01), and the first agent layer was formed by spreading it almost evenly with a finger. Then, the second agent of the test sample was dropped on the first agent layer in an amount of 1 mg/ cm2 , and the second agent was spread almost evenly with a finger to form a film. The absorbance of the formed film was measured using a Hitachi Ltd. U-3500 self-recording spectrophotometer. Here, an uncoated plate was used as a control.
  • the improvement rate of the UV protection performance based on the control sample was calculated using the following formula 3. It can be said that the higher the improvement rate, the better the UV protection performance.
  • the sample of Comparative Example 4 was used as the control sample.
  • Test Example Each test sample in this test example was prepared according to the following method. In this test example, the influence of an oil-soluble UV absorber on an unsaturated organopolysiloxane having a phenyl group and a vinyl group was examined. The results are shown in Table 2. In Table 2, “Mw” refers to the weight average molecular weight, and “moles of phenyl groups/moles of vinyl groups” refers to the moles of phenyl groups relative to the moles of vinyl groups in the unsaturated organopolysiloxane having a phenyl group.
  • a first agent was prepared by uniformly mixing 24.3 parts by weight of vinyl dimethicone having a viscosity of 165,000 cst as the first unsaturated organopolysiloxane, 4.7 parts by weight of hydrogen dimethicone as the first hydride-functionalized polysiloxane, and 71.0 parts by weight of volatile dimethicone.
  • Examples 1 to 9 and Comparative Examples 2 to 8 A first agent was prepared in the same manner as in Comparative Example 1, except that the components and their amounts in the first agent were changed to those shown in Table 2. The second agent used was the same as in Comparative Example 1.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

The purpose of the present invention is to provide a film-forming agent for application which contains an oil-soluble ultraviolet absorber and is capable of forming a film that exhibits excellent ultraviolet protection performance. A film-forming agent for application according to the present disclosure contains a first agent containing a crosslinkable component as a constituent of a film and a second agent containing a catalyst for crosslinking the crosslinkable component. The first agent and/or the second agent contains an unsaturated organopolysiloxane having a phenyl group and a vinyl group. The first agent and/or the second agent containing the unsaturated organopolysiloxane having a phenyl group and a vinyl group contains an oil-soluble ultraviolet absorber. In the unsaturated organopolysiloxane having a phenyl group and a vinyl group, the ratio of the number of moles of the phenyl group to the number of moles of the vinyl group is 0.40 or less.

Description

塗布型皮膜形成剤、及び該形成剤を含むキットCoating-type film-forming agent and kit containing said agent

 本開示は、塗布型皮膜形成剤、及び該形成剤を含むキットに関する。 The present disclosure relates to a coating-type film-forming agent and a kit containing the agent.

 体表に塗布して、しわ、傷跡などを補正可能な皮膜を形成し得る、塗布型の皮膜形成剤などが知られている。 There are known application-type film-forming agents that can be applied to the body surface to form a film that can correct wrinkles, scars, etc.

 特許文献1には、1以上の架橋可能なポリマーを含む、対象の皮膚表面での層のその場形成のための組成物、及び該組成物から形成される層を含む人工皮膚が開示されている。 Patent document 1 discloses a composition for in situ formation of a layer on the skin surface of a subject, the composition comprising one or more crosslinkable polymers, and an artificial skin comprising a layer formed from the composition.

特表2019-503396号公報Special table 2019-503396 publication

 特許文献1に記載されるような塗布型の皮膜形成剤に対し、油溶性の紫外線吸収剤を配合したときに、得られる皮膜が好適な紫外線防御性能を発現しない場合があることが判明した。 It has been found that when an oil-soluble UV absorber is blended with a coating-type film-forming agent such as that described in Patent Document 1, the resulting film may not exhibit suitable UV protection performance.

 したがって、本開示の主題は、油溶性の紫外線吸収剤を含み、優れた紫外線防御性能を呈する皮膜を形成することが可能な塗布型皮膜形成剤を提供することである。 The subject of this disclosure is therefore to provide a coating-type film-forming agent that contains an oil-soluble UV absorber and is capable of forming a film that exhibits excellent UV protection performance.

〈態様1〉
 皮膜を構成する架橋反応性成分を含む第1剤、及び前記架橋反応性成分を架橋させる触媒を含む第2剤を含む、塗布型皮膜形成剤であって、
 前記第1剤及び/又は前記第2剤が、フェニル基及びビニル基を有する不飽和オルガノポリシロキサンを含み、かつ、前記フェニル基及びビニル基を有する不飽和オルガノポリシロキサンを含む前記第1剤及び/又は前記第2剤が、油溶性紫外線吸収剤を含み、
 前記フェニル基及びビニル基を有する不飽和オルガノポリシロキサンは、前記ビニル基のモル数に対する前記フェニル基のモル数が、0.40以下である、
塗布型皮膜形成剤。
〈態様2〉
 前記第1剤が、第1の不飽和オルガノポリシロキサン及び第1のヒドリド官能化ポリシロキサンからなる群から選択される少なくとも一種を含み、
 前記第1剤が、前記第1の不飽和オルガノポリシロキサン及び前記第1のヒドリド官能化ポリシロキサンのうち、前記第1の不飽和オルガノポリシロキサンのみを含む場合には、前記第2剤は、前記第2のヒドリド官能化ポリシロキサンを含み、
 前記第1剤が、前記第1の不飽和オルガノポリシロキサン及び前記第1のヒドリド官能化ポリシロキサンのうち、前記第1のヒドリド官能化ポリシロキサンのみを含む場合には、前記第2剤は、前記第2の不飽和オルガノポリシロキサンを含み、
 前記第1の不飽和オルガノポリシロキサン及び前記第2の不飽和オルガノポリシロキサンのうちの少なくとも一方が、前記フェニル基及びビニル基を有する不飽和オルガノポリシロキサンを含む、態様1に記載の形成剤。
〈態様3〉
 前記油溶性紫外線吸収剤が、IOBが0.10以上の紫外線吸収剤を含む、態様1又は2に記載の形成剤。
〈態様4〉
 前記第1剤が、前記フェニル基及びビニル基を有する不飽和オルガノポリシロキサン及び前記油溶性紫外線吸収剤を含む、態様1~3のいずれかに記載の形成剤。
〈態様5〉
 前記フェニル基及びビニル基を有する不飽和オルガノポリシロキサンは、前記ビニル基のモル数に対する前記フェニル基のモル数が、0.0040以上である、態様1~4のいずれかに記載の形成剤。
〈態様6〉
 前記フェニル基及びビニル基を有する不飽和オルガノポリシロキサンの重量平均分子量が、100,000以下である、態様1~5のいずれかに記載の形成剤。
〈態様7〉
 前記フェニル基及びビニル基を有する不飽和オルガノポリシロキサンを含む前記第1剤及び/又は前記第2剤が、シリコーン油を含む、態様1~6のいずれかに記載の形成剤。
〈態様8〉
 前記フェニル基及びビニル基を有する不飽和オルガノポリシロキサンを含む前記第1剤及び/又は前記第2剤が、無機粒子を含む、態様1~7のいずれかに記載の形成剤。
〈態様9〉
 前記フェニル基及びビニル基を有する不飽和オルガノポリシロキサンが、ビニル末端ジフェニルシロキサン-ジメチルシロキサンコポリマー、ビニル末端ポリフェニルメチルシロキサン、及びビニルフェニルメチル末端ビニルフェニルシロキサン-フェニルメチルシロキサンコポリマーからなる群から選択される少なくとも一種である、態様1~8のいずれかに記載の形成剤。
〈態様10〉
 前記第1のヒドリド官能化ポリシロキサン及び前記第2のヒドリド官能化ポリシロキサンが、非末端及び/又は末端で水素化されたオルガノポリシロキサンである、態様2~9のいずれかに記載の形成剤。
〈態様11〉
 前記第1のヒドリド官能化ポリシロキサン及び前記第2のヒドリド官能化ポリシロキサンが、ヒドリド末端ポリジメチルシロキサン、ヒドリド末端ポリフェニル-(ジメチルヒドロシロキシ)シロキサン、ヒドリド末端メチルヒドロシロキサン-フェニルメチルシロキサンコポリマー、トリメチルシロキシ末端メチルヒドロシロキサン-ジメチルシロキサンコポリマー、ポリメチルヒドロシロキサン、トリメチルシロキシ末端ポリエチルヒドロシロキサン、トリエチルシロキサン、メチルヒドロシロキサン-フェニルオクチルメチルシロキサンコポリマー、及びメチルヒドロシロキサン-フェニルオクチルメチルシロキサンターポリマーからなる群から選択される少なくとも一種である、態様10に記載の形成剤。
〈態様12〉
 前記触媒が、白金触媒、ロジウム触媒、及びスズ触媒からなる群から選択される少なくとも一種である、態様1~11のいずれかに記載の形成剤。
〈態様13〉
 前記触媒が、白金触媒であり、かつ、該白金触媒が、白金カルボニルシクロビニルメチルシロキサン錯体、白金ジビニルテトラメチルジシロキサン錯体、白金シクロビニルメチルシロキサン錯体、及び白金オクタンアルデヒド/オクタノール錯体からなる群から選択される少なくとも一種である、態様12に記載の形成剤。
〈態様14〉
 態様1~13のいずれかに記載の形成剤における前記第1剤及び前記第2剤が、別々の容器に内包されている、又は2つ以上の区画を有する容器の各区画内に別々に内包されている、キット。
<Aspect 1>
A coating-type film-forming agent comprising a first agent containing a crosslinkable reactive component that constitutes a coating, and a second agent containing a catalyst that crosslinks the crosslinkable reactive component,
the first agent and/or the second agent contains an unsaturated organopolysiloxane having a phenyl group and a vinyl group, and the first agent and/or the second agent containing the unsaturated organopolysiloxane having a phenyl group and a vinyl group contains an oil-soluble ultraviolet absorber,
In the unsaturated organopolysiloxane having a phenyl group and a vinyl group, the molar ratio of the phenyl group to the molar ratio of the vinyl group is 0.40 or less.
A paint-type film-forming agent.
<Aspect 2>
the first agent comprises at least one selected from the group consisting of a first unsaturated organopolysiloxane and a first hydride-functionalized polysiloxane;
When the first agent contains only the first unsaturated organopolysiloxane among the first unsaturated organopolysiloxane and the first hydride-functionalized polysiloxane, the second agent contains the second hydride-functionalized polysiloxane;
When the first agent contains only the first hydride-functionalized polysiloxane among the first unsaturated organopolysiloxane and the first hydride-functionalized polysiloxane, the second agent contains the second unsaturated organopolysiloxane;
2. The forming agent according to claim 1, wherein at least one of the first unsaturated organopolysiloxane and the second unsaturated organopolysiloxane comprises the unsaturated organopolysiloxane having a phenyl group and a vinyl group.
<Aspect 3>
The forming agent according to claim 1 or 2, wherein the oil-soluble UV absorber comprises an UV absorber having an IOB of 0.10 or more.
<Aspect 4>
The forming agent according to any one of Aspects 1 to 3, wherein the first agent comprises the unsaturated organopolysiloxane having a phenyl group and a vinyl group, and the oil-soluble ultraviolet absorber.
<Aspect 5>
The forming agent according to any one of aspects 1 to 4, wherein the unsaturated organopolysiloxane having a phenyl group and a vinyl group has a molar ratio of the phenyl group to the molar number of the vinyl group of 0.0040 or more.
Aspect 6
Aspect 6. The forming agent according to any one of aspects 1 to 5, wherein the weight average molecular weight of the unsaturated organopolysiloxane having a phenyl group and a vinyl group is 100,000 or less.
Aspect 7
A forming agent according to any one of Aspects 1 to 6, wherein the first agent containing the unsaturated organopolysiloxane having a phenyl group and a vinyl group and/or the second agent contains a silicone oil.
<Aspect 8>
A forming agent according to any one of Aspects 1 to 7, wherein the first agent and/or the second agent containing the unsaturated organopolysiloxane having a phenyl group and a vinyl group contains inorganic particles.
<Aspect 9>
The forming agent according to any one of aspects 1 to 8, wherein the unsaturated organopolysiloxane having a phenyl group and a vinyl group is at least one selected from the group consisting of vinyl-terminated diphenylsiloxane-dimethylsiloxane copolymer, vinyl-terminated polyphenylmethylsiloxane, and vinylphenylmethyl-terminated vinylphenylsiloxane-phenylmethylsiloxane copolymer.
Aspect 10
A forming agent according to any one of aspects 2 to 9, wherein the first hydride-functionalized polysiloxane and the second hydride-functionalized polysiloxane are non-terminally and/or terminally hydrogenated organopolysiloxanes.
<Aspect 11>
11. The forming agent of claim 10, wherein the first hydride-functionalized polysiloxane and the second hydride-functionalized polysiloxane are at least one selected from the group consisting of hydride-terminated polydimethylsiloxane, hydride-terminated polyphenyl-(dimethylhydrosiloxy)siloxane, hydride-terminated methylhydrosiloxane-phenylmethylsiloxane copolymer, trimethylsiloxy-terminated methylhydrosiloxane-dimethylsiloxane copolymer, polymethylhydrosiloxane, trimethylsiloxy-terminated polyethylhydrosiloxane, triethylsiloxane, methylhydrosiloxane-phenyloctylmethylsiloxane copolymer, and methylhydrosiloxane-phenyloctylmethylsiloxane terpolymer.
<Aspect 12>
The forming agent according to any one of the preceding aspects, wherein the catalyst is at least one selected from the group consisting of platinum catalysts, rhodium catalysts, and tin catalysts.
<Aspect 13>
The forming agent according to aspect 12, wherein the catalyst is a platinum catalyst, and the platinum catalyst is at least one selected from the group consisting of platinum carbonylcyclovinylmethylsiloxane complex, platinum divinyltetramethyldisiloxane complex, platinum cyclovinylmethylsiloxane complex, and platinum octanaldehyde/octanol complex.
<Aspect 14>
A kit, in which the first agent and the second agent in the forming agent according to any one of aspects 1 to 13 are contained in separate containers, or are contained separately in each compartment of a container having two or more compartments.

 本開示によれば、油溶性の紫外線吸収剤を含み、優れた紫外線防御性能を呈する皮膜を形成することが可能な塗布型皮膜形成剤を提供することができる。 According to the present disclosure, it is possible to provide a coating-type film-forming agent that contains an oil-soluble UV absorber and is capable of forming a film that exhibits excellent UV protection performance.

 以下、本開示の実施の形態について詳述する。本開示は、以下の実施の形態に限定されるものではなく、発明の本旨の範囲内で種々変形して実施できる。 The following describes in detail the embodiments of the present disclosure. The present disclosure is not limited to the embodiments below, and can be modified in various ways within the scope of the invention.

 本開示の塗布型皮膜形成剤は、皮膜を構成する架橋反応性成分を含む第1剤、及びこの架橋反応性成分を架橋させる触媒を含む第2剤を含み、第1剤及び/又は第2剤が、フェニル基及びビニル基を有する不飽和オルガノポリシロキサンを含み、かつ、このフェニル基及びビニル基を有する不飽和オルガノポリシロキサンを含む第1剤及び/又は第2剤が、油溶性紫外線吸収剤を含み、このフェニル基及びビニル基を有する不飽和オルガノポリシロキサンは、ビニル基のモル数に対するフェニル基のモル数が、0.40以下である。 The applied film-forming agent of the present disclosure includes a first agent containing a crosslinkable reactive component that constitutes a film, and a second agent containing a catalyst that crosslinks the crosslinkable reactive component, the first agent and/or the second agent containing an unsaturated organopolysiloxane having a phenyl group and a vinyl group, and the first agent and/or the second agent containing the unsaturated organopolysiloxane having a phenyl group and a vinyl group contains an oil-soluble ultraviolet absorber, and the unsaturated organopolysiloxane having a phenyl group and a vinyl group has a ratio of the number of moles of phenyl groups to the number of moles of vinyl groups of 0.40 or less.

 原理によって限定されるものではないが、本開示の塗布型皮膜形成剤が、油溶性の紫外線吸収剤を含むことができ、かつ、優れた紫外線防御性能を呈する皮膜を形成することが可能な作用原理は以下のとおりであると考える。 Although not limited by the theory, the principle of action of the applied film-forming agent disclosed herein is believed to be as follows, which allows the agent to contain an oil-soluble UV absorber and form a film that exhibits excellent UV protection performance.

 特許文献1に記載されるような塗布型皮膜形成剤は、典型的には、油分にも該当する不飽和オルガノポリシロキサンなどを含んでいる。したがって、紫外線吸収剤を使用するときに、油溶性の紫外線吸収剤を採用すれば、得られる皮膜は良好な紫外線防御性能を発現すると予想していた。しかしながら、油溶性の紫外線吸収剤を採用したとしても、得られた皮膜は良好な紫外線防御性能を呈しない場合があることが判明した。 The paint-type film-forming agent described in Patent Document 1 typically contains unsaturated organopolysiloxanes, which are also considered to be oils. Therefore, it was expected that if an oil-soluble UV absorber was used when an ultraviolet absorber was used, the resulting film would exhibit good ultraviolet protection performance. However, it was found that even if an oil-soluble UV absorber was used, the resulting film may not exhibit good ultraviolet protection performance.

 本発明者は、不飽和オルガノポリシロキサンとして、フェニル基を特定の割合で含む、フェニル基及びビニル基を有する不飽和オルガノポリシロキサンを用いると、意外にも、油溶性の紫外線吸収剤を用いたときに、得られる皮膜が優れた紫外線防御性能を呈することを見出した。 The inventors have unexpectedly discovered that when an unsaturated organopolysiloxane containing a phenyl group and a vinyl group, in which the phenyl group is contained in a specific ratio, is used as the unsaturated organopolysiloxane, and when an oil-soluble ultraviolet absorber is used, the resulting film exhibits excellent ultraviolet protection performance.

 フェニル基及びビニル基を有する不飽和オルガノポリシロキサン自体は、紫外線防御性能に優れているわけではない。それにも関わらず、かかる材料を用いたときに得られる皮膜が優れた紫外線防御性能を呈し得るのは、皮膜形成剤中の不飽和オルガノポリシロキサンと紫外線吸収剤との相溶性が影響していると考えている。 Unsaturated organopolysiloxanes containing phenyl and vinyl groups themselves do not have excellent UV protection performance. Nevertheless, the films obtained when using such materials are thought to have excellent UV protection performance due to the compatibility of the unsaturated organopolysiloxane in the film-forming agent with the UV absorber.

 特定の割合でフェニル基を有さない不飽和オルガノポリシロキサンを用いた場合であっても、油溶性紫外線吸収剤は皮膜からブリードアウトしてこないため、皮膜中に存在していると考えられる。しかし、かかる系では、油溶性紫外線吸収剤は相溶性が悪く、皮膜中に均一に分散せず、局所的に一体となって存在しているため、紫外線防御性能が十分に発揮されなかったと考えている。一方、特定の割合でフェニル基を有する不飽和オルガノポリシロキサンを用いた場合には、かかる特定割合のフェニル基の影響によって油溶性紫外線吸収剤が混ざりやすくなり、その結果、油溶性紫外線吸収剤が皮膜中に均一に分散するようになるため、紫外線防御性能が向上したと考えている。 Even when an unsaturated organopolysiloxane that does not have a specific proportion of phenyl groups is used, the oil-soluble UV absorber does not bleed out from the film and is therefore believed to be present in the film. However, in such a system, the oil-soluble UV absorber has poor compatibility and is not uniformly dispersed in the film, but exists locally as one body, and it is believed that this is why UV protection performance is not fully demonstrated. On the other hand, when an unsaturated organopolysiloxane that has a specific proportion of phenyl groups is used, the oil-soluble UV absorber becomes more easily mixed due to the influence of the specific proportion of phenyl groups, and as a result, the oil-soluble UV absorber becomes uniformly dispersed in the film, which is believed to improve UV protection performance.

 なお、従来の日焼け止め化粧料は、汗又はこすれなどによって例えば皮膚に適用した化粧料が剥がれ落ちてしまうという課題を有していた。本開示の塗布型皮膜形成剤は、かかる剤を、例えば皮膚に適用して架橋させて皮膜を形成することができるため、得られる架橋皮膜は、従来の日焼け止め化粧料などを皮膚に適用して得られた膜に比べ、こすれなどによる剥がれ落ちに対する耐性に優れている。したがって、良好な紫外線防御性能を発現し得る本開示の塗布型皮膜形成剤は、従来の日焼け止め化粧料が有していた剥がれ落ちに関する課題に対しても貢献することができると考えている。 Conventional sunscreen cosmetics have had the problem that, for example, when applied to the skin, the cosmetics peel off due to sweat or rubbing. The applied-type film-forming agent of the present disclosure can be applied to the skin, for example, to cause crosslinking to form a film, and the resulting crosslinked film has superior resistance to peeling due to rubbing, etc., compared to films obtained by applying conventional sunscreen cosmetics to the skin. Therefore, it is believed that the applied-type film-forming agent of the present disclosure, which can exhibit good UV protection performance, can also contribute to solving the problem of peeling that conventional sunscreen cosmetics have.

 また、従来の日焼け止め化粧料は、例えば皮膚から除去する場合には、洗浄料などを用いて皮膚を洗い流す必要があった。一方、本開示の塗布型皮膜形成剤による皮膜は、架橋構造を有しているため、架橋構造を有さない皮膜に比べて皮膜強度に優れている。その結果、従来の日焼け止め化粧料によって形成された膜とは異なり、かかる皮膜を、例えば皮膚から容易に剥がし得るといった利点も有している。 Furthermore, when removing conventional sunscreen cosmetics from the skin, for example, it is necessary to wash the skin off with a cleanser or the like. On the other hand, the film formed by the applied film-forming agent of the present disclosure has a crosslinked structure, and therefore has superior film strength compared to films that do not have a crosslinked structure. As a result, unlike films formed by conventional sunscreen cosmetics, this film has the advantage that it can be easily peeled off from the skin, for example.

 本開示における用語の定義は以下のとおりである。 The definitions of terms used in this disclosure are as follows:

 本開示において「身体補正皮膜」とは、対象者の皮膚に形成されたときに、皮膜が自然な皮膚の外観を呈するようにすることを意図した皮膜を意味する。ここで、「自然な皮膚の外観」とは、皮膚に適用された場合、身体補正皮膜が、実際の皮膚の外見、感触、及び質感から選択される少なくとも一種と類似又は同一の性能を呈し、例えば、皮膜処理した皮膚が、実際の(例えば、現状の)皮膚の物理特性(例えば、弾力性及び硬さ)を呈し得ることを意味する。 In the present disclosure, a "body correction coating" refers to a coating that is intended to provide a coating that, when applied to a subject's skin, has the appearance of natural skin. In this context, "natural skin appearance" means that when applied to the skin, the body correction coating will provide performance similar to or identical to at least one of the appearance, feel, and texture of actual skin, e.g., the treated skin may provide physical properties (e.g., elasticity and firmness) of actual (e.g., current) skin.

 本開示において「身体補正」とは、対象者の身体の欠点又は皮膚の欠点を、マスクし、覆い隠し又はカバーして、身体又は皮膚の欠点を視覚的及び/又は触覚的に改善することを意味するが、人間を手術、治療又は診断する方法は包含しない。ここで、「身体の欠点」とは、例えば、対象者がしみ若しくは傷と感じ、又は当業者、例えば、皮膚科医、エステティシャン又は整形外科医が、しみ又は傷と考える対象者の身体のこのような部分を意味することができる。「身体の欠点」には、皮膚の欠点及び身体の軟部組織の弛み(例えば、皮膚の緩み又は弛み、乳房、臀部、腹部、顎、頸部などの弛み)などが包含される。また、「皮膚の欠点」には、対象者がしみ又は傷と感じる対象者の皮膚のこれらの項目が包含される。皮膚の欠点の例としては、焔状母斑又は火炎状母斑(例えば、単純性血管腫若しくは正中火炎状母斑)、肝斑、しわ、しみ、にきび、ほくろ、傷跡、刺青、あざ、皮膚の変形、母斑、日焼け、老化、不均一な皮膚の色合い、弛んだ皮膚、皮膚の粗さ、色素沈着過度、毛穴の拡大、毛細管拡張症、赤み、てかり、セルライト、妊娠線、又は皮膚の弾力の低下が挙げられる。 In this disclosure, "body correction" means to mask, conceal or cover a body or skin imperfection of a subject to visually and/or tactilely improve the body or skin imperfection, but does not include methods of surgery, treatment or diagnosis of a human. Here, "body imperfection" can mean, for example, such part of the subject's body that the subject perceives as a blemish or blemish, or that a person skilled in the art, e.g., a dermatologist, esthetician or plastic surgeon, would consider to be a blemish or blemish. "Body imperfection" includes skin imperfections and loose soft tissues of the body (e.g., loose or sagging skin, looseness of breasts, buttocks, abdomen, chin, neck, etc.), and the like. Also, "skin imperfection" includes those items of the subject's skin that the subject perceives as a blemish or blemish. Examples of skin imperfections include nevus flammeus or nevus flameus (e.g., hemangioma simplex or midline nevus flammeus), melasma, wrinkles, age spots, acne, moles, scars, tattoos, birthmarks, skin deformities, birthmarks, sun damage, aging, uneven skin tone, loose skin, rough skin, hyperpigmentation, enlarged pores, telangiectasias, redness, shine, cellulite, stretch marks, or reduced skin elasticity.

 本開示において「粘度」とは、剪断応力又は引張応力のいずれかによって変形させられている流体の抵抗の尺度を指す。例えば、塗布型皮膜形成剤における第1剤及び第2剤の粘度は、基板の上に形成される層の厚さ、展延性、並びに均一性及び/又は一様性に影響を与える。粘度は、動的粘度(別名、絶対粘度、代表的な単位はPa・s、ポアズ、P、cPである。)又は運動学的粘度(代表的な単位はcm/s、ストーク、St、cstである。)のいずれかとして報告することができ、この運動学的粘度は、動的粘度を測定された流体の密度で割ったものである。本明細書に開示される成分の粘度範囲は、一般に、各成分の供給業者によって、レオメーター又はキャノン・フェンスケ(Cannon-Fenske)チューブ粘度計を用いて測定される運動学的粘度の単位(例えば、cst)として提供されるが、流体の粘度は、例えば、レオメーター(例えば、線形剪断レオメーター若しくは動的剪断レオメーター)又は粘度計(粘度測定計、例えば、毛細管粘度計もしくは回転粘度計とも呼ばれる)を用いて測定することもできる。 In this disclosure, "viscosity" refers to a measure of the resistance of a fluid to being deformed by either shear or tensile stress. For example, the viscosity of the first and second parts of a paint-on film former affects the thickness, spreadability, and uniformity and/or uniformity of the layer formed on a substrate. Viscosity can be reported as either dynamic viscosity (also known as absolute viscosity, typical units are Pa·s, poise, P, cP) or kinematic viscosity (typical units are cm 2 /s, stokes, St, cst), which is the dynamic viscosity divided by the density of the measured fluid. The viscosity ranges of the components disclosed herein are generally provided by the suppliers of each component in units of kinematic viscosity (e.g., cst) measured using a rheometer or a Cannon-Fenske tube viscometer, although the viscosity of a fluid can also be measured using, for example, a rheometer (e.g., a linear shear rheometer or a dynamic shear rheometer) or a viscometer (a viscometric meter, also called a capillary viscometer or a rotational viscometer).

 本開示における「架橋」には、一般に「硬化」と称する概念も包含される。 In this disclosure, "crosslinking" also includes the concept commonly referred to as "curing."

 本開示において「対象部位」とは、紫外線防御性能を付与したい部位(例えば皮膚)を意図する。 In this disclosure, the term "target area" refers to the area (e.g., skin) to which it is desired to impart UV protection performance.

《塗布型皮膜形成剤》
 本開示の塗布型皮膜形成剤(単に「形成剤」と称する場合がある。)は、皮膜を構成する架橋反応性成分を含む第1剤と、この架橋反応性成分を架橋させる触媒を含む第2剤とを含み、かかる第1剤及び/又は第2剤が、フェニル基及びビニル基を有する不飽和オルガノポリシロキサンを含み、かつ、フェニル基及びビニル基を有する不飽和オルガノポリシロキサンを含む第1剤及び/又は第2剤が、油溶性紫外線吸収剤を含み、また、フェニル基及びビニル基を有する不飽和オルガノポリシロキサンは、ビニル基のモル数に対するフェニル基のモル数が、0.40以下である。
<<Coating-type film-forming agent>>
The apply-type film-forming agent (which may be simply referred to as a "former") of the present disclosure comprises a first agent containing a crosslinkable reactive component that constitutes a film, and a second agent containing a catalyst that crosslinks this crosslinkable reactive component, wherein the first agent and/or the second agent contains an unsaturated organopolysiloxane having a phenyl group and a vinyl group, and the first agent and/or the second agent containing the unsaturated organopolysiloxane having a phenyl group and a vinyl group contains an oil-soluble ultraviolet absorber, and further wherein the unsaturated organopolysiloxane having a phenyl group and a vinyl group has a ratio of the number of moles of phenyl groups to the number of moles of vinyl groups of 0.40 or less.

 本開示の塗布型皮膜形成剤によって得られる皮膜は、身体補正機能を有する身体補正皮膜であってもよく、或いは、身体補正機能を有さない皮膜であってもよい。本開示の塗布型皮膜形成剤によって得られる皮膜は、皮膜の強度(例えば靭性)を向上させることができる結果、身体補正機能も向上させることができる。そのため、本開示の塗布型皮膜形成剤は、塗布型身体補正皮膜形成剤として好適に使用することができる。 The film obtained by the applied-type film-forming agent of the present disclosure may be a body-correcting film having a body-correcting function, or may be a film without a body-correcting function. The film obtained by the applied-type film-forming agent of the present disclosure can improve the strength (e.g., toughness) of the film, and as a result, can also improve the body-correcting function. Therefore, the applied-type film-forming agent of the present disclosure can be suitably used as an applied-type body-correcting film-forming agent.

〈第1剤〉
 本開示の塗布型皮膜形成剤は、皮膜を構成する架橋反応性成分を含む第1剤を含んでいる。
<First Agent>
The paint-type film-forming agent of the present disclosure includes a first agent that includes a crosslinking reactive component that forms a film.

 第1剤は、上述した、フェニル基を特定の割合で含むフェニル基及びビニル基を有する不飽和オルガノポリシロキサン(単に「フェニル基及びビニル基を有する不飽和オルガノポリシロキサン」と称する場合がある。)を含み得る。第1剤は、皮膜を構成する架橋反応性成分を含んでおり、最終的な皮膜を形成し得ることから、第1剤が、フェニル基及びビニル基を有する不飽和オルガノポリシロキサンとともに油溶性紫外線吸収剤を含んでいると、得られる皮膜の紫外線防御性能をより向上させることができる。 The first agent may contain the above-mentioned unsaturated organopolysiloxane having a phenyl group and a vinyl group, which contains a specific ratio of phenyl groups (sometimes simply referred to as "unsaturated organopolysiloxane having a phenyl group and a vinyl group"). Since the first agent contains a crosslinking reactive component that constitutes the film and can form the final film, if the first agent contains an oil-soluble UV absorber together with the unsaturated organopolysiloxane having a phenyl group and a vinyl group, the UV protection performance of the resulting film can be further improved.

(フェニル基及びビニル基を有する不飽和オルガノポリシロキサン)
 フェニル基及びビニル基を有する不飽和オルガノポリシロキサンにおける、ビニル基のモル数に対するフェニル基のモル数は、得られる皮膜の強度、油溶性紫外線吸収剤との相溶性、及び紫外線防御性能等の観点から、0.37以下、0.35以下、0.33以下、0.30以下、0.27以下、0.25以下、又は0.23以下が好ましく、また、0.0040以上、0.0045以上、0.0050以上、0.0070以上、0.010以上、0.010超、0.011以上、0.012以上、0.013以上、又は0.014以上が好ましい。ここで、不飽和オルガノポリシロキサン中のビニル基及びフェニル基のモル数は、H-NMR(核磁気共鳴)による相対定量法で測定することができる。
(Unsaturated organopolysiloxane having phenyl and vinyl groups)
In the unsaturated organopolysiloxane having phenyl groups and vinyl groups, the molar number of phenyl groups relative to the molar number of vinyl groups is preferably 0.37 or less, 0.35 or less, 0.33 or less, 0.30 or less, 0.27 or less, 0.25 or less, or 0.23 or less, from the viewpoints of the strength of the resulting coating, compatibility with the oil-soluble ultraviolet absorber, and ultraviolet protection performance, and is also preferably 0.0040 or more, 0.0045 or more, 0.0050 or more, 0.0070 or more, 0.010 or more, more than 0.010, 0.011 or more, 0.012 or more, 0.013 or more, or 0.014 or more. Here, the molar numbers of vinyl groups and phenyl groups in the unsaturated organopolysiloxane can be measured by a relative quantitative method using 1 H-NMR (nuclear magnetic resonance).

 フェニル基及びビニル基を有する不飽和オルガノポリシロキサンは、油溶性紫外線吸収剤との相溶性、及び紫外線防御性能等の観点から、重量平均分子量が、100,000以下、80,000以下、60,000以下、50,000以下、又は40,000以下であることが好ましく、30,000以下、29,000以下、28,000以下、又は27,000以下であることがより好ましく、また、5,000以上、6,000以上、7,000以上、又は8,000以上が好ましく、9,000以上、9,300以上、又は9,500以上であることがより好ましい。ここで、本開示における「重量平均分子量」とは、ゲルパーミエーションクロマトグラフ測定における、ポリスチレン換算の重量平均分子量を意図する。 From the viewpoints of compatibility with oil-soluble UV absorbers and UV protection performance, the unsaturated organopolysiloxane having phenyl groups and vinyl groups preferably has a weight average molecular weight of 100,000 or less, 80,000 or less, 60,000 or less, 50,000 or less, or 40,000 or less, more preferably 30,000 or less, 29,000 or less, 28,000 or less, or 27,000 or less, and more preferably 5,000 or more, 6,000 or more, 7,000 or more, or 8,000 or more, and more preferably 9,000 or more, 9,300 or more, or 9,500 or more. Here, the "weight average molecular weight" in this disclosure refers to the weight average molecular weight in terms of polystyrene in gel permeation chromatography measurement.

 フェニル基及びビニル基を有する不飽和オルガノポリシロキサンは、25℃で、100~200,000cstの粘度を有することができる。かかる粘度の下限値としては、200cst以上、300cst以上、400cst以上、又は500cst以上とすることができる。粘度の上限値としては、150,000cst以下、100,000cst以下、80,000cst以下、又は60,000cst以下とすることができる。 The unsaturated organopolysiloxane having phenyl groups and vinyl groups can have a viscosity of 100 to 200,000 cst at 25°C. The lower limit of the viscosity can be 200 cst or more, 300 cst or more, 400 cst or more, or 500 cst or more. The upper limit of the viscosity can be 150,000 cst or less, 100,000 cst or less, 80,000 cst or less, or 60,000 cst or less.

 フェニル基及びビニル基を有する不飽和オルガノポリシロキサンとしては特に制限はなく、例えば、ビニル末端ジフェニルシロキサン-ジメチルシロキサンコポリマー、ビニル末端ポリフェニルメチルシロキサン、及びビニルフェニルメチル末端ビニルフェニルシロキサン-フェニルメチルシロキサンコポリマーからなる群から選択される少なくとも一種を挙げることができる。なかでも、油溶性紫外線吸収剤との相溶性、及び紫外線防御性能等の観点から、フェニル基及びビニル基を有する不飽和オルガノポリシロキサンとして、ビニル末端ジフェニルシロキサン-ジメチルシロキサンコポリマーを含むことが好ましい。 The unsaturated organopolysiloxane having a phenyl group and a vinyl group is not particularly limited, and may be, for example, at least one selected from the group consisting of vinyl-terminated diphenylsiloxane-dimethylsiloxane copolymer, vinyl-terminated polyphenylmethylsiloxane, and vinylphenylmethyl-terminated vinylphenylsiloxane-phenylmethylsiloxane copolymer. Among these, from the viewpoints of compatibility with oil-soluble ultraviolet absorbers and ultraviolet protection performance, it is preferable that the unsaturated organopolysiloxane having a phenyl group and a vinyl group contains a vinyl-terminated diphenylsiloxane-dimethylsiloxane copolymer.

 いくつかの実施態様において、本開示の第1剤は、かかる架橋反応性成分として、第1の不飽和オルガノポリシロキサン及び第1のヒドリド官能化ポリシロキサンからなる群から選択される少なくとも一種を含んでいる。良好な皮膜を得る観点から、第1剤が、第1の不飽和オルガノポリシロキサン及び第1のヒドリド官能化ポリシロキサンのうち、第1の不飽和オルガノポリシロキサンのみを含む場合には、本開示の形成剤における第2剤は、第2のヒドリド官能化ポリシロキサンを含み、また、第1剤が、第1の不飽和オルガノポリシロキサン及び第1のヒドリド官能化ポリシロキサンのうち、第1のヒドリド官能化ポリシロキサンのみを含む場合には、第2剤は、第2の不飽和オルガノポリシロキサンを含むことが好ましい。より良好な皮膜を得る観点から、第1剤には、第1の不飽和オルガノポリシロキサン及び第1のヒドリド官能化ポリシロキサンの両方が含まれていることが好ましい。そして、第1の不飽和オルガノポリシロキサン及び第2の不飽和オルガノポリシロキサンのうちの少なくとも一方が、上述したフェニル基及びビニル基を有する不飽和オルガノポリシロキサンを含む。 In some embodiments, the first agent of the present disclosure contains at least one selected from the group consisting of a first unsaturated organopolysiloxane and a first hydride-functionalized polysiloxane as such a crosslinking reactive component. From the viewpoint of obtaining a good coating, when the first agent contains only the first unsaturated organopolysiloxane among the first unsaturated organopolysiloxane and the first hydride-functionalized polysiloxane, the second agent in the forming agent of the present disclosure contains a second hydride-functionalized polysiloxane, and when the first agent contains only the first hydride-functionalized polysiloxane among the first unsaturated organopolysiloxane and the first hydride-functionalized polysiloxane, it is preferable that the second agent contains a second unsaturated organopolysiloxane. From the viewpoint of obtaining a better coating, it is preferable that the first agent contains both the first unsaturated organopolysiloxane and the first hydride-functionalized polysiloxane. At least one of the first unsaturated organopolysiloxane and the second unsaturated organopolysiloxane contains the above-mentioned unsaturated organopolysiloxane having a phenyl group and a vinyl group.

 第1剤の剤型としては特に制限はなく、例えば、油相で構成された単相系、非乳化型の水中油型若しくは油中水型の二相系の形態、又は水中油型乳化組成物若しくは油中水型乳化組成物の形態で構成された二相系であってもよい。ここで、油相で構成された単相系とは、典型的には無水の形態である。本開示において「無水」とは、組成物中に水が含まれていないことを意図することに加え、水の含有量が低量、即ち、10質量%以下、5質量%以下、2質量%以下、1質量%以下、0.1質量%以下、又は0.01質量%以下であることも意図する。また、非乳化型の二相系とは、水と油に分離した状態の液体を振とうさせることによって、油を含む分散媒中に水滴を強制的に分散させた油中水型の組成物、又は水を含む分散媒中に油滴を強制的に分散させた水中油型の組成物が包含され得る。 The dosage form of the first agent is not particularly limited, and may be, for example, a single-phase system composed of an oil phase, a non-emulsified oil-in-water or water-in-oil two-phase system, or a two-phase system composed of an oil-in-water emulsion composition or a water-in-oil emulsion composition. Here, a single-phase system composed of an oil phase is typically an anhydrous form. In this disclosure, "anhydrous" not only means that the composition does not contain water, but also means that the water content is low, i.e., 10% by mass or less, 5% by mass or less, 2% by mass or less, 1% by mass or less, 0.1% by mass or less, or 0.01% by mass or less. In addition, a non-emulsified two-phase system may include a water-in-oil composition in which water droplets are forcibly dispersed in a dispersion medium containing oil by shaking a liquid in a state in which the water and oil are separated, or an oil-in-water composition in which oil droplets are forcibly dispersed in a dispersion medium containing water.

 これらの各剤型は、架橋反応性成分と、任意に、後述するような、油分、乳化剤、及び水などの公知の材料とを用い、常法によって適宜調製することができる。 Each of these formulations can be prepared appropriately by conventional methods using a crosslinking reactive component and, optionally, known materials such as oils, emulsifiers, and water, as described below.

 第1剤は、対象部位(例えば皮膚)に対して塗布などによって適用されるため、塗布性能の観点から、体温以下のガラス転移温度を有することが好ましい。例えば、ガラス転移温度は、37℃以下、25℃以下、10℃以下、又は0℃以下にすることができる。ガラス転移温度の下限値については特に制限はないが、例えば、-30℃以上、-20℃以上、又は-10℃以上とすることができる。ここで、「ガラス転移温度」とは、固体状態から液体状態への転移が起こる温度を指し、例えば、ASTM D3418-03に準拠した示差走査熱量計(DSC)を用いて測定することができる。 The first agent is applied to the target site (e.g., skin) by painting, etc., and therefore, from the viewpoint of application performance, it preferably has a glass transition temperature below body temperature. For example, the glass transition temperature can be 37°C or lower, 25°C or lower, 10°C or lower, or 0°C or lower. There is no particular restriction on the lower limit of the glass transition temperature, but it can be, for example, -30°C or higher, -20°C or higher, or -10°C or higher. Here, "glass transition temperature" refers to the temperature at which a transition from a solid state to a liquid state occurs, and can be measured, for example, using a differential scanning calorimeter (DSC) in accordance with ASTM D3418-03.

(第1の不飽和オルガノポリシロキサン)
 第1の不飽和オルガノポリシロキサンとしては、不飽和部を有するオルガノポリシロキサン、例えば、少なくとも2つの炭素-炭素二重結合又は少なくとも1つの炭素-炭素三重結合を分子内に有する一種以上のオルガノポリシロキサンを挙げることができる。かかる不飽和オルガノポリシロキサンとして好ましくは、平均して少なくとも2つのアルケニル官能基(例えばビニル官能基)を有し、かつ25℃で1,00~2,000,000cstの粘度を有する一種以上のオルガノポリシロキサンを挙げることができる。ここで、本開示における「不飽和部」とは、「炭素-炭素二重結合」及び「炭素-炭素三重結合」を有する部分を意味し、これらは単に「二重結合」及び「三重結合」と称する場合がある。第1の不飽和オルガノポリシロキサンは、単独で又は二種以上組み合わせて使用することができる。
(First Unsaturated Organopolysiloxane)
The first unsaturated organopolysiloxane may be an organopolysiloxane having an unsaturated portion, for example, one or more organopolysiloxanes having at least two carbon-carbon double bonds or at least one carbon-carbon triple bond in the molecule. Such unsaturated organopolysiloxanes are preferably one or more organopolysiloxanes having at least two alkenyl functional groups (e.g., vinyl functional groups) on average and having a viscosity of 1,00 to 2,000,000 cst at 25°C. Here, the "unsaturated portion" in the present disclosure means a portion having a "carbon-carbon double bond" and a "carbon-carbon triple bond", which may be simply referred to as a "double bond" and a "triple bond". The first unsaturated organopolysiloxane may be used alone or in combination of two or more kinds.

 このようなオルガノポリシロキサンは、不飽和部(二重結合部分又は三重結合部分)を、ポリマーの末端単位に、ポリマーの非末端モノマー単位に、又はこれらの組合せにおいて含んでもよい。 Such organopolysiloxanes may contain unsaturation (double or triple bond moieties) in the terminal units of the polymer, in the non-terminal monomer units of the polymer, or in a combination thereof.

 ある実施態様では、第1の不飽和オルガノポリシロキサン、なかでもフェニル基及びビニル基を有する不飽和オルガノポリシロキサン以外の他の不飽和オルガノポリシロキサン(単に「他の不飽和オルガノポリシロキサン」と称する場合がある。)中の二重結合含有モノマー単位は、平均して、40モノマー単位以上、200モノマー単位以上、400モノマー単位以上、1,000モノマー単位以上、又は2,000モノマー単位以上離れていてもよい。 In one embodiment, the double bond-containing monomer units in the first unsaturated organopolysiloxane, particularly the other unsaturated organopolysiloxane other than the unsaturated organopolysiloxane having a phenyl group and a vinyl group (sometimes simply referred to as "other unsaturated organopolysiloxane"), may be separated on average by 40 monomer units or more, 200 monomer units or more, 400 monomer units or more, 1,000 monomer units or more, or 2,000 monomer units or more.

 ある実施態様では、第1の不飽和オルガノポリシロキサン、なかでも他の不飽和オルガノポリシロキサンの不飽和部の含有量は、0.001mmol/g以上、0.005mmol/g以上、0.010mmol/g以上、0.050mmol/g以上、又は0.10mmol/g以上にすることができ、5.0mmol/g以下、3.0mmol/g以下、1.0mmol/g以下、0.50mmol/g以下、0.40mmol/g以下、0.30mmol/g以下、0.25mmol/g以下、0.20mmol/g以下、又は0.15mmol/g以下にすることができる。かかるオルガノポリシロキサン中の不飽和部の近似モル量は、オルガノポリシロキサンの平均分子量に基づいて計算することができる。 In one embodiment, the content of unsaturated moieties in the first unsaturated organopolysiloxane, particularly the other unsaturated organopolysiloxane, can be 0.001 mmol/g or more, 0.005 mmol/g or more, 0.010 mmol/g or more, 0.050 mmol/g or more, or 0.10 mmol/g or more, and can be 5.0 mmol/g or less, 3.0 mmol/g or less, 1.0 mmol/g or less, 0.50 mmol/g or less, 0.40 mmol/g or less, 0.30 mmol/g or less, 0.25 mmol/g or less, 0.20 mmol/g or less, or 0.15 mmol/g or less. The approximate molar amount of unsaturated moieties in such organopolysiloxanes can be calculated based on the average molecular weight of the organopolysiloxane.

 ある実施態様では、第1の不飽和オルガノポリシロキサン、なかでも他の不飽和オルガノポリシロキサンは、25℃で、500~2,000,000cstの粘度を有することができる。かかる粘度の下限値としては、700cst以上、1,000cst以上、3,000cst以上、5,000cst以上、10,000cst以上、20,000cst以上、40,000cst以上、60,000cst以上、80,000cst以上、100,000cst以上、125,000cst以上、又は150,000cst以上とすることができる。粘度の上限値としては、1,000,000cst以下、500,000cst以下、450,000cst以下、400,000cst以下、350,000cst以下、300,000cst以下、250,000cst以下、200,000cst以下、180,000cst以下、170,000cst以下、又は165,000cst以下とすることができる。 In one embodiment, the first unsaturated organopolysiloxane, particularly the other unsaturated organopolysiloxane, can have a viscosity of 500 to 2,000,000 cst at 25° C. The lower limit of the viscosity can be 700 cst or more, 1,000 cst or more, 3,000 cst or more, 5,000 cst or more, 10,000 cst or more, 20,000 cst or more, 40,000 cst or more, 60,000 cst or more, 80,000 cst or more, 100,000 cst or more, 125,000 cst or more, or 150,000 cst or more. The upper limit of the viscosity can be 1,000,000 cst or less, 500,000 cst or less, 450,000 cst or less, 400,000 cst or less, 350,000 cst or less, 300,000 cst or less, 250,000 cst or less, 200,000 cst or less, 180,000 cst or less, 170,000 cst or less, or 165,000 cst or less.

 ある実施態様では、第1の不飽和オルガノポリシロキサン、なかでも他の不飽和オルガノポリシロキサンは、30,000Da~500,000Daの平均分子量を有することができる。かかる平均分子量の下限値としては、35,000Da以上、40,000Da以上、50,000Da以上、60,000Da以上、72,000Da以上、84,000Da以上、96,000Da以上、又は100,000Da以上であることが好ましく、140,000Da以上又は150,000Da以上であることがより好ましい。平均分子量の上限値としては、200,000Da以下、190,000Da以下、180,000Da以下、又は170,000Da以下であることが好ましく、160,000Da以下であることがより好ましく、155,000Da以下がさらに好ましい。本開示における平均分子量は、ゲル浸透クロマトグラフ(GPC)法により求めることができる。 In one embodiment, the first unsaturated organopolysiloxane, particularly the other unsaturated organopolysiloxane, can have an average molecular weight of 30,000 Da to 500,000 Da. The lower limit of such average molecular weight is preferably 35,000 Da or more, 40,000 Da or more, 50,000 Da or more, 60,000 Da or more, 72,000 Da or more, 84,000 Da or more, 96,000 Da or more, or 100,000 Da or more, and more preferably 140,000 Da or more or 150,000 Da or more. The upper limit of the average molecular weight is preferably 200,000 Da or less, 190,000 Da or less, 180,000 Da or less, or 170,000 Da or less, more preferably 160,000 Da or less, and even more preferably 155,000 Da or less. The average molecular weight in this disclosure can be determined by gel permeation chromatography (GPC).

 第1の不飽和オルガノポリシロキサンとして、例えば、上述したフェニル基及びビニル基を有する不飽和オルガノポリシロキサン、並びに他の不飽和オルガノポリシロキサンからなる群から選択される少なくとも一種の不飽和オルガノポリシロキサンを使用することができる。 As the first unsaturated organopolysiloxane, for example, at least one unsaturated organopolysiloxane selected from the group consisting of the above-mentioned unsaturated organopolysiloxanes having phenyl groups and vinyl groups, and other unsaturated organopolysiloxanes, can be used.

 第1の不飽和オルガノポリシロキサンとして使用可能な他の不飽和オルガノポリシロキサンとしては、例えば、ビニル基を有するオルガノポリシロキサン、ビニル末端化されたオルガノポリシロキサン、及びビニル化された分岐鎖を有するオルガノポリシロキサンからなる群から選択される少なくとも一種の不飽和オルガノポリシロキサンを使用することができる。 Other unsaturated organopolysiloxanes that can be used as the first unsaturated organopolysiloxane include, for example, at least one unsaturated organopolysiloxane selected from the group consisting of organopolysiloxanes having vinyl groups, vinyl-terminated organopolysiloxanes, and organopolysiloxanes having vinylated branched chains.

 他の不飽和オルガノポリシロキサンとして、具体的には、例えば、ビニル末端ポリジメチルシロキサン、ビニル末端トリフルオロプロピルメチルシロキサン-ジメチルシロキサンコポリマー、ビニル末端ジエチルシロキサン-ジメチルシロキサンコポリマー、ビニルメチルシロキサン-ジメチルシロキサンコポリマー、トリメチルシロキシ末端ビニルメチルシロキサン-ジメチルシロキサンコポリマー、シラノール末端ビニルメチルシロキサン-ジメチルシロキサンコポリマー、ビニルメチルシロキサンホモポリマー、ビニルT-構造ポリマー、ビニルQ-構造ポリマー、モノビニル末端ポリジメチルシロキサン、ビニルメチルシロキサンターポリマー、及びビニルメトキシシランホモポリマーを挙げることができる。第1の不飽和オルガノポリシロキサンは、単独で又は二種以上組み合わせて使用することができる。なかでも、ビニル末端ポリジメチルシロキサンが好ましく、ビニルジメチコン(ジビニルジメチコン)がより好ましい。本開示において「末端」とは、片末端及び両末端のいずれかを意図している。これらを区別する場合には、例えば、「ビニル片末端」、「ビニル両末端」と表記することができる。 Specific examples of other unsaturated organopolysiloxanes include vinyl-terminated polydimethylsiloxane, vinyl-terminated trifluoropropylmethylsiloxane-dimethylsiloxane copolymer, vinyl-terminated diethylsiloxane-dimethylsiloxane copolymer, vinylmethylsiloxane-dimethylsiloxane copolymer, trimethylsiloxy-terminated vinylmethylsiloxane-dimethylsiloxane copolymer, silanol-terminated vinylmethylsiloxane-dimethylsiloxane copolymer, vinylmethylsiloxane homopolymer, vinyl T-structure polymer, vinyl Q-structure polymer, monovinyl-terminated polydimethylsiloxane, vinylmethylsiloxane terpolymer, and vinylmethoxysilane homopolymer. The first unsaturated organopolysiloxane can be used alone or in combination of two or more kinds. Among them, vinyl-terminated polydimethylsiloxane is preferred, and vinyl dimethicone (divinyl dimethicone) is more preferred. In this disclosure, "end" refers to either one end or both ends. When distinguishing between these, they can be written as, for example, "vinyl one-terminated" and "vinyl both-terminated".

 第1剤中における不飽和オルガノポリシロキサンの配合量としては、第1剤全体に対し、5.0質量%以上、10質量%以上、20質量%以上、25質量%以上、30質量%以上、35質量%以上、又は40質量%以上とすることができ、90質量%以下、85質量%以下、80質量%以下、75質量%以下、70質量%以下、65質量%以下、60質量%以下、55質量%以下、50質量%以下、45質量%以下、又は40質量%以下とすることができる。 The amount of unsaturated organopolysiloxane in the first agent can be 5.0% by mass or more, 10% by mass or more, 20% by mass or more, 25% by mass or more, 30% by mass or more, 35% by mass or more, or 40% by mass or more, and can be 90% by mass or less, 85% by mass or less, 80% by mass or less, 75% by mass or less, 70% by mass or less, 65% by mass or less, 60% by mass or less, 55% by mass or less, 50% by mass or less, 45% by mass or less, or 40% by mass or less, based on the entire first agent.

 第1剤が、不飽和オルガノポリシロキサンとして、フェニル基及びビニル基を有する不飽和オルガノポリシロキサンを含むとき、フェニル基及びビニル基を有する不飽和オルガノポリシロキサンの配合量は、油溶性紫外線吸収剤との相溶性、及び紫外線防御性能等の観点から、不飽和オルガノポリシロキサンの全量に対し、40質量%以上、50質量%以上、60質量%以上、70質量%以上、80質量%以上、又は90質量%以上とすることができ、100質量%以下又は100質量%未満とすることができる。 When the first agent contains an unsaturated organopolysiloxane having a phenyl group and a vinyl group as the unsaturated organopolysiloxane, the amount of the unsaturated organopolysiloxane having a phenyl group and a vinyl group can be 40% by mass or more, 50% by mass or more, 60% by mass or more, 70% by mass or more, 80% by mass or more, or 90% by mass or more relative to the total amount of the unsaturated organopolysiloxane, and can be 100% by mass or less or less than 100% by mass, from the standpoint of compatibility with the oil-soluble ultraviolet absorber and ultraviolet protection performance, etc.

(第1のヒドリド官能化ポリシロキサン)
 第1のヒドリド官能化ポリシロキサンとしては特に制限はなく、ヒドリド官能化部を有するポリシロキサン、例えば、以下の式1の化合物を挙げることができる。第1のヒドリド官能化ポリシロキサンは単独で又は二種以上組み合わせて使用することができる:
First Hydride-Functionalized Polysiloxane
The first hydride-functionalized polysiloxane is not particularly limited, and may be a polysiloxane having a hydride-functionalized moiety, such as a compound represented by the following formula 1. The first hydride-functionalized polysiloxane may be used alone or in combination of two or more kinds:

 式1中、R1b、R2b、R3b、R4b、R5b、R6b、R7b、R8b、R9b及びR10bは、それぞれ独立して、水素、C1-20アルキル、C2-20アルケニル、C5-10アリール、ヒドロキシル、又はC1-20アルコキシから選択され、m及びnは、それぞれ独立して、10~6,000の整数である。但し、R1b、R2b、R3b、R4b、R5b、R6b、R7b、R8b、R9b及びR10bの少なくとも1つは水素である。 In formula 1, R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b , R 9b and R 10b are each independently selected from hydrogen, C 1-20 alkyl, C 2-20 alkenyl, C 5-10 aryl, hydroxyl, or C 1-20 alkoxy, and m and n are each independently an integer from 10 to 6,000, provided that at least one of R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b , R 9b and R 10b is hydrogen.

 いくつかの実施態様において、R1b、R2b、R3b、R4b、R5b、R6b、R7b、R8b、R9b及びR10bの少なくとも1つは水素であり、残りはC1-20アルキルである。 In some embodiments, at least one of R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b , R 9b and R 10b is hydrogen, and the remainder are C 1-20 alkyl.

 いくつかの実施態様において、R1b、R2b、R3b、R4b、R5b、R6b、R7b、R8b、R9b及びR10bの少なくとも2つは水素である(例えば、官能化ヒドリドポリシロキサン分子当たり2個のSi-H単位)。 In some embodiments, at least two of R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b , R 9b and R 10b are hydrogen (e.g., two Si—H units per functionalized hydridopolysiloxane molecule).

 他の実施態様において、R1b、R2b、R3b、R4b、R5b、R6b、R7b、R8b、R9b及びR10bの少なくとも3つは水素(例えば、官能化ヒドリドポリシロキサン分子当たり3個のSi-H単位)である。 In other embodiments, at least three of R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b , R 9b and R 10b are hydrogen (e.g., three Si—H units per functionalized hydridopolysiloxane molecule).

 いくつかの実施態様において、R1b、R2b、R3b、R4b、R5b、R6b、R7b、R8b、R9b及びR10bの少なくとも2つは水素(例えば、官能化ヒドリドポリシロキサン分子当たり2個のSi-H単位)であり、残りはC1-20アルキルである。 In some embodiments, at least two of R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b , R 9b and R 10b are hydrogen (e.g., two Si—H units per functionalized hydridopolysiloxane molecule), and the remainder are C 1-20 alkyl.

 他の実施態様において、R1b、R2b、R3b、R4b、R5b、R6b、R7b、R8b、R9b及びR10bの少なくとも3つは水素(例えば、官能化ヒドリドポリシロキサン分子当たり3個のSi-H単位)であり、残りはC1-20アルキルである。 In other embodiments, at least three of R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b , R 9b and R 10b are hydrogen (e.g., three Si—H units per functionalized hydridopolysiloxane molecule), and the remainder are C 1-20 alkyl.

 いくつかの実施態様において、R4b、R5b、R9b及びR10bの少なくとも2つは水素(例えば、官能化ヒドリドポリシロキサン分子当たり2個のSi-H単位)であり、残りはC1-20アルキルである。 In some embodiments, at least two of R 4b , R 5b , R 9b and R 10b are hydrogen (eg, two Si—H units per functionalized hydridopolysiloxane molecule), and the remainder are C 1-20 alkyl.

 他の実施態様において、R4b、R5b、R9b及びR10bの少なくとも3つは水素(例えば、官能化ヒドリドポリシロキサン分子当たり3個のSi-H単位)であり、残りはC1-20アルキルである。 In other embodiments, at least three of R 4b , R 5b , R 9b and R 10b are hydrogen (eg, three Si—H units per functionalized hydridopolysiloxane molecule), and the remainder are C 1-20 alkyl.

 いくつかの実施態様において、m及びnの合計は、10~1,300、10~1,100、10~600、15~500、15~400、20~300、20~200、25~100、25~75、30~50、又は40~45の整数である。 In some embodiments, the sum of m and n is an integer between 10 and 1,300, between 10 and 1,100, between 10 and 600, between 15 and 500, between 15 and 400, between 20 and 300, between 20 and 200, between 25 and 100, between 25 and 75, between 30 and 50, or between 40 and 45.

 いくつかの実施態様において、第1のヒドリド官能化ポリシロキサンとして、非末端及び/又は末端で水素化されたオルガノポリシロキサンを挙げることができ、少なくとも2つのSi-H単位を分子内に有する一種以上のオルガノポリシロキサンから構成され、好ましくは、平均して少なくとも2つのSi-H単位を有し、かつ25℃で2~100,000cstの粘度を有する一種以上のオルガノポリシロキサンを挙げることができる。 In some embodiments, the first hydride-functionalized polysiloxane can be a non-terminally and/or terminally hydrogenated organopolysiloxane, which is composed of one or more organopolysiloxanes having at least two Si-H units in the molecule, and preferably one or more organopolysiloxanes having an average of at least two Si-H units and a viscosity of 2 to 100,000 cst at 25°C.

 ある実施態様では、Si-H単位を有するオルガノポリシロキサンは、このようなSi-H単位を、ポリマーの末端単位に、ポリマーの非末端モノマー単位に、又はこれらの組合せにおいて含んでもよい。なかでも、Si-H単位は、ポリマーの非末端モノマー単位に含むことが好ましい。この場合の第1のヒドリド官能化ポリシロキサンは、アルキル末端化されていてもよい。例えば、式1中、R2b及びR7bの1つ又は両方が、C1-20アルキルであってもよい。 In an embodiment, the organopolysiloxane having Si—H units may contain such Si—H units in a terminal unit of the polymer, in a non-terminal monomer unit of the polymer, or in a combination thereof. Of these, it is preferred that the Si—H units are contained in a non-terminal monomer unit of the polymer. In this case, the first hydride-functionalized polysiloxane may be alkyl-terminated. For example, in formula 1, one or both of R 2b and R 7b may be a C 1-20 alkyl.

 一実施態様において、式1中、R1b、R2b、R3b、R6b、R7b及びR8bの1つ、2つ、3つ、4つ、5つ又は6つが、C1-20アルキルであってもよい。 In one embodiment, in formula 1, one, two, three, four, five or six of R 1b , R 2b , R 3b , R 6b , R 7b and R 8b may be C 1-20 alkyl.

 一実施態様において、R1b、R2b、R3b、R4b、R5b、R6b、R7b、R8b及びR10bは、それぞれC1-20アルキル、例えば、Cアルキル(例えば、メチル)であり、R9bは水素であってもよい。 In one embodiment, R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b and R 10b are each C 1-20 alkyl, for example C 1 alkyl (for example methyl), and R 9b may be hydrogen.

 一実施態様において、R1b、R2b、R3b、R4b、R5b、R6b、R7b、R8b及びR9bは、それぞれC1-20アルキル、例えば、Cアルキル(例えば、メチル)であり、R10bは水素であってもよい。 In one embodiment, R 1b , R 2b , R 3b , R 4b , R 5b , R 6b , R 7b , R 8b and R 9b are each C 1-20 alkyl, for example C 1 alkyl (for example methyl), and R 10b may be hydrogen.

 ある実施態様では、オルガノポリシロキサン中のSi-H含有モノマー単位は、平均して、1モノマー単位以上、2モノマー単位以上、5モノマー単位以上、10モノマー単位以上、20モノマー単位以上、40モノマー単位以上、200モノマー単位以上、400モノマー単位以上、1,000モノマー単位以上、又は2,000モノマー単位以上離れていてもよい。 In some embodiments, the Si-H containing monomer units in the organopolysiloxane may be spaced apart, on average, by 1 monomer unit or more, 2 monomer units or more, 5 monomer units or more, 10 monomer units or more, 20 monomer units or more, 40 monomer units or more, 200 monomer units or more, 400 monomer units or more, 1,000 monomer units or more, or 2,000 monomer units or more.

 ある実施態様では、Si-H単位を有するオルガノポリシロキサンのSi-H含有量は、0.10mmol/g以上、0.50mmol/g以上、1.0mmol/g以上、2.0mmol/g以上、3.0mmol/g以上、又は4.0mmol/g以上にすることができ、20mmol/g以下、10mmol/g以下、9.0mmol/g以下、8.0mmol/g以下、7.0mmol/g以下、6.0mmol/g以下、又は5.0mmol/g以下にすることができる。オルガノポリシロキサン中のSi-H単位の近似モル量は、オルガノポリシロキサンの平均分子量に基づいて計算することができる。 In some embodiments, the Si-H content of the organopolysiloxane having Si-H units can be 0.10 mmol/g or more, 0.50 mmol/g or more, 1.0 mmol/g or more, 2.0 mmol/g or more, 3.0 mmol/g or more, or 4.0 mmol/g or more, and can be 20 mmol/g or less, 10 mmol/g or less, 9.0 mmol/g or less, 8.0 mmol/g or less, 7.0 mmol/g or less, 6.0 mmol/g or less, or 5.0 mmol/g or less. The approximate molar amount of Si-H units in the organopolysiloxane can be calculated based on the average molecular weight of the organopolysiloxane.

 ある実施態様では、第1のヒドリド官能化ポリシロキサンは、25℃で、2~500,000cstの粘度を有することができる。かかる粘度の下限値としては、3cst以上、4cst以上、5cst以上、10cst以上、12cst以上、15cst以上、20cst以上、25cst以上、又は30cst以上であることが好ましく、40cst以上であることがより好ましい。粘度の上限値としては、200,000cst以下、100,000cst以下、50,000cst以下、20,000cst以下、10,000cst以下、5,000cst以下、2,000cst以下、又は1,000cst以下であることが好ましく、500cst以下であることがより好ましい。ヒドリド官能化ポリシロキサンの粘度としては、25℃で、45~100cst、又は45~50cstの範囲が特に好ましい。 In one embodiment, the first hydride-functionalized polysiloxane can have a viscosity of 2 to 500,000 cst at 25° C. The lower limit of the viscosity is preferably 3 cst or more, 4 cst or more, 5 cst or more, 10 cst or more, 12 cst or more, 15 cst or more, 20 cst or more, 25 cst or more, or 30 cst or more, and more preferably 40 cst or more. The upper limit of the viscosity is preferably 200,000 cst or less, 100,000 cst or less, 50,000 cst or less, 20,000 cst or less, 10,000 cst or less, 5,000 cst or less, 2,000 cst or less, or 1,000 cst or less, and more preferably 500 cst or less. The viscosity of the hydride-functionalized polysiloxane is particularly preferably in the range of 45 to 100 cst or 45 to 50 cst at 25°C.

 ある実施態様では、ヒドリド官能化ポリシロキサンは、400~500,000Daの平均分子量を有することができる。かかる平均分子量の下限値としては、500Da以上、800Da以上、900Da以上、1,000Da以上、1,200Da以上、1,400Da以上、1,600Da以上、1,800Da以上、2,000Da以上、又は2,200Da以上であることが好ましく、2,300Da以上であることがより好ましい。平均分子量の上限値としては、250,000Da以下、140,000Da以下、100,000Da以下、72,000Da以下、62,700Da以下、60,000Da以下、50,000Da以下、49,500Da以下、36,000Da以下、28,000Da以下、25,000Da以下、20,000Da以下、15,000Da以下、10,000Da以下、5,000Da以下、又は4,000Da以下であることが好ましく、2,500Da以下であることがより好ましい。 In one embodiment, the hydride-functionalized polysiloxane can have an average molecular weight of 400 to 500,000 Da. The lower limit of the average molecular weight is preferably 500 Da or more, 800 Da or more, 900 Da or more, 1,000 Da or more, 1,200 Da or more, 1,400 Da or more, 1,600 Da or more, 1,800 Da or more, 2,000 Da or more, or 2,200 Da or more, and more preferably 2,300 Da or more. The upper limit of the average molecular weight is preferably 250,000 Da or less, 140,000 Da or less, 100,000 Da or less, 72,000 Da or less, 62,700 Da or less, 60,000 Da or less, 50,000 Da or less, 49,500 Da or less, 36,000 Da or less, 28,000 Da or less, 25,000 Da or less, 20,000 Da or less, 15,000 Da or less, 10,000 Da or less, 5,000 Da or less, or 4,000 Da or less, and more preferably 2,500 Da or less.

 第1のヒドリド官能化ポリシロキサンは、次のものに限定されないが、例えば、ヒドリド末端ポリジメチルシロキサン、ヒドリド末端ポリフェニル-(ジメチルヒドロシロキシ)シロキサン、ヒドリド末端メチルヒドロシロキサン-フェニルメチルシロキサンコポリマー、トリメチルシロキシ末端メチルヒドロシロキサン-ジメチルシロキサンコポリマー、ポリメチルヒドロシロキサン、トリメチルシロキシ末端ポリエチルヒドロシロキサン、トリエチルシロキサン、メチルヒドロシロキサン-フェニルオクチルメチルシロキサンコポリマー、及びメチルヒドロシロキサン-フェニルオクチルメチルシロキサンターポリマーからなる群から選択される少なくとも一種を採用することができる。なかでも、ヒドリド末端ポリジメチルシロキサンが好ましく、ハイドロゲンジメチコンがより好ましい。 The first hydride-functionalized polysiloxane may be, but is not limited to, at least one selected from the group consisting of hydride-terminated polydimethylsiloxane, hydride-terminated polyphenyl-(dimethylhydrosiloxy)siloxane, hydride-terminated methylhydrosiloxane-phenylmethylsiloxane copolymer, trimethylsiloxy-terminated methylhydrosiloxane-dimethylsiloxane copolymer, polymethylhydrosiloxane, trimethylsiloxy-terminated polyethylhydrosiloxane, triethylsiloxane, methylhydrosiloxane-phenyloctylmethylsiloxane copolymer, and methylhydrosiloxane-phenyloctylmethylsiloxane terpolymer. Among these, hydride-terminated polydimethylsiloxane is preferred, and hydrogen dimethicone is more preferred.

 第1剤中における第1のヒドリド官能化ポリシロキサンの配合量については特に制限はなく、例えば、第1剤全体に対し、1.0質量%以上、2.0質量%以上、3.0質量%以上、4.0質量%以上、又は4.5質量%以上とすることができ、50質量%以下、40質量%以下、30質量%以下、20質量%以下、15質量%以下、10質量%以下、8.0質量%以下、又は5.0質量%以下とすることができる。 There are no particular limitations on the amount of the first hydride-functionalized polysiloxane in the first agent, and it can be, for example, 1.0% by mass or more, 2.0% by mass or more, 3.0% by mass or more, 4.0% by mass or more, or 4.5% by mass or more relative to the entire first agent, and can be 50% by mass or less, 40% by mass or less, 30% by mass or less, 20% by mass or less, 15% by mass or less, 10% by mass or less, 8.0% by mass or less, or 5.0% by mass or less.

〈第2剤〉
 本開示の塗布型皮膜形成剤を構成する第2剤は、上述した第1剤中の架橋反応性成分を架橋させる触媒を含んでいる。本開示の第2剤は、上述したフェニル基及びビニル基を有する不飽和オルガノポリシロキサンを同様に含んでもよい。
<Second Agent>
The second agent constituting the paint-on type film-forming agent of the present disclosure contains a catalyst that crosslinks the crosslinking reactive component in the first agent described above. The second agent of the present disclosure may also contain the unsaturated organopolysiloxane having a phenyl group and a vinyl group described above.

(触媒)
 触媒としては特に制限はなく、例えば、皮膜を構成する架橋反応性成分である不飽和オルガノポリシロキサン及びヒドリド官能化ポリシロキサンに対し、物理的及び/又は化学的な架橋反応を引き起こし、促進し、又は開始させることが可能な任意の物質を挙げることができる。触媒は、プロセスの間又はプロセスの終了時に、恒久的な物理的及び/又は化学的変化を受けてもよいし、受けなくてもよい。
(catalyst)
The catalyst is not particularly limited, and may be, for example, any substance capable of causing, promoting, or initiating a physical and/or chemical crosslinking reaction of the unsaturated organopolysiloxane and hydride-functionalized polysiloxane, which are crosslinking reactive components constituting the coating. The catalyst may or may not undergo permanent physical and/or chemical changes during or at the end of the process.

 触媒は、次のものに限定されないが、体温以下で架橋を開始させ及び/又は促進することができる金属触媒、例えば、第VIII族の金属触媒、例えば、白金触媒、ロジウム触媒、パラジウム触媒、コバルト触媒、ニッケル触媒、ルテニウム触媒、オスミウム触媒、及びイリジウム触媒、並びに第IVA族の金属触媒、例えば、ゲルマニウム触媒及びスズ触媒を挙げることができる。なかでも、白金触媒、ロジウム触媒、又はスズ触媒が好ましい。触媒は、単独で又は二種以上組み合わせて使用することができる。 The catalyst may be, but is not limited to, a metal catalyst capable of initiating and/or promoting crosslinking at or below body temperature, such as Group VIII metal catalysts, for example, platinum catalysts, rhodium catalysts, palladium catalysts, cobalt catalysts, nickel catalysts, ruthenium catalysts, osmium catalysts, and iridium catalysts, and Group IVA metal catalysts, for example, germanium catalysts and tin catalysts. Of these, platinum catalysts, rhodium catalysts, and tin catalysts are preferred. The catalysts may be used alone or in combination of two or more.

 白金触媒としては、例えば、白金カルボニルシクロビニルメチルシロキサン錯体、白金ジビニルテトラメチルジシロキサン錯体、白金シクロビニルメチルシロキサン錯体、白金オクタンアルデヒド/オクタノール錯体、及び他のPt(0)触媒、例えば、カールシュテット触媒、白金-アルコール錯体、白金-アルコキシド錯体、白金-エーテル錯体、白金-アルデヒド錯体、白金-ケトン錯体、白金-ハロゲン錯体、白金-硫黄錯体、白金-窒素錯体、白金-リン錯体、白金-炭素二重結合錯体、白金炭素三重結合錯体、白金-イミド錯体、白金-アミド錯体、白金-エステル錯体、白金-リン酸エステル錯体、白金-チオールエステル錯体、白金孤立電子対錯体、白金-芳香族錯体、白金π-電子錯体、及びこれらの組合せが挙げられる。なかでも、白金カルボニルシクロビニルメチルシロキサン錯体、白金ジビニルテトラメチルジシロキサン錯体、白金シクロビニルメチルシロキサン錯体、及び白金オクタンアルデヒド/オクタノール錯体からなる群から選択される少なくとも一種が好ましい。 Platinum catalysts include, for example, platinum carbonylcyclovinylmethylsiloxane complexes, platinum divinyltetramethyldisiloxane complexes, platinum cyclovinylmethylsiloxane complexes, platinum octanaldehyde/octanol complexes, and other Pt(0) catalysts, such as Karstedt's catalyst, platinum-alcohol complexes, platinum-alkoxide complexes, platinum-ether complexes, platinum-aldehyde complexes, platinum-ketone complexes, platinum-halogen complexes, platinum-sulfur complexes, platinum-nitrogen complexes, platinum-phosphorus complexes, platinum-carbon double bond complexes, platinum-carbon triple bond complexes, platinum-imido complexes, platinum-amide complexes, platinum-ester complexes, platinum-phosphate ester complexes, platinum-thiol ester complexes, platinum lone pair complexes, platinum-aromatic complexes, platinum π-electron complexes, and combinations thereof. Among these, at least one selected from the group consisting of platinum carbonylcyclovinylmethylsiloxane complex, platinum divinyltetramethyldisiloxane complex, platinum cyclovinylmethylsiloxane complex, and platinum octanaldehyde/octanol complex is preferred.

 ロジウム触媒としては、例えば、三塩化トリス(ジブチルスルフィド)ロジウム及び三塩化ロジウム水和物が挙げられる。 Rhodium catalysts include, for example, tris(dibutylsulfide)rhodium trichloride and rhodium trichloride hydrate.

 スズ触媒としては、例えば、オクタン酸スズ(II)、ネオデカン酸スズ(II)、ジブチルスズジイソオクチルマレエート、ジ-n-ブチルビス(2,4-ペンタンジオネート)スズ、ジ-n-ブチルブトキシクロロスズ、ジブチルスズジラウレート、ジメチルスズジネオデカノエート、ジメチルヒドロキシ(オレエート)スズ、及びオレイン酸スズ(II)が挙げられる。 Examples of tin catalysts include tin(II) octanoate, tin(II) neodecanoate, dibutyltin diisooctylmaleate, di-n-butyl bis(2,4-pentanedionate)tin, di-n-butylbutoxychlorotin, dibutyltin dilaurate, dimethyltin dineodecanoate, dimethylhydroxy(oleate)tin, and tin(II) oleate.

 これらの触媒の中でも、白金触媒がより好ましく、白金ジビニルテトラメチルジシロキサン錯体(「白金ジビニルジシロキサン」と称する場合もある。)が特に好ましい。 Among these catalysts, platinum catalysts are more preferred, with platinum divinyltetramethyldisiloxane complex (sometimes called "platinum divinyldisiloxane") being particularly preferred.

 第2剤中の触媒の配合量については、要する皮膜性能等に応じて適宜調整すればよく、特に制限はない。例えば、触媒の配合量としては、第2剤の全量に対し、0.001質量%以上、0.005質量%以上、又は0.010質量%以上とすることができ、5.0質量%以下、3.0質量%以下、1.0質量%以下、0.10質量%以下、又は0.050質量%以下とすることができる。 The amount of catalyst in the second agent is not particularly limited and may be adjusted as appropriate according to the required film performance, etc. For example, the amount of catalyst may be 0.001 mass% or more, 0.005 mass% or more, or 0.010 mass% or more, and 5.0 mass% or less, 3.0 mass% or less, 1.0 mass% or less, 0.10 mass% or less, or 0.050 mass% or less, relative to the total amount of the second agent.

 本開示の第2剤の剤型としては特に制限はなく、例えば、無水の形態である油相で構成された単相系、非乳化型の水中油型若しくは油中水型の二相系の形態、又は水中油型乳化組成物若しくは油中水型乳化組成物の形態で構成された二相系であってもよい。 The formulation of the second agent of the present disclosure is not particularly limited, and may be, for example, a single-phase system composed of an oil phase in an anhydrous form, a non-emulsified oil-in-water or water-in-oil two-phase system, or a two-phase system composed of an oil-in-water emulsion composition or a water-in-oil emulsion composition.

 これらの各剤型は、触媒と、任意に、後述するような、油分、乳化剤、及び水などの公知の材料とを用い、常法によって適宜調製することができる。なお、油分としては、シリコーン油を使用することができ、このシリコーン油として、上述した第1剤で使用され得る第1の不飽和オルガノポリシロキサン及び第1のヒドリド官能化ポリシロキサンを同様に使用してもよい。この場合、第1剤中の第1の不飽和オルガノポリシロキサン及び第1のヒドリド官能化ポリシロキサンと区別するために、第2剤中の不飽和オルガノポリシロキサン及びヒドリド官能化ポリシロキサンは、第2の不飽和オルガノポリシロキサン及び第2のヒドリド官能化ポリシロキサンと称することができる。 Each of these formulations can be prepared appropriately by conventional methods using a catalyst and, optionally, known materials such as oil, emulsifier, and water, as described below. Silicone oil can be used as the oil, and the first unsaturated organopolysiloxane and the first hydride-functionalized polysiloxane that can be used in the first agent described above may be used as this silicone oil. In this case, the unsaturated organopolysiloxane and the hydride-functionalized polysiloxane in the second agent can be called the second unsaturated organopolysiloxane and the second hydride-functionalized polysiloxane to distinguish them from the first unsaturated organopolysiloxane and the first hydride-functionalized polysiloxane in the first agent.

 ある実施態様では、第2の不飽和オルガノポリシロキサン、なかでもフェニル基及びビニル基を有する不飽和オルガノポリシロキサン以外の他の不飽和オルガノポリシロキサンは、25℃で、50~165,000cstの粘度を有することができる。かかる粘度の上限値としては、150,000cst以下、100,000cst以下、80,000cst以下、50,000cst以下、30,000cst以下、又は10,000cst以下であることがより好ましく、5,000cst以下、2,000cst以下、又は1,000cst以下であることが特に好ましく、500cst以下であることが最も好ましい。かかる粘度の下限値としては、70cst以上、100cst以上、130cst以上、又は150cst以上であることが好ましい。 In one embodiment, the second unsaturated organopolysiloxane, particularly the unsaturated organopolysiloxane other than the unsaturated organopolysiloxane having a phenyl group and a vinyl group, can have a viscosity of 50 to 165,000 cst at 25°C. The upper limit of the viscosity is preferably 150,000 cst or less, 100,000 cst or less, 80,000 cst or less, 50,000 cst or less, 30,000 cst or less, or 10,000 cst or less, and more preferably 5,000 cst or less, 2,000 cst or less, or 1,000 cst or less, and most preferably 500 cst or less. The lower limit of the viscosity is preferably 70 cst or more, 100 cst or more, 130 cst or more, or 150 cst or more.

〈油溶性紫外線吸収剤〉
 本開示の塗布型皮膜形成剤は、少なくとも、フェニル基及びビニル基を有する不飽和オルガノポリシロキサンを含む第1剤及び/又は第2剤が、油溶性紫外線吸収剤を含んでいる。ここで、フェニル基及びビニル基を有する不飽和オルガノポリシロキサンが、例えば、第1剤又は第2剤のいずれかのみに含まれている場合には、かかる不飽和オルガノポリシロキサンを含まない剤に対し、油溶性紫外線吸収剤を配合しなくてもよく或いは配合してもよい。また、フェニル基及びビニル基を有する不飽和オルガノポリシロキサンが、第1剤及び第2剤の両方に含まれている場合には、油溶性紫外線吸収剤は、かかる第1剤及び第2剤のうちの少なくとも一方に含まれていればよい。したがって、本開示において、「フェニル基及びビニル基を有する不飽和オルガノポリシロキサンを含む第1剤及び第2剤が、油溶性紫外線吸収剤を含む」とは、油溶性紫外線吸収剤が、かかる第1剤及び第2剤のうちの少なくとも一方に含まれることを意図する。油溶性紫外線吸収剤は単独で又は二種以上組み合わせて使用することができる。本開示において「油溶性」とは、紫外線吸収剤を配合する第1剤及び/又は第2剤中の油分に対して溶解する性能を意図する。
<Oil-soluble UV absorber>
In the coating-type film-forming agent of the present disclosure, at least the first agent and/or the second agent containing an unsaturated organopolysiloxane having a phenyl group and a vinyl group contains an oil-soluble ultraviolet absorber. Here, when the unsaturated organopolysiloxane having a phenyl group and a vinyl group is contained in, for example, only one of the first agent or the second agent, the oil-soluble ultraviolet absorber may not be blended with the agent that does not contain such an unsaturated organopolysiloxane, or may be blended with the agent. In addition, when the unsaturated organopolysiloxane having a phenyl group and a vinyl group is contained in both the first agent and the second agent, the oil-soluble ultraviolet absorber may be contained in at least one of the first agent and the second agent. Therefore, in the present disclosure, "the first agent and the second agent containing the unsaturated organopolysiloxane having a phenyl group and a vinyl group contain an oil-soluble ultraviolet absorber" means that the oil-soluble ultraviolet absorber is contained in at least one of the first agent and the second agent. The oil-soluble ultraviolet absorber can be used alone or in combination of two or more. In the present disclosure, the term "oil-soluble" refers to the ability to dissolve in the oil in the first agent and/or the second agent in which the ultraviolet absorbent is blended.

 油溶性紫外線吸収剤のなかでも、フェニル基及びビニル基を有する不飽和オルガノポリシロキサンとの相溶性、及び紫外線防御性能等の観点から、IOBが0.10以上の紫外線吸収剤が好ましい。かかる紫外線吸収剤のIOB値は、例えば、0.10以上、0.11以上、0.12以上、又は0.13以上とすることでき、また、0.50以下、0.45以下、又は0.40以下とすることができる。ここで、IOB値とは、Inorganic/Organic Balance(無機性/有機性比)の略であって、無機性値の有機性値に対する比率を表す値であり、有機化合物の極性の度合いを示す指標となるものである。IOB値は、具体的には、IOB値=無機性値/有機性値として表される。「無機性値」、「有機性値」のそれぞれについては、例えば、分子中の炭素原子1個について「有機性値」が20、水酸基1個について「無機性値」が100といったように、各種原子又は官能基に応じた「無機性値」、「有機性値」が設定されており、有機化合物中の全ての原子及び官能基の「無機性値」、「有機性値」を積算することによって、当該有機化合物のIOB値を算出することができる(例えば、甲田善生著、「有機概念図-基礎と応用-」、p.11~17、三共出版、1984年発行参照)。 Among oil-soluble UV absorbers, UV absorbers with an IOB of 0.10 or more are preferred from the viewpoints of compatibility with unsaturated organopolysiloxanes having phenyl and vinyl groups, and UV protection performance. The IOB value of such UV absorbers can be, for example, 0.10 or more, 0.11 or more, 0.12 or more, or 0.13 or more, and can be 0.50 or less, 0.45 or less, or 0.40 or less. Here, the IOB value is an abbreviation for Inorganic/Organic Balance, which is a value that represents the ratio of the inorganic value to the organic value, and is an index that indicates the degree of polarity of an organic compound. Specifically, the IOB value is expressed as IOB value = inorganic value / organic value. For each "inorganic value" and "organic value", for example, an "organic value" of 20 for one carbon atom in a molecule and an "inorganic value" of 100 for one hydroxyl group are set according to the type of atom or functional group, and the IOB value of an organic compound can be calculated by accumulating the "inorganic value" and "organic value" of all atoms and functional groups in the organic compound (see, for example, Koda Yoshio, "Organic Conceptual Diagram - Basics and Applications", pp. 11-17, Sankyo Publishing, 1984).

 IOBが0.10以上の紫外線吸収剤としては、例えば、メトキシケイヒ酸エチルヘキシル、オクトクリレン、ポリシリコーン-15、t-ブチルメトキシジベンゾイルメタン、エチルヘキシルトリアゾン、ビスエチルヘキシルオキシフェノールメトキシフェニルトリアジン、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル、オキシベンゾン-3、メチレンビスベンゾトリアゾリルテトラメチルブチルフェノール、ホモサレート、サリチル酸エチルへキシル(「サリチル酸オクチル」と称する場合もある。)、メトキシケイ皮酸クレジル、ドロメトリゾールトリシロキサン、及びフェニレンビス-ジフェニルトリアジン等の有機系の紫外線吸収剤を挙げることができる。なかでも、フェニル基及びビニル基を有する不飽和オルガノポリシロキサンとの相溶性、及び紫外線防御性能等の観点から、オクトクリレン、t-ブチルメトキシジベンゾイルメタン、ホモサレート、及びサリチル酸エチルへキシルからなる群から選択される少なくとも一種が好ましい。 Examples of UV absorbers with an IOB of 0.10 or more include organic UV absorbers such as ethylhexyl methoxycinnamate, octocrylene, polysilicone-15, t-butyl methoxydibenzoylmethane, ethylhexyl triazone, bisethylhexyloxyphenol methoxyphenyl triazine, diethylamino hydroxybenzoyl hexyl benzoate, oxybenzone-3, methylene bisbenzotriazolyl tetramethylbutylphenol, homosalate, ethylhexyl salicylate (sometimes called "octyl salicylate"), cresyl methoxycinnamate, drometrizole trisiloxane, and phenylene bis-diphenyl triazine. Among these, at least one selected from the group consisting of octocrylene, t-butyl methoxydibenzoylmethane, homosalate, and ethylhexyl salicylate is preferred from the standpoint of compatibility with unsaturated organopolysiloxanes having phenyl and vinyl groups, and UV protection performance.

 油溶性紫外線吸収剤の配合量としては特に制限はなく、要する紫外線防御性能に応じて適宜配合することができる。油溶性紫外線吸収剤の配合量として、例えば、第1剤又は第2剤の全体に対し、1.0質量%以上、3.0質量%以上、5.0質量%以上、7.0質量%以上、10質量%以上、13質量%以上、15質量%以上、17質量%以上、又は20質量%以上とすることができ、40質量%以下、37質量%以下、35質量%以下、33質量%以下、30質量%以下、又は25質量%以下とすることができる。 There are no particular limitations on the amount of oil-soluble UV absorber blended, and it can be blended appropriately depending on the required UV protection performance. The amount of oil-soluble UV absorber blended can be, for example, 1.0% by mass or more, 3.0% by mass or more, 5.0% by mass or more, 7.0% by mass or more, 10% by mass or more, 13% by mass or more, 15% by mass or more, 17% by mass or more, or 20% by mass or more relative to the entire first or second agent, and can be 40% by mass or less, 37% by mass or less, 35% by mass or less, 33% by mass or less, 30% by mass or less, or 25% by mass or less.

〈任意成分〉
 本開示の塗布型皮膜形成剤は、第1剤及び/又は第2剤に対し、本開示の効果に悪影響を及ぼさない範囲で、各種成分を適宜配合することができる。これらの任意成分は、フェニル基及びビニル基を有する不飽和オルガノポリシロキサンを含む第1剤及び/又は第2剤に対しても配合することができる。任意成分は、単独で又は二種以上組み合わせて使用することができる。
<Optional ingredients>
In the paint-type film-forming agent of the present disclosure, various components can be appropriately blended with the first agent and/or the second agent within a range that does not adversely affect the effects of the present disclosure. These optional components can also be blended with the first agent and/or the second agent containing the unsaturated organopolysiloxane having a phenyl group and a vinyl group. The optional components can be used alone or in combination of two or more.

 任意成分としては特に制限はないが、例えば、感触改質剤、粘着改質剤、展延性促進剤、希釈剤、接着改質剤、油分、乳化剤(界面活性剤)、無機粒子、有機粒子、水、ヒューメクタント、保存料、色材(例えば顔料、染料、色素)、パール剤、マット剤、ビーズ、布、ゴム材料(例えば、シリコーンゴム等からなるゴムシート)、水相又は油相を増粘させる成分(増粘剤)、保護コロイド剤、皮膚透過促進剤、光学改質剤、散乱剤、吸着剤、磁気材料、気体輸送改質剤、液体輸送改質剤、pH改質剤、増感改質剤、及び審美的改質剤を挙げることができる。 The optional components are not particularly limited, but examples include feel modifiers, adhesion modifiers, spreadability promoters, diluents, adhesion modifiers, oils, emulsifiers (surfactants), inorganic particles, organic particles, water, humectants, preservatives, coloring materials (e.g., pigments, dyes, colorants), pearling agents, matting agents, beads, cloth, rubber materials (e.g., rubber sheets made of silicone rubber, etc.), components that thicken the water or oil phase (thickeners), protective colloids, skin permeation promoters, optical modifiers, scattering agents, adsorbents, magnetic materials, gas transport modifiers, liquid transport modifiers, pH modifiers, sensitization modifiers, and aesthetic modifiers.

 この他、例えば、保湿剤、皮膚保護剤、皮膚鎮静剤、皮膚美白剤、皮膚光沢剤、皮膚軟化剤、皮膚平滑化剤、皮膚漂白剤、皮膚角質除去剤、皮膚引き締め剤、美容剤、ビタミン、抗酸化剤、細胞シグナル伝達剤、細胞調節剤、細胞相互作用剤、皮膚日焼け剤、老化防止剤、しわ防止剤、スポットリデューサー、α-ヒドロキシ酸、β-ヒドロキシ酸、及びセラミドなどの化粧剤を挙げることができ;また、例えば、疼痛緩和剤、鎮痛薬、抗掻痒剤、抗座瘡剤(例えば、β-ヒドロキシ酸、サリチル酸、過酸化ベンゾイル)、抗炎症剤、抗ヒスタミン薬、コルチコステロイド、NSAID(非ステロイド性抗炎症薬)、防腐剤、抗生物質、抗細菌剤、抗真菌剤、抗ウイルス剤、抗アレルギー剤、抗刺激物質、虫除け剤、光線療法剤、血液凝固剤、抗新生物薬、免疫系増進剤、免疫系抑制剤、コールタール、アントラリン、フルオシノニド、メトトレキセート、シクロスポリン、ピメクロリムス、タクロリムス、アザチオプリン、フルオロウラシル、セラミド、反対刺激剤、及び皮膚冷却化合物などの治療剤を挙げることができ;また、例えば、抗酸化剤、ビタミン、ビタミンD類似体、レチノイド、ミネラル、ミネラルオイル、ワセリン、脂肪酸、植物抽出物、ポリペプチド、抗体、タンパク質、糖、ヒューメクタント、及びエモリエント剤を挙げることができる。 Other examples of the skin care products include cosmetic agents such as moisturizers, skin protectants, skin soothing agents, skin whitening agents, skin brighteners, skin softeners, skin smoothing agents, skin bleaching agents, skin exfoliants, skin tightening agents, beauty agents, vitamins, antioxidants, cell signaling agents, cell regulating agents, cell interacting agents, skin tanning agents, anti-aging agents, anti-wrinkle agents, spot reducers, alpha-hydroxy acids, beta-hydroxy acids, and ceramides; and other cosmetic agents such as pain relievers, analgesics, anti-pruritic agents, anti-acne agents (e.g., beta-hydroxy acids, salicylic acid, benzoyl peroxide), anti-inflammatory agents, anti Included may be therapeutic agents such as histamines, corticosteroids, NSAIDs (nonsteroidal anti-inflammatory drugs), antiseptics, antibiotics, antibacterials, antifungals, antivirals, antiallergy agents, anti-irritants, insect repellents, phototherapy agents, blood clotting agents, antineoplastic agents, immune system enhancers, immune system suppressants, coal tar, anthralin, fluocinonide, methotrexate, cyclosporine, pimecrolimus, tacrolimus, azathioprine, fluorouracil, ceramides, counterirritants, and skin cooling compounds; and may include, for example, antioxidants, vitamins, vitamin D3 analogs, retinoids, minerals, mineral oils, petrolatum, fatty acids, plant extracts, polypeptides, antibodies, proteins, sugars, humectants, and emollients.

 ここで、任意成分のうちのいくつかの主要な材料について以下に詳細に記載する。 Here, some of the main optional ingredients are described in detail below.

(油分)
 油分としては、例えば、液体油脂、固体油脂、ロウ類、炭化水素油、エステル油、シリコーン油、及び、上述した油溶性紫外線吸収剤以外の極性油を挙げることができる。油分は、不揮発性油であってもよく、揮発性油であってもよい。油分は単独で又は二種以上組み合わせて使用することができる。ここで、「揮発性」とは、大気圧下、105℃で3時間放置したときの揮発分が5%超を呈するものを意図する。かかる揮発分としては、10%以上、20%以上、40%以上、50%以上、60%以上、80%以上、又は100%と規定することもできる。あるいは、揮発性の指針として、1気圧(101.325kPa)下における沸点を使用することができる。この沸点は、250℃以下、240℃以下、又は230℃以下とすることができ、また、80℃以上、100℃以上、120℃以上、150℃以上、又は160℃以上とすることができる。また、本開示において「不揮発性」とは、105℃で3時間放置したときの揮発分が5%以下を呈するものを意図する。
(Oil content)
Examples of the oil include liquid oils and fats, solid oils and fats, waxes, hydrocarbon oils, ester oils, silicone oils, and polar oils other than the above-mentioned oil-soluble UV absorbers. The oil may be a non-volatile oil or a volatile oil. The oil may be used alone or in combination of two or more. Here, "volatile" refers to an oil that exhibits a volatile content of more than 5% when left at atmospheric pressure and 105°C for 3 hours. Such a volatile content can be specified as 10% or more, 20% or more, 40% or more, 50% or more, 60% or more, 80% or more, or 100%. Alternatively, the boiling point at 1 atmosphere (101.325 kPa) can be used as an indicator of volatility. This boiling point can be 250°C or less, 240°C or less, or 230°C or less, and can be 80°C or more, 100°C or more, 120°C or more, 150°C or more, or 160°C or more. In addition, in the present disclosure, "non-volatile" refers to a material that exhibits a volatile content of 5% or less when left at 105°C for 3 hours.

 例えば、シリコーン油としては、上述した不飽和オルガノポリシロキサン及びヒドリド官能化ポリシロキサン以外のシリコーン油を使用することができる。このようなシリコーン油として、例えば、ジメチルポリシロキサン(ジメチコン)、メチルフェニルポリシロキサン、メチルハイドロジェンポリシロキサン等の鎖状シリコーン;ジフェニルシロキシフェニルトリメチコン、オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサシロキサン等の環状シリコーンなどを使用することができる。シリコーン油は、フェニル基及びビニル基を有する不飽和オルガノポリシロキサンと相溶しやすいため、フェニル基及びビニル基を有する不飽和オルガノポリシロキサンを含む第1剤及び/又は第2剤に対して好適に配合することができる。 For example, silicone oils other than the above-mentioned unsaturated organopolysiloxanes and hydride-functionalized polysiloxanes can be used as the silicone oil. Examples of such silicone oils that can be used include linear silicones such as dimethylpolysiloxane (dimethicone), methylphenylpolysiloxane, and methylhydrogenpolysiloxane; and cyclic silicones such as diphenylsiloxyphenyltrimethicone, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, and dodecamethylcyclohexasiloxane. Silicone oils are easily compatible with unsaturated organopolysiloxanes having phenyl and vinyl groups, and can therefore be suitably blended with the first agent and/or the second agent that contains unsaturated organopolysiloxanes having phenyl and vinyl groups.

 油分(例えばシリコーン油)の配合量としては特に制限はなく、例えば、採用する剤型の種類、要する皮膜強度などに応じて適宜配合することができる。油分(例えばシリコーン油)の配合量として、例えば、第1剤又は第2剤の全体に対し、5.0質量%以上、7.0質量%以上、10質量%以上、15質量%以上、20質量%以上、23質量%以上、25質量%以上、27質量%以上、又は30質量%以上とすることができ、60質量%以下、57質量%以下、55質量%以下、50質量%以下、45質量%以下、40質量%以下、35質量%以下、30質量%以下、25質量%以下、又は20質量%以下とすることができる。 The amount of oil (e.g., silicone oil) to be blended is not particularly limited, and can be blended appropriately depending on, for example, the type of formulation used, the required film strength, etc. The amount of oil (e.g., silicone oil) to be blended can be, for example, 5.0% by mass or more, 7.0% by mass or more, 10% by mass or more, 15% by mass or more, 20% by mass or more, 23% by mass or more, 25% by mass or more, 27% by mass or more, or 30% by mass or more relative to the entire first or second agent, and can be 60% by mass or less, 57% by mass or less, 55% by mass or less, 50% by mass or less, 45% by mass or less, 40% by mass or less, 35% by mass or less, 30% by mass or less, 25% by mass or less, or 20% by mass or less.

(無機粒子)
 本開示の塗布型皮膜形成剤における第1剤及び第2剤の少なくとも一方は、無機粒子を含み得る。なかでも、フェニル基及びビニル基を有する不飽和オルガノポリシロキサンと油溶性紫外線吸収剤を含む第1剤及び/又は第2剤に対して無機粒子を配合すると、紫外線防御性能をより向上させることができる。無機粒子は単独で又は二種以上組み合わせて使用することができる。
(Inorganic particles)
At least one of the first agent and the second agent in the coating-type film-forming agent of the present disclosure may contain inorganic particles. In particular, when inorganic particles are blended with the first agent and/or the second agent containing the unsaturated organopolysiloxane having a phenyl group and a vinyl group and the oil-soluble ultraviolet absorber, the ultraviolet protection performance can be further improved. The inorganic particles can be used alone or in combination of two or more kinds.

 紫外線防御性能をより向上させる観点から、無機粒子は、無機酸化物粒子であることが好ましい。無機粒子は、疎水化処理された粒子(疎水性無機粒子)のみ若しくは未処理粒子(例えば親水性無機粒子)のみを使用してもよく、又は疎水化処理された粒子(疎水性無機粒子)と未処理粒子(例えば親水性無機粒子)を併用してもよい。 From the viewpoint of further improving the UV protection performance, the inorganic particles are preferably inorganic oxide particles. As for the inorganic particles, only hydrophobically treated particles (hydrophobic inorganic particles) or only untreated particles (e.g., hydrophilic inorganic particles) may be used, or hydrophobically treated particles (hydrophobic inorganic particles) and untreated particles (e.g., hydrophilic inorganic particles) may be used in combination.

 無機酸化物粒子を構成する無機酸化物としては、例えば、酸化亜鉛、酸化チタン、酸化アルミニウム、及び酸化ケイ素(例えば、フュームドシリカ及び無水シリカ)を挙げることができる。なかでも、紫外線防御性能をより向上させる観点から、酸化ケイ素、酸化チタン、及び酸化亜鉛からなる群から選択される少なくとも一種が好ましく、酸化ケイ素がより好ましい。 Examples of inorganic oxides constituting the inorganic oxide particles include zinc oxide, titanium oxide, aluminum oxide, and silicon oxide (e.g., fumed silica and anhydrous silica). Among these, from the viewpoint of further improving the UV protection performance, at least one selected from the group consisting of silicon oxide, titanium oxide, and zinc oxide is preferred, and silicon oxide is more preferred.

 疎水化無機粒子(疎水性無機粒子)は、典型的には、表面処理剤で疎水化処理された無機粒子を使用することができる。疎水化処理としては特に制限はなく、例えば、シリル化処理、ジメチルシリル化処理、及びトリメチルシリル化処理からなる群から選択される少なくとも一種を挙げることができる。 The hydrophobic inorganic particles can typically be inorganic particles that have been hydrophobized with a surface treatment agent. There are no particular limitations on the hydrophobization treatment, and examples of the treatment include at least one selected from the group consisting of silylation treatment, dimethylsilylation treatment, and trimethylsilylation treatment.

 無機粒子(例えば無機酸化物粒子又は疎水化無機酸化物粒子)の配合量としては、紫外線防御性能をより向上させる観点から、例えば、第1剤又は第2剤の全体に対し、0.1質量%以上、0.5質量%以上、1.0質量%以上、2.0質量%以上、3.0質量%以上、4.0質量%以上、4.5質量%以上、又は5.0質量%以上とすることができ、20質量%以下、15質量%以下、10質量%以下、7.0質量%以下、又は5.0質量%以下とすることができる。 The amount of inorganic particles (e.g., inorganic oxide particles or hydrophobized inorganic oxide particles) can be, for example, 0.1% by mass or more, 0.5% by mass or more, 1.0% by mass or more, 2.0% by mass or more, 3.0% by mass or more, 4.0% by mass or more, 4.5% by mass or more, or 5.0% by mass or more relative to the entire first or second agent, and can be 20% by mass or less, 15% by mass or less, 10% by mass or less, 7.0% by mass or less, or 5.0% by mass or less, from the viewpoint of further improving the UV protection performance.

(乳化剤)
 乳化剤としては、例えば、アニオン性、カチオン性、両性、又は非イオン性の乳化剤を使用することができる。乳化剤は単独で又は二種以上組み合わせて使用することができる。ここで、本開示における乳化剤とは、乳化機能(界面活性能)を有する剤を意図し、一般に界面活性剤と称する剤も包含することができる。
(emulsifier)
As the emulsifier, for example, anionic, cationic, amphoteric, or nonionic emulsifiers can be used. The emulsifiers can be used alone or in combination of two or more. Here, the emulsifier in the present disclosure refers to an agent having an emulsifying function (surface activity), and can also include agents generally called surfactants.

 具体的には、乳化剤として、例えば、炭化水素系界面活性剤、シリコーン系界面活性剤、及び両親媒性粉末からなる群から選択される少なくとも一種を挙げることができる。 Specific examples of the emulsifier include at least one selected from the group consisting of hydrocarbon surfactants, silicone surfactants, and amphiphilic powders.

 炭化水素系界面活性剤としては、例えば、ポリオキシエチレンアルキルエーテル、ポリオキシエチレンステリルエーテル、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレン多価アルコール脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンソルビタン脂肪酸エステル、グリコール脂肪酸エステル、グリセリン脂肪酸エステル、ソルビタン脂肪酸エステル、ショ糖脂肪酸エステル、及びポリグリセリン脂肪酸エステルを挙げることができる。 Examples of hydrocarbon surfactants include polyoxyethylene alkyl ethers, polyoxyethylene steryl ethers, polyoxyethylene fatty acid esters, polyoxyethylene polyhydric alcohol fatty acid esters, polyoxyethylene hydrogenated castor oil, polyoxyethylene sorbitan fatty acid esters, glycol fatty acid esters, glycerin fatty acid esters, sorbitan fatty acid esters, sucrose fatty acid esters, and polyglycerin fatty acid esters.

 シリコーン系界面活性剤としては、例えば、ポリエーテル変性シリコーン、及びアルキル共変性ポリエーテル変性シリコーンを挙げることができる。 Examples of silicone surfactants include polyether-modified silicone and alkyl-co-modified polyether-modified silicone.

 乳化剤の配合量としては特に制限はなく、例えば、乳化安定性等の観点から、第1剤又は第2剤の全量に対し、0.01質量%以上、0.05質量%以上、0.1質量%以上、又は0.2質量%以上とすることができる。乳化剤の配合量の上限値としては特に制限はなく、例えば、5.0質量%以下、4.0質量%以下、3.0質量%以下、2.0質量%以下、1.0質量%以下、又は0.5質量%以下とすることができる。 There is no particular limit to the amount of emulsifier used, and from the standpoint of emulsion stability, for example, it can be 0.01% by mass or more, 0.05% by mass or more, 0.1% by mass or more, or 0.2% by mass or more relative to the total amount of the first or second agent. There is no particular limit to the upper limit of the amount of emulsifier used, and it can be, for example, 5.0% by mass or less, 4.0% by mass or less, 3.0% by mass or less, 2.0% by mass or less, 1.0% by mass or less, or 0.5% by mass or less.

(水)
 水としては特に制限はなく、例えば、化粧料又は医薬部外品において使用される水を使用することができる。例えば、イオン交換水、蒸留水、超純水、及び水道水を使用することができる。
(water)
The water is not particularly limited, and for example, water used in cosmetics or quasi-drugs can be used, such as ion-exchanged water, distilled water, ultrapure water, and tap water.

 水の配合量としては特に制限はなく、例えば、採用する剤型の種類等に応じて適宜調整することができる。 There are no particular limitations on the amount of water to be added, and it can be adjusted as appropriate depending on, for example, the type of formulation used.

《塗布型皮膜形成剤の使用方法》
 本開示の塗布型皮膜形成剤の使用方法としては特に制限はなく、例えば、以下のいずれかの工程を含み得る。なお、かかる方法によれば、例えば、顔などに対して化粧も施し得るため、該方法は、化粧方法と称することもできる。また、本開示の塗布型皮膜形成剤の使用方法には、人間を手術、治療又は診断する方法は包含しない:
 第1剤を対象部位に適用して第1剤層を形成した後に、該第1剤層上に第2剤を適用し、皮膜を形成する、又は、
 第2剤を対象部位に適用して第2剤層を形成した後に、該第2剤層上に第1剤を適用し、皮膜を形成する、又は
 第1剤及び第2剤を混合して混合物を調製した後に、該混合物を対象部位に適用し、被膜を形成する。
How to use the coating agent
The method of using the applied-type film-forming agent of the present disclosure is not particularly limited, and may include, for example, any of the following steps. Note that, according to this method, for example, makeup can be applied to the face, and therefore the method can also be called a makeup method. In addition, the method of using the applied-type film-forming agent of the present disclosure does not include methods for surgery, treatment, or diagnosis of humans:
Applying the first agent to the target site to form a first agent layer, and then applying the second agent onto the first agent layer to form a coating, or
The second agent is applied to the target area to form a second agent layer, and then the first agent is applied onto the second agent layer to form a film; or, the first agent and the second agent are mixed to prepare a mixture, and then the mixture is applied to the target area to form a film.

 むらの少ない均一な皮膜を得る観点から、かかる使用方法としては、第1剤を対象部位に適用して第1剤層を形成した後に、この第1剤層上に第2剤を適用し、架橋させて皮膜を形成する方法が好ましい。ここで、第1剤、及び第2剤については、上述した材料を同様に使用することができる。 From the viewpoint of obtaining a uniform coating with few unevenness, the preferred method of use is to apply the first agent to the target area to form a first agent layer, and then apply the second agent onto this first agent layer and crosslink it to form a coating. Here, the materials described above can be used for the first agent and the second agent in the same way.

 この方法は、1回で済ませてもよく、或いは、形成した皮膜に対して、かかる方法を複数回(例えば2回以上又は3回以上)実施してもよい。複数回実施する場合には、該方法は、例えば、以下のいずれかの操作を含み得る:
 形成した皮膜に対して第1剤を適用して第1剤層を形成した後に、該第1剤層上に第2剤を適用し、皮膜をさらに形成する操作、又は、
 形成した皮膜に対して第2剤を適用して第2剤層を形成した後に、該第2剤層上に第1剤を適用し、皮膜をさらに形成する操作、又は
 第1剤及び第2剤を混合して混合物を調製した後に、形成した皮膜に対して混合物を適用し、皮膜をさらに形成する操作。
This method may be performed once, or may be performed multiple times (e.g., two or more times, or three or more times) on the formed coating. When performed multiple times, the method may include, for example, any of the following operations:
Applying a first agent to the formed coating to form a first agent layer, and then applying a second agent onto the first agent layer to further form a coating; or
An operation of applying a second agent to the formed coating to form a second agent layer, and then applying a first agent onto the second agent layer to further form a coating; or an operation of mixing the first agent and the second agent to prepare a mixture, and then applying the mixture to the formed coating to further form a coating.

 いくつかの実施態様では、第1剤、第2剤、又は第1剤及び第2剤を含む混合物を対象部位に適用する前に、化粧料を対象部位に適用してもよく;第1剤を対象部位に適用して第1剤層を形成し、該第1剤層上に化粧料を適用した後に、該化粧料を覆うように前記第2剤を適用してもよく;第2剤を対象部位に適用して第2剤層を形成し、該第2剤層上に化粧料を適用した後に、該化粧料を覆うように第1剤を適用してもよく;又は、皮膜を形成した後に、該皮膜に化粧料を適用してもよい。 In some embodiments, a cosmetic may be applied to the target site before applying the first agent, the second agent, or a mixture containing the first agent and the second agent to the target site; a first agent may be applied to the target site to form a first agent layer, a cosmetic may be applied onto the first agent layer, and the second agent may then be applied to cover the cosmetic; a second agent may be applied to the target site to form a second agent layer, a cosmetic may be applied onto the second agent layer, and the first agent may then be applied to cover the cosmetic; or a film may be formed, and then a cosmetic may be applied to the film.

 化粧料としては特に制限はなく、例えば、美容液、化粧水、乳液等のスキンケア化粧料、サンスクリーン化粧料(日焼け止め化粧料)、下地用化粧料、若しくはファンデーション、グロス、口紅、アイシャドー、マニキュア等のメイクアップ化粧料、又はこれらの化粧料の機能を2つ以上複合した化粧料を使用することができる。 There are no particular limitations on the cosmetics, and examples of the cosmetics that can be used include skin care cosmetics such as serums, lotions, and emulsions, sunscreen cosmetics (sun protection cosmetics), base cosmetics, or make-up cosmetics such as foundations, glosses, lipsticks, eye shadows, and nail polishes, or cosmetics that combine the functions of two or more of these cosmetics.

 また、いくつかの実施態様において、本開示の塗布型皮膜形成剤の使用方法は、美容方法として利用することもできる。例えば、乾燥にさらされた皮膚は、知らず知らずのうちに水分が奪われ、肌表面の角質層の水分量が保てない状態になる場合がある。肌の水分が足りなくなると、肌自らがつくりだす保湿成分(天然保湿因子:Natural Moisturizing Factor (NMF))がうまくつくりだせなくなる。その結果、肌表面におけるバリア機能及び保湿機能が低下し、肌はダメージを受けやすくなるため、うるおいを失って肌あれ等を引き起こすと考えられている。 Furthermore, in some embodiments, the method of using the applied film-forming agent of the present disclosure can also be used as a cosmetic method. For example, when skin is exposed to dryness, moisture is unknowingly lost, and the stratum corneum on the skin surface may not be able to maintain its moisture content. When the skin does not have enough moisture, it is no longer able to effectively produce the moisturizing components (Natural Moisturizing Factors (NMFs)) that it produces itself. As a result, the barrier function and moisturizing function of the skin surface are reduced, making the skin more susceptible to damage, which is thought to cause a loss of moisture and lead to rough skin, etc.

 一方、例えば皮膚に対して本開示の塗布型皮膜形成剤による皮膜を適用すると、肌に対して有害な紫外線を防御することができるとともに、皮膜によるオクルージョン効果(肌から水分が抜けることを防ぐ効果)によって皮膚を良好に保湿することができる。その結果、例えば、肌自らがつくりだす保湿成分の生成機能が改善されるとともに、角質層におけるターンオーバーの不調も改善されるため肌あれ等のトラブルが生じがたくなり、美容効果を高めることができる。なお、「美容方法」とは、本開示の塗布型皮膜形成剤を対象部位に適用して皮膜を形成し、対象部位(例えば皮膚)の状態を美しく整えることを意味し、人間を手術、治療又は診断する方法とは相違する。 On the other hand, for example, when a film made from the applied film-forming agent of the present disclosure is applied to the skin, it is possible to protect the skin from harmful ultraviolet rays, and the occlusion effect of the film (the effect of preventing moisture from escaping from the skin) allows the skin to be well moisturized. As a result, for example, the skin's own production function of moisturizing ingredients is improved, and turnover problems in the stratum corneum are also improved, making skin problems such as roughness less likely to occur, and improving the beauty effect. Note that a "beauty method" refers to applying the applied film-forming agent of the present disclosure to a target site to form a film and improve the condition of the target site (for example, skin), and is different from a method of surgery, treatment, or diagnosis of humans.

 対象部位、化粧料適用層、又は第1剤層若しくは第2剤層に対し、第1剤又は第2剤を適用する方法としては特に制限はなく、例えば、指などで塗り広げる手段、スプレー塗布、転写などを採用することができる。 There are no particular limitations on the method for applying the first or second agent to the target area, the cosmetic application layer, or the first or second agent layer, and for example, methods such as spreading with fingers, spray application, transfer, etc. can be used.

 また、例えば、第1剤及び/又は第2剤が水と油に分離しているときは、第1剤と第2剤との架橋反応性、及び皮膜内における油溶性紫外線吸収剤の分散性等の観点から、これらの剤を振とうして強制的に二相系(水中油型又は油中水型)にすることが好ましい。 In addition, for example, when the first agent and/or the second agent are separated into water and oil, it is preferable to shake these agents to forcibly make them into a two-phase system (oil-in-water type or water-in-oil type) from the viewpoint of the crosslinking reactivity between the first agent and the second agent, and the dispersibility of the oil-soluble UV absorber in the coating.

〈対象部位〉
 本開示の塗布型皮膜形成剤は、体のあらゆる部分、例えば皮膚の表面に対して適用することができる。本開示の塗布型皮膜形成剤は、例えば、頭(例えば頭皮など)、顔(例えば唇、目元、鼻、頬、額など)、首、耳、手、腕、脚、足、胸、腹、背中、臀部、爪、体毛(例えば髪の毛、まつ毛、眉毛、髭など)等に対して適宜適用することができる。
<Target area>
The applied film-forming agent of the present disclosure can be applied to any part of the body, for example, the surface of the skin. The applied film-forming agent of the present disclosure can be appropriately applied to, for example, the head (e.g., scalp, etc.), face (e.g., lips, eyes, nose, cheeks, forehead, etc.), neck, ears, hands, arms, legs, feet, chest, abdomen, back, buttocks, nails, body hair (e.g., hair, eyelashes, eyebrows, beard, etc.), etc.

《塗布型皮膜形成剤を備えるキット》
 本開示の塗布型皮膜形成剤は、かかる形成剤を構成する上述した第1剤及び第2剤を有するキットとして提供することができる。キットは、第1剤及び第2剤以外に、例えば、第1剤などを対象部位へ塗布しやすくするための部材、上述した各種化粧料などの任意の部材を有していてもよく、或いは、任意の部材と組み合わせて用いてもよい。
<<Kit with a coating-type film-forming agent>>
The paint-type film-forming agent of the present disclosure can be provided as a kit having the above-mentioned first and second agents constituting the agent. In addition to the first and second agents, the kit may have optional components such as a component for facilitating application of the first agent, etc. to a target site, the various cosmetics described above, or the kit may be used in combination with optional components.

 任意の部材としては、例えば、使用説明書、へら状のアプリケータ、刷毛、綿棒、カッター、ハサミ、上述した各種化粧料、形成した皮膜を対象部位から除去するためのリムーバー、鏡等を挙げることができる。ここで、「使用説明書」とは、キット内に書類の形態で添付されている一般的な使用説明書以外に、例えば、キットを収容する包装容器、又は第1剤等を注入するチューブ等の包装容器に対して使用説明文が印字された状態のものも包含することができる。 Optional components include, for example, an instruction manual, a spatula-shaped applicator, a brush, a cotton swab, a cutter, scissors, the various cosmetics mentioned above, a remover for removing the formed film from the target area, a mirror, etc. Here, "instructions for use" can include not only general instructions for use that are attached in the form of a document within the kit, but also instructions for use printed on, for example, the packaging container that contains the kit, or the packaging container such as a tube for injecting the first agent, etc.

 ある実施態様では、キットは、第1剤及び第2剤の接触を防止するために、例えば、これらの剤が、別々の容器に内包されていてもよく、又は2つ以上の区画を有する容器の各区画内に別々に内包されていてもよい。また、これらの内包されている剤は、1度に1つずつ適用されるように構成されてもよく、又は使用前若しくは使用時に一緒に混合されるように構成されてもよい。 In some embodiments, the kit may include, for example, the first and second agents packaged in separate containers or in separate compartments of a container having two or more compartments to prevent contact between the first and second agents. The packaged agents may be configured to be applied one at a time or to be mixed together before or during use.

 ある実施態様では、キットは、形成した皮膜を対象部位から除去するためのリムーバーと組み合わせて使用することができる。ここで「組み合わせて使用する」とは、キットとリムーバーを一体として使用すること、すなわち、キット内にリムーバーを内包させること、又は、キットとリムーバーを別体として使用することを含む。例えば、個人に最適な塗布型皮膜形成剤とリムーバーを提供できることから、塗布型皮膜形成剤を備えるキットと、リムーバーとは別体として組み合わせて使用することが好ましい。 In one embodiment, the kit can be used in combination with a remover for removing the formed film from the target site. Here, "use in combination" includes using the kit and remover as an integrated unit, i.e., including the remover in the kit, or using the kit and remover separately. For example, it is preferable to use a kit including a coat-type film-forming agent in combination with a separate remover, since it is possible to provide an optimal coat-type film-forming agent and remover for each individual.

〈リムーバー〉
 本開示の塗布型皮膜形成剤によって対象部位に形成された皮膜は、以下に示す特定のリムーバーを用いると、対象部位から好適に除去することができる。本開示の特定のリムーバーを用いた場合には、皮膜の強度を低下させることがないため、皮膜を破ることなく対象部位から一度に剥がすことができる。従来の日焼け止め化粧料は、例えば皮膚に適用した化粧料を皮膚から除去する場合には、洗浄料などを用いて洗い流す作業などが必要であった。一方、本開示の塗布型皮膜形成剤による皮膜は、このような作業を要せずに、より簡易に紫外線防御性能を呈する皮膜を対象部位(例えば皮膚)から剥がすことができる。
Remover
The film formed on the target site by the applied film-forming agent of the present disclosure can be suitably removed from the target site by using the specific remover shown below. When the specific remover of the present disclosure is used, the strength of the film is not reduced, so the film can be peeled off from the target site in one go without breaking. For example, when a conventional sunscreen cosmetic is applied to the skin and then removed from the skin, it is necessary to wash it off with a detergent or the like. On the other hand, the film formed by the applied film-forming agent of the present disclosure does not require such a procedure, and the film exhibiting ultraviolet protection performance can be peeled off from the target site (e.g., skin) more easily.

 いくつかの実施形態において、本開示の塗布型皮膜形成剤によって形成された皮膜の除去に使用される好適なリムーバーは、重量平均分子量が300以上800以下の炭化水素油、及び重量平均分子量が260以上400以下である極性油からなる群から選択される少なくとも一種を含む。皮膜を好適に除去する観点から、かかる炭化水素油と極性油は併用することが好ましい。 In some embodiments, a suitable remover used to remove a film formed by the applied film-forming agent of the present disclosure contains at least one selected from the group consisting of a hydrocarbon oil having a weight-average molecular weight of 300 or more and 800 or less, and a polar oil having a weight-average molecular weight of 260 or more and 400 or less. From the viewpoint of effectively removing the film, it is preferable to use such a hydrocarbon oil and a polar oil in combination.

(炭化水素油)
 炭化水素油の重量平均分子量は、皮膜を好適に除去する観点から、320以上、又は350以上であることが好ましく、380以上であることがより好ましく、また、750以下又は700以下であることが好ましく、690以下であることがより好ましい。炭化水素油は、単独で又は二種以上組み合わせて使用することができる。
(Hydrocarbon oil)
From the viewpoint of suitably removing the film, the weight average molecular weight of the hydrocarbon oil is preferably 320 or more, or 350 or more, and more preferably 380 or more, and is preferably 750 or less, or 700 or less, and more preferably 690 or less. The hydrocarbon oils can be used alone or in combination of two or more kinds.

 炭化水素油の種類としては特に制限はなく、例えば、流動パラフィン(ミネラルオイル)、オレフィンオリゴマー及びその水素添加物(例えば水添ポリデセン)、並びにスクワランを挙げることができる。 The type of hydrocarbon oil is not particularly limited, and examples include liquid paraffin (mineral oil), olefin oligomers and their hydrogenated products (e.g., hydrogenated polydecene), and squalane.

 炭化水素油の配合量としては特に制限はなく、例えば、皮膜を好適に除去する観点から、リムーバーを構成する組成物の全量に対し、1.0質量%以上、5.0質量%以上、10質量%以上、20質量%以上、又は30質量%以上とすることができる。配合量の上限値としては特に制限はなく、例えば、100質量%以下、100質量%未満、80質量%以下、70質量%以下、60質量%以下、又は50質量%以下とすることができる。 The amount of hydrocarbon oil is not particularly limited, and from the viewpoint of effectively removing the film, it can be, for example, 1.0 mass% or more, 5.0 mass% or more, 10 mass% or more, 20 mass% or more, or 30 mass% or more relative to the total amount of the composition constituting the remover. There is no particular upper limit to the amount, and it can be, for example, 100 mass% or less, less than 100 mass%, 80 mass% or less, 70 mass% or less, 60 mass% or less, or 50 mass% or less.

(極性油)
 極性油の重量平均分子量は、皮膜を好適に除去する観点から、265以上又は270以上であることが好ましく、また、390以下、380以下、又は370以下あることが好ましい。極性油のIOB値は、皮膜を好適に除去する観点から、0.12以上又は0.13以上であることが好ましく、また、1.48以下、1.47以下、又は1.46以下であることが好ましい。極性油は、単独で又は二種以上組み合わせて使用することができる。
(polar oil)
From the viewpoint of suitable removal of the film, the weight average molecular weight of the polar oil is preferably 265 or more or 270 or more, and preferably 390 or less, 380 or less, or 370 or less. From the viewpoint of suitable removal of the film, the IOB value of the polar oil is preferably 0.12 or more or 0.13 or more, and preferably 1.48 or less, 1.47 or less, or 1.46 or less. The polar oils may be used alone or in combination of two or more kinds.

 極性油の種類としては特に制限はなく、例えば、エステル油を挙げることができる。その具体例としては、ミリスチン酸イソプロピル(IOB値=0.18)、エチルヘキサン酸エチルヘキシル(IOB値=0.20)、安息香酸アルキル(C12-15)(IOB値=0.18)、コハク酸ジエチルヘキシル(IOB値=0.32)、ジヘプタン酸ネオペンチルグリコール(IOB値=0.33)、トリ(カプリル酸/カプリン酸)グリセリル(IOB値=0.28)、及びジピバリン酸PPG-3(IOB値=1.46)、パルミチン酸オクチル(IOB値=0.13)を挙げることができる。 There are no particular limitations on the type of polar oil, and examples include ester oils. Specific examples include isopropyl myristate (IOB value = 0.18), ethylhexyl ethylhexanoate (IOB value = 0.20), alkyl benzoate (C12-15) (IOB value = 0.18), diethylhexyl succinate (IOB value = 0.32), neopentyl glycol diheptanoate (IOB value = 0.33), tri(caprylic acid/capric acid)glyceryl (IOB value = 0.28), PPG-3 dipivalate (IOB value = 1.46), and octyl palmitate (IOB value = 0.13).

 極性油の配合量としては特に制限はなく、例えば、皮膜を好適に除去する観点から、リムーバーを構成する組成物の全量に対し、1.0質量%以上、5.0質量%以上、10質量%以上、15質量%以上、又は20質量%以上とすることができる。配合量の上限値としては特に制限はなく、例えば、100質量%以下、100質量%未満、80質量%以下、70質量%以下、60質量%以下、又は50質量%以下とすることができる。 There is no particular limit to the amount of polar oil blended, and from the viewpoint of effectively removing the film, for example, it can be 1.0 mass% or more, 5.0 mass% or more, 10 mass% or more, 15 mass% or more, or 20 mass% or more relative to the total amount of the composition constituting the remover. There is no particular limit to the upper limit of the blended amount, and it can be, for example, 100 mass% or less, less than 100 mass%, 80 mass% or less, 70 mass% or less, 60 mass% or less, or 50 mass% or less.

(任意成分)
 本開示のリムーバーは、皮膜の除去効果に悪影響を及ぼさない範囲で、各種成分を適宜配合することができる。各種成分としては、例えば、界面活性剤(乳化剤)、保湿剤、増粘剤、水溶性高分子、油溶性高分子、皮膜形成剤、高級脂肪酸、金属イオン封鎖剤、低級アルコール、高級アルコール、多価アルコール、変性アルコール、各種抽出液、糖、アミノ酸、有機アミン、高分子エマルジョン、キレート剤、紫外線吸収剤、pH調整剤、皮膚栄養剤、ビタミン、医薬品、医薬部外品、化粧品等に適用可能な水溶性薬剤、緩衝剤、退色防止剤、酸化防止剤、防腐剤、分散剤、噴射剤、充填剤、顔料、染料、色素、香料、水、上記以外の他の油分を挙げることができる。任意成分は単独で又は二種以上組み合わせて使用することができる。
(optional ingredient)
The remover of the present disclosure can be appropriately blended with various components within a range that does not adversely affect the film removal effect. Examples of various components include surfactants (emulsifiers), moisturizers, thickeners, water-soluble polymers, oil-soluble polymers, film-forming agents, higher fatty acids, sequestering agents, lower alcohols, higher alcohols, polyhydric alcohols, denatured alcohols, various extracts, sugars, amino acids, organic amines, polymer emulsions, chelating agents, UV absorbers, pH adjusters, skin nutrients, vitamins, water-soluble drugs applicable to medicines, quasi-drugs, cosmetics, etc., buffers, color-fading inhibitors, antioxidants, preservatives, dispersants, propellants, fillers, pigments, dyes, colorings, fragrances, water, and other oils other than those mentioned above. Optional components can be used alone or in combination of two or more.

 本開示のリムーバーは、上記の炭化水素油及び極性油以外の他の油分を含み得る。しかしながら、シリコーン油は、皮膜の強度を低下させるおそれがあり、その結果、皮膜の除去性能を低下させるおそれがある。したがって、シリコーン油の配合量としては、皮膜を好適に除去する観点から、リムーバーを構成する組成物の全量に対し、10質量%以下、5.0質量%以下、1.0質量%以下、0.5質量%以下、又は0.1質量%以下とすることが好ましく、また、シリコーン油はリムーバーを構成する組成物に含まれないことがより好ましい。 The remover of the present disclosure may contain oils other than the above-mentioned hydrocarbon oils and polar oils. However, silicone oils may reduce the strength of the film, and as a result, may reduce the film removal performance. Therefore, from the viewpoint of effectively removing the film, the amount of silicone oil is preferably 10 mass % or less, 5.0 mass % or less, 1.0 mass % or less, 0.5 mass % or less, or 0.1 mass % or less relative to the total amount of the composition constituting the remover, and it is more preferable that silicone oil is not included in the composition constituting the remover.

〈リムーバーの使用方法〉
 リムーバーの使用方法としては特に制限はない。一般的には、リムーバーは、対象部位に形成した皮膜の一部又は全体に塗布し、任意にこするなどして使用することができる。そして、対象部位から剥がれた皮膜を指などで引っ張ることによって皮膜を除去することができる。
How to use the remover
There is no particular limitation on the method of using the remover. In general, the remover can be applied to a part or the whole of the film formed on the target site, and then optionally rubbed. Then, the film can be removed by pulling the film that has peeled off from the target site with a finger or the like.

《皮膜》
〈厚さ〉
 上述した本開示の塗布型皮膜形成剤を用いて形成した皮膜の厚さとしては特に制限はなく、例えば、紫外線防御性能、通気性、不可視性、対象部位(例えば皮膚)に対する閉塞性、審美性等を考慮して適宜調整することができる。皮膜の厚さとしては、例えば、0.5μm以上、1μm以上、10μm以上、30μm以上、又は40μm以上にすることができる。厚さの上限値については特に制限はないが、例えば、150μm以下、100μm以下、90μm以下、80μm以下、70μm以下、60μm以下、又は50μm以下にすることができる。ここで、厚さは、高精度デジマチックマイクロメータ(MDH-25MB、株式会社ミツトヨ製)を使用し、皮膜の任意の部分の厚さを5回測定して算出した平均値として定義することができる。
Membrane
<Thickness>
The thickness of the film formed using the coating-type film-forming agent of the present disclosure described above is not particularly limited, and can be appropriately adjusted in consideration of, for example, UV protection performance, breathability, invisibility, occlusion to the target site (e.g., skin), aesthetics, etc. The thickness of the film can be, for example, 0.5 μm or more, 1 μm or more, 10 μm or more, 30 μm or more, or 40 μm or more. There is no particular limit to the upper limit of the thickness, but it can be, for example, 150 μm or less, 100 μm or less, 90 μm or less, 80 μm or less, 70 μm or less, 60 μm or less, or 50 μm or less. Here, the thickness can be defined as the average value calculated by measuring the thickness of any part of the film five times using a high-precision digital micrometer (MDH-25MB, manufactured by Mitutoyo Corporation).

〈紫外線防御性能〉
 上述した本開示の塗布型皮膜形成剤を用いて形成した皮膜は、優れた紫外線防御性能(紫外線吸収能)を呈することができる。かかる性能は、後述する吸光度積算値を用いて算出される紫外線防御性能の向上率によって評価することができる。本開示の皮膜は、130%超、135%以上、140%以上、143%以上、145%以上、147%以上、又は150%以上の向上率を呈することができる。かかる向上率の上限値としては、例えば、250%以下、230%以下、又は200%以下を達成することができる。
<Ultraviolet protection performance>
The coating film formed using the coating-type coating agent of the present disclosure can exhibit excellent ultraviolet protection performance (ultraviolet light absorption ability). Such performance can be evaluated by the improvement rate of ultraviolet protection performance calculated using the absorbance integrated value described below. The coating film of the present disclosure can exhibit an improvement rate of more than 130%, 135% or more, 140% or more, 143% or more, 145% or more, 147% or more, or 150% or more. The upper limit of such improvement rate can be, for example, 250% or less, 230% or less, or 200% or less.

 以下に実施例を挙げて、本発明についてさらに詳しく説明を行うが、本発明はこれらに限定されるものではない。なお、以下、特に断りのない限り、配合量は質量%で示す。また、実施例に記載される評価方法は、実施例に記載される形成剤及び該形成剤によって形成された皮膜に限らず、上述した形成剤及び該形成剤によって形成された皮膜に対しても同様に採用することができる。 The present invention will be described in more detail below with reference to examples, but the present invention is not limited to these. Unless otherwise specified, the blend amounts are shown in mass %. The evaluation methods described in the examples are not limited to the forming agents and films formed by the forming agents described in the examples, but can be similarly applied to the above-mentioned forming agents and films formed by the forming agents.

《評価試験》
 下記の製造方法により得た各試験サンプルを用いて以下に示す各試験を実施し、その結果を表2に示す。
Evaluation Test
The following tests were carried out using the test samples obtained by the manufacturing methods described below, and the results are shown in Table 2.

〈皮膜形成性試験〉
 手の甲に試験サンプルの第1剤及び第2剤を順に塗布し、5分後に、塗布した部位を指で触り、指で触っても剥がれないような皮膜が形成されているかを確認した。表には、このような皮膜が形成されている場合を「合格」、このような皮膜が形成されていない場合を「不合格」と表記した。
<Film-forming property test>
The first and second agents of the test sample were applied to the back of the hand in that order, and after 5 minutes, the applied area was touched with a finger to confirm whether a film that would not peel off when touched with a finger had been formed. In the table, the case where such a film was formed is indicated as "passed," and the case where such a film was not formed is indicated as "failed."

〈紫外線防御試験〉
 測定プレート(Sプレート)(5×5cmのV溝PMMA板、SPFMASTER-PA01)に、試験サンプルの第1剤を1mg/cmの量で滴下し、略均一に指で塗り広げて第1剤層を形成した後、この第1剤層上に試験サンプルの第2剤を1mg/cmの量で滴下し、略均一に指で塗り広げて皮膜を形成した。形成した皮膜の吸光度を、株式会社日立製作所製のU-3500型自記録分光光度計を用いて測定した。ここで、無塗布のプレートをコントロールとした。吸光度(Abs)を以下の式2により算出し、280nm~400nmにおける測定値を積算し、吸光度積算値を求めた:
 Abs=-log(T/To)   …式2
  T:サンプルの透過率、To:無塗布のプレートの透過率
<UV protection test>
The first agent of the test sample was dropped in an amount of 1 mg/ cm2 onto a measurement plate (S plate) (5 x 5 cm V-groove PMMA plate, SPFMASTER-PA01), and the first agent layer was formed by spreading it almost evenly with a finger. Then, the second agent of the test sample was dropped on the first agent layer in an amount of 1 mg/ cm2 , and the second agent was spread almost evenly with a finger to form a film. The absorbance of the formed film was measured using a Hitachi Ltd. U-3500 self-recording spectrophotometer. Here, an uncoated plate was used as a control. The absorbance (Abs) was calculated according to the following formula 2, and the measured values at 280 nm to 400 nm were integrated to obtain the integrated absorbance value:
Abs=-log(T/To)...Formula 2
T: transmittance of sample, To: transmittance of uncoated plate

 求めたサンプルの吸光度積算値から、対照試料を基準とする紫外線防御性能の向上率を以下の式3により算出した。なお、向上率は、数値が高いほど、紫外線防御性能に優れると言える。また、対照試料としては、比較例4のサンプルを採用した。比較例1のサンプルは紫外線吸収剤を含んでおらず、比較例2及び3のサンプルは皮膜を形成できなかったため、紫外線防御試験を実施しなかった:
 紫外線防御性能の向上率(%)=[サンプルの吸光度積算値]/[対照試料の吸光度積算値]×100   …式3
From the obtained integrated absorbance values of the samples, the improvement rate of the UV protection performance based on the control sample was calculated using the following formula 3. It can be said that the higher the improvement rate, the better the UV protection performance. The sample of Comparative Example 4 was used as the control sample. The sample of Comparative Example 1 did not contain an ultraviolet absorber, and the samples of Comparative Examples 2 and 3 could not form a film, so the UV protection test was not performed:
Improvement rate (%) of UV protection performance = [integrated absorbance value of sample] / [integrated absorbance value of control sample] × 100 ... formula 3

《試験例》
 本試験例における各試験サンプルを、以下の方法にしたがって調製した。本試験例では、フェニル基及びビニル基を有する不飽和オルガノポリシロキサンが及ぼす油溶性紫外線吸収剤の影響について検討した。その結果を表2に示す。なお、表2中の「Mw」は、重量平均分子量を意図し、「フェニル基のモル数/ビニル基のモル数」は、フェニル基を有する不飽和オルガノポリシロキサンにおけるビニル基のモル数に対するフェニル基のモル数を意図する。
Test Example
Each test sample in this test example was prepared according to the following method. In this test example, the influence of an oil-soluble UV absorber on an unsaturated organopolysiloxane having a phenyl group and a vinyl group was examined. The results are shown in Table 2. In Table 2, "Mw" refers to the weight average molecular weight, and "moles of phenyl groups/moles of vinyl groups" refers to the moles of phenyl groups relative to the moles of vinyl groups in the unsaturated organopolysiloxane having a phenyl group.

〈比較例1〉
(第1剤)
 第1の不飽和オルガノポリシロキサンとして粘度が165,000cstのビニルジメチコン24.3質量部、第1のヒドリド官能化ポリシロキサンとしてハイドロゲンジメチコン4.7質量部、及び揮発性ジメチコン71.0質量部を均一に混合して第1剤を調製した。
Comparative Example 1
(First Agent)
A first agent was prepared by uniformly mixing 24.3 parts by weight of vinyl dimethicone having a viscosity of 165,000 cst as the first unsaturated organopolysiloxane, 4.7 parts by weight of hydrogen dimethicone as the first hydride-functionalized polysiloxane, and 71.0 parts by weight of volatile dimethicone.

(第2剤)
 表1の処方成分を均一に混合して第2剤を調製した。
(Second Agent)
The ingredients in Table 1 were mixed uniformly to prepare a second agent.

〈実施例1~9及び比較例2~8〉
 第1剤における各成分及びその配合量を表2に記載されるものに変更したこと以外は、比較例1と同様にして第1剤を調製した。第2剤は比較例1と同一のものを使用した。
Examples 1 to 9 and Comparative Examples 2 to 8
A first agent was prepared in the same manner as in Comparative Example 1, except that the components and their amounts in the first agent were changed to those shown in Table 2. The second agent used was the same as in Comparative Example 1.

〈結果〉
 表2の結果から明らかなように、例えば、フェニル基を有さない不飽和オルガノポリシロキサンを用いた構成の比較例5~7、及びフェニル基を特定の割合で含まない不飽和オルガノポリシロキサンを用いた構成の比較例8に比べ、フェニル基を特定の割合で含む不飽和オルガノポリシロキサンを用いた構成の実施例1~9の方が、紫外線防御性能が向上することが分かった。
<result>
As is clear from the results in Table 2, for example, it was found that Examples 1 to 9, which were configured using an unsaturated organopolysiloxane containing phenyl groups in a specific proportion, had improved UV protection performance compared to Comparative Examples 5 to 7, which were configured using an unsaturated organopolysiloxane that did not contain phenyl groups in a specific proportion, and Comparative Example 8, which was configured using an unsaturated organopolysiloxane that did not contain phenyl groups in a specific proportion.

Claims (14)

 皮膜を構成する架橋反応性成分を含む第1剤、及び前記架橋反応性成分を架橋させる触媒を含む第2剤を含む、塗布型皮膜形成剤であって、
 前記第1剤及び/又は前記第2剤が、フェニル基及びビニル基を有する不飽和オルガノポリシロキサンを含み、かつ、前記フェニル基及びビニル基を有する不飽和オルガノポリシロキサンを含む前記第1剤及び/又は前記第2剤が、油溶性紫外線吸収剤を含み、
 前記フェニル基及びビニル基を有する不飽和オルガノポリシロキサンは、前記ビニル基のモル数に対する前記フェニル基のモル数が、0.40以下である、
塗布型皮膜形成剤。
A coating-type film-forming agent comprising a first agent containing a crosslinkable reactive component that constitutes a coating, and a second agent containing a catalyst that crosslinks the crosslinkable reactive component,
the first agent and/or the second agent contains an unsaturated organopolysiloxane having a phenyl group and a vinyl group, and the first agent and/or the second agent containing the unsaturated organopolysiloxane having a phenyl group and a vinyl group contains an oil-soluble ultraviolet absorber,
In the unsaturated organopolysiloxane having a phenyl group and a vinyl group, the molar ratio of the phenyl group to the molar ratio of the vinyl group is 0.40 or less.
A paint-type film-forming agent.
 前記第1剤が、第1の不飽和オルガノポリシロキサン及び第1のヒドリド官能化ポリシロキサンからなる群から選択される少なくとも一種を含み、
 前記第1剤が、前記第1の不飽和オルガノポリシロキサン及び前記第1のヒドリド官能化ポリシロキサンのうち、前記第1の不飽和オルガノポリシロキサンのみを含む場合には、前記第2剤は、前記第2のヒドリド官能化ポリシロキサンを含み、
 前記第1剤が、前記第1の不飽和オルガノポリシロキサン及び前記第1のヒドリド官能化ポリシロキサンのうち、前記第1のヒドリド官能化ポリシロキサンのみを含む場合には、前記第2剤は、前記第2の不飽和オルガノポリシロキサンを含み、
 前記第1の不飽和オルガノポリシロキサン及び前記第2の不飽和オルガノポリシロキサンのうちの少なくとも一方が、前記フェニル基及びビニル基を有する不飽和オルガノポリシロキサンを含む、請求項1に記載の形成剤。
the first agent comprises at least one selected from the group consisting of a first unsaturated organopolysiloxane and a first hydride-functionalized polysiloxane;
When the first agent contains only the first unsaturated organopolysiloxane among the first unsaturated organopolysiloxane and the first hydride-functionalized polysiloxane, the second agent contains the second hydride-functionalized polysiloxane;
When the first agent contains only the first hydride-functionalized polysiloxane among the first unsaturated organopolysiloxane and the first hydride-functionalized polysiloxane, the second agent contains the second unsaturated organopolysiloxane;
2. The forming agent according to claim 1, wherein at least one of the first unsaturated organopolysiloxane and the second unsaturated organopolysiloxane comprises the unsaturated organopolysiloxane having a phenyl group and a vinyl group.
 前記油溶性紫外線吸収剤が、IOBが0.10以上の紫外線吸収剤を含む、請求項1又は2に記載の形成剤。 The forming agent according to claim 1 or 2, wherein the oil-soluble UV absorber includes an UV absorber having an IOB of 0.10 or more.  前記第1剤が、前記フェニル基及びビニル基を有する不飽和オルガノポリシロキサン及び前記油溶性紫外線吸収剤を含む、請求項1又は2に記載の形成剤。 The forming agent according to claim 1 or 2, wherein the first agent contains the unsaturated organopolysiloxane having a phenyl group and a vinyl group and the oil-soluble ultraviolet absorber.  前記フェニル基及びビニル基を有する不飽和オルガノポリシロキサンは、前記ビニル基のモル数に対する前記フェニル基のモル数が、0.0040以上である、請求項1又は2に記載の形成剤。 The forming agent according to claim 1 or 2, wherein the unsaturated organopolysiloxane having phenyl groups and vinyl groups has a molar ratio of the phenyl groups to the molar ratio of the vinyl groups of 0.0040 or more.  前記フェニル基及びビニル基を有する不飽和オルガノポリシロキサンの重量平均分子量が、100,000以下である、請求項1又は2に記載の形成剤。 The forming agent according to claim 1 or 2, wherein the weight average molecular weight of the unsaturated organopolysiloxane having a phenyl group and a vinyl group is 100,000 or less.  前記フェニル基及びビニル基を有する不飽和オルガノポリシロキサンを含む前記第1剤及び/又は前記第2剤が、シリコーン油を含む、請求項1又は2に記載の形成剤。 The forming agent according to claim 1 or 2, wherein the first agent and/or the second agent containing the unsaturated organopolysiloxane having a phenyl group and a vinyl group contains silicone oil.  前記フェニル基及びビニル基を有する不飽和オルガノポリシロキサンを含む前記第1剤及び/又は前記第2剤が、無機粒子を含む、請求項1又は2に記載の形成剤。 The forming agent according to claim 1 or 2, wherein the first agent and/or the second agent containing the unsaturated organopolysiloxane having a phenyl group and a vinyl group contains inorganic particles.  前記フェニル基及びビニル基を有する不飽和オルガノポリシロキサンが、ビニル末端ジフェニルシロキサン-ジメチルシロキサンコポリマー、ビニル末端ポリフェニルメチルシロキサン、及びビニルフェニルメチル末端ビニルフェニルシロキサン-フェニルメチルシロキサンコポリマーからなる群から選択される少なくとも一種である、請求項1又は2に記載の形成剤。 The forming agent according to claim 1 or 2, wherein the unsaturated organopolysiloxane having a phenyl group and a vinyl group is at least one selected from the group consisting of vinyl-terminated diphenylsiloxane-dimethylsiloxane copolymer, vinyl-terminated polyphenylmethylsiloxane, and vinylphenylmethyl-terminated vinylphenylsiloxane-phenylmethylsiloxane copolymer.  前記第1のヒドリド官能化ポリシロキサン及び前記第2のヒドリド官能化ポリシロキサンが、非末端及び/又は末端で水素化されたオルガノポリシロキサンである、請求項2に記載の形成剤。 The forming agent according to claim 2, wherein the first hydride-functionalized polysiloxane and the second hydride-functionalized polysiloxane are non-terminally and/or terminally hydrogenated organopolysiloxanes.  前記第1のヒドリド官能化ポリシロキサン及び前記第2のヒドリド官能化ポリシロキサンが、ヒドリド末端ポリジメチルシロキサン、ヒドリド末端ポリフェニル-(ジメチルヒドロシロキシ)シロキサン、ヒドリド末端メチルヒドロシロキサン-フェニルメチルシロキサンコポリマー、トリメチルシロキシ末端メチルヒドロシロキサン-ジメチルシロキサンコポリマー、ポリメチルヒドロシロキサン、トリメチルシロキシ末端ポリエチルヒドロシロキサン、トリエチルシロキサン、メチルヒドロシロキサン-フェニルオクチルメチルシロキサンコポリマー、及びメチルヒドロシロキサン-フェニルオクチルメチルシロキサンターポリマーからなる群から選択される少なくとも一種である、請求項10に記載の形成剤。 The forming agent according to claim 10, wherein the first hydride-functionalized polysiloxane and the second hydride-functionalized polysiloxane are at least one member selected from the group consisting of hydride-terminated polydimethylsiloxane, hydride-terminated polyphenyl-(dimethylhydrosiloxy)siloxane, hydride-terminated methylhydrosiloxane-phenylmethylsiloxane copolymer, trimethylsiloxy-terminated methylhydrosiloxane-dimethylsiloxane copolymer, polymethylhydrosiloxane, trimethylsiloxy-terminated polyethylhydrosiloxane, triethylsiloxane, methylhydrosiloxane-phenyloctylmethylsiloxane copolymer, and methylhydrosiloxane-phenyloctylmethylsiloxane terpolymer.  前記触媒が、白金触媒、ロジウム触媒、及びスズ触媒からなる群から選択される少なくとも一種である、請求項1又は2に記載の形成剤。 The forming agent according to claim 1 or 2, wherein the catalyst is at least one selected from the group consisting of platinum catalysts, rhodium catalysts, and tin catalysts.  前記触媒が、白金触媒であり、かつ、該白金触媒が、白金カルボニルシクロビニルメチルシロキサン錯体、白金ジビニルテトラメチルジシロキサン錯体、白金シクロビニルメチルシロキサン錯体、及び白金オクタンアルデヒド/オクタノール錯体からなる群から選択される少なくとも一種である、請求項12に記載の形成剤。 The forming agent according to claim 12, wherein the catalyst is a platinum catalyst, and the platinum catalyst is at least one selected from the group consisting of platinum carbonylcyclovinylmethylsiloxane complex, platinum divinyltetramethyldisiloxane complex, platinum cyclovinylmethylsiloxane complex, and platinum octanaldehyde/octanol complex.  請求項1又は2に記載の形成剤における前記第1剤及び前記第2剤が、別々の容器に内包されている、又は2つ以上の区画を有する容器の各区画内に別々に内包されている、キット。 A kit in which the first agent and the second agent in the forming agent according to claim 1 or 2 are contained in separate containers, or are contained separately in each compartment of a container having two or more compartments.
PCT/JP2024/039102 2023-11-17 2024-11-01 Film-forming agent for application and kit including said forming agent Pending WO2025105223A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2023-196132 2023-11-17
JP2023196132 2023-11-17

Publications (1)

Publication Number Publication Date
WO2025105223A1 true WO2025105223A1 (en) 2025-05-22

Family

ID=95742472

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2024/039102 Pending WO2025105223A1 (en) 2023-11-17 2024-11-01 Film-forming agent for application and kit including said forming agent

Country Status (1)

Country Link
WO (1) WO2025105223A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015532659A (en) * 2012-08-01 2015-11-12 ダウ コーニング コーポレーションDow Corning Corporation Aqueous silicone dispersion and film and preparation thereof
US20170189317A1 (en) * 2015-12-31 2017-07-06 L'oreal Compositions and methods for improving the appearance of the skin
JP2019085388A (en) * 2017-03-17 2019-06-06 信越化学工業株式会社 Organic group-modified organosilicon resin and method of preparing the same, and cosmetics containing the organic group-modified organosilicon resin
WO2022215531A1 (en) * 2021-04-07 2022-10-13 株式会社 資生堂 Oil-in-water composition for second agent for coating-type body corrective film formation agent

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015532659A (en) * 2012-08-01 2015-11-12 ダウ コーニング コーポレーションDow Corning Corporation Aqueous silicone dispersion and film and preparation thereof
US20170189317A1 (en) * 2015-12-31 2017-07-06 L'oreal Compositions and methods for improving the appearance of the skin
JP2019085388A (en) * 2017-03-17 2019-06-06 信越化学工業株式会社 Organic group-modified organosilicon resin and method of preparing the same, and cosmetics containing the organic group-modified organosilicon resin
WO2022215531A1 (en) * 2021-04-07 2022-10-13 株式会社 資生堂 Oil-in-water composition for second agent for coating-type body corrective film formation agent

Similar Documents

Publication Publication Date Title
JP4647190B2 (en) Cosmetic composition using polyethersiloxane copolymer network composition
JP5139899B2 (en) Polyethersiloxane copolymer network composition
JP5725709B2 (en) Acrylate-crosslinked silicone copolymer network.
EP3223775B1 (en) Hydroalcoholic or aqueous gel of synthetic phyllosilicates as a thickening, mattifying and/or application homogenising agent
EP2841488B1 (en) Liquid aryl group-containing polyorganosiloxane
CN105452342B (en) The derivative modified organosilicon of diglycerol containing long chain hydrocarbon groups and its application
US20240156692A1 (en) Oil-in-water composition for second agent for coating-type body corrective film formation agent
JP2009535407A (en) Cosmetic composition utilizing a network of acrylate cross-linked silicone copolymers
JP2009516025A (en) Swellable silicone composition and preparation method thereof
US10806691B2 (en) Organopolysiloxane, acid-neutralized salt thereof, and applications thereof
WO2022215533A1 (en) Second agent of coating-type body corrective film-forming agent comprising first and second agents, and lubricant layer-forming agent to be applied to body corrective film
WO2022124079A1 (en) Oil-in-water type emulsion composition containing platinum catalyst and method of using same
US20180064630A1 (en) Pituitous silicone fluid composition
CN108623810B (en) A kind of organosilicon cross-linked polymer and its preparation method and application
JP7257147B2 (en) Crosslinked polyorganosiloxane and personal care compositions containing same
WO2021223652A1 (en) Cosmetic product and making-up method
WO2025105223A1 (en) Film-forming agent for application and kit including said forming agent
US20240358624A1 (en) Application type body-correcting-film forming agent
WO2024142934A1 (en) Application-type coating formation agent and kit that includes said formation agent
JP6832853B2 (en) Cosmetic composition and preparation method
WO2024154597A1 (en) Oil-in-water composition for second agent of coating-type film-forming agent
WO2022030284A1 (en) Base coat agent for coating-type body corrective film and method for using same
WO2025105304A1 (en) Coating-type film-forming agent, kit including said forming agent, and method of using said forming agent
JP2025119949A (en) Cosmetic and application-type film-forming cosmetic containing said cosmetic
WO2024090246A1 (en) Lip application-type film-forming agent and method for using said film-forming agent

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 24891262

Country of ref document: EP

Kind code of ref document: A1